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resumo 
 
 
A lesão traumática da medula espinal é um evento devastador que leva à perda 
de funções neurológicas abaixo do nível vertebral da lesão. Devido à falta de 
capacidade regenerativa dos neurónios adultos do sistema nervoso central, 
quando lesionados, as consequências das lesões são parcial ou totalmente 
irreversíveis. A falta de capacidade de regeneração dos neurónios do SNC tem 
sido estudada há anos, mas ainda não foi encontrado um tratamento efetivo para 
esta patologia; apenas os esteroides são validados e reconhecidos como um 
tratamento farmacológico, mas só limitam a extensão da lesão. Este trabalho 
centrou-se na procura de genes hipoteticamente envolvidos em regeneração do 
sistema nervoso, que possam ser candidatos a alvos de terapia para lesões na 
medula. Foi realizada uma análise bioinformática baseada em estudos com 
modelos de roedores com lesão da medula espinal, onde uma tentativa de 
tratamento regenerativo foi aplicada e observou-se recuperação funcional, e 
foram levantados os genes regulados comuns aos três estudos. Os genes KIF4A 
e MPP3 foram destacados para estudos experimentais adicionais num modelo 
regenerativo: um modelo de roedor, de lesão do sistema nervoso periférico, com 
esmagamento ou corte do nervo ciático. Os resultados demonstraram que os 
genes KIF4A e MPP3 são expressos e regulados no nervo ciático lesionado e 
nos gânglios da raiz dorsal correspondentes. Além disso, estes genes também 
mostraram distribuição proteica em secções de tecido de medula espinhal, de 
nervo ciático e em cortes de DRG, desvendando que possam ser específicos de 
tecido neuronal. Estes resultados representam observações importantes para 
instigar estudos adicionais sobre o papel destes genes nos processos 
regenerativos de tecidos neuronais lesionados e a possibilidade de se tornarem 
alvos terapêuticos importantes para lesões ou patologias relacionadas que 
afetem a integridade da medula espinal. 
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abstract 
 
Traumatic spinal cord injury (SCI) is a devastating event that leads to loss of 
neurological functions below the vertebral level of the lesion. As adult neurons 
from central nervous system (CNS) fail to regenerate when injured, the 
consequences of SCI are partially or totally irreversible. The lack of regeneration 
ability of CNS neurons has been studied for years but still no effective treatment 
was found for this pathology; only steroids are validated and recognized as a 
pharmacologic treatment attempt, but just limit the lesion extent. This work 
focused on finding putative candidate genes involved in regeneration that could 
be targeted for therapy. A bioinformatics analysis based on studies with rodent 
SCI models, where a regenerative treatment attempt was applied and functional 
recovery was observed, was performed and some common regulated genes 
were found in the analysed studies. KIF4A and MPP3 genes were highlighted for 
further experimental studies in a regenerative model: a rodent model of 
peripheral nervous system (PNS) injury, with crush or transection of the sciatic 
nerve. Our results demonstrated that KIF4A and MPP3 are expressed and 
regulated in the lesioned sciatic nerve and in the corresponding dorsal root 
ganglia (DRG). Moreover, these genes also showed protein distribution in spinal 
cord tissue sections, in sciatic nerve and in DRG cuts, revealing that they are 
neuronal specific. These results represent important remarks to instigate further 
studies regarding the role of these genes in regenerative processes of lesioned 
neuronal tissues and the possibility of becoming important therapeutic targets in 
spinal cord injuries or related pathologies affecting the spinal cord integrity. 
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1.1.	Nervous	system	anatomy	
The	nervous	system	is	divided	in	central	and	peripheral	structures.	The	peripheral	structures	
are	the	12	pairs	of	cranial	nerves	and	31	pairs	of	spinal	nerves,	which	are	located	outside	of	the	bone	
structures	that	protect	the	central	neuronal	structures.	It	has	sensory	(afferent)	and	motor	(efferent)	
components.	Sensory	neurons	connect	the	sensory	receptors	in	skin,	muscle	and	joints	with	circuits	
in	the	central	nervous	system	(CNS).	The	motor	components	consist	of	two	types:	the	motor	neurons	
that	connect	the	brain	and	the	spinal	cord	(SC)	to	skeletal	muscles	(somatic	motor	system)	and	the	
neuronal	cells	that	connect	the	cardiac	muscle,	smooth	muscles	and	glands	(autonomic	or	visceral	
motor	system)	(1).	
The	 CNS	 consists	 of	 the	 SC	 and	 the	 brain	 (brainstem,	 cerebellum,	 diencephalon,	 and	
telencephalon)	 that	 are	 protected	 by	 the	 vertebrate	 spinal	 column	 and	 the	 cranial	 bones,	
respectively	(1,2).	
1.1.1.	Neuroanatomical	terminology	
In	 Figure	 1	 are	 represented	 the	 different	 axes	 and	 orientation	 planes	 used	 to	 describe	
anatomical	structures	of	brain	and	spinal	cord.	The	orientation	of	the	components	of	the	nervous	
system	is	described	based	on	three	axes:	horizontal,	coronal	and	sagittal.	In	SC,	rostral	means	toward	
the	head	and	caudal	means	toward	the	coccix	(in	humans)	or	toward	the	tail	(in	animals	like	rats	and	
mice).	Ventral	(anterior)	means	toward	the	belly,	and	dorsal	(posterior)	means	toward	the	back	(2).		
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Figure	1.	Organizational	axes	of	brain	and	spinal	cord.	A)	In	the	SC,	rostral	means	toward	the	head	and	caudal	
means	toward	the	coccix/tail;	B)	Ventral	or	anterior	means	toward	the	belly,	and	dorsal	or	posterior	means	
toward	the	back;	C)	Anatomical	planes	are	organized	in	3	axes:	horizontal,	coronal	and	sagittal.	Adapted	from	
(3).	
1.1.2.	Cellular	components	of	the	nervous	system	
Nervous	system	cells	can	be	divided	into	two	categories:	neurons	and	supporting	cells	called	
neuroglia.	Neurons	have	the	basic	components	of	a	cell	but	vary	in	the	cytoskeleton	structure;	actin,	
tubulin,	 and	 myosin	 are	 organized	 in	 a	 specialized	 way	 to	 support	 synaptic	 junctions.	 These	
combined	 with	 vesicular	 motor	 and	 scaffolding	 proteins	 are	 essential	 to	 the	 growth,	 trafficking	
events	and	positioning	of	membrane	components	of	axons	and	dendrites.	These	proteins	are	also	
important	 for	 processes	 of	 exocytosis	 and	 endocytosis,	 fundamental	 processes	 for	 synapses.	
Synaptic	 communication	 is	 a	 cellular	 specialization	 that	 allows	 the	 transformation	 of	 electrical	
information	that	runs	along	the	dendrites	and	axons,	into	chemical	messages.	Dendrites	receive	the	
B1	
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synaptic	input	from	other	neurons	and	axons	carry	it	to	the	next	neuron.	Axons	that	run	from	the	
human	spinal	cord	to	the	foot	can	reach	about	a	meter	of	length	(1).	
Glial	cells	are	neuronal	cells	with	different	features	from	neurons,	are	more	numerous	and	
do	not	participate	directly	in	synapses	and	electrical	communication,	but	have	supportive	functions.	
There	 are	 three	 varieties	 of	 neuroglial	 cells	 (Figure	 2):	 astrocytes	 that	 have	 a	 physical	 support	
function,	oligodendrocytes	that	are	responsible	for	the	myelinization	and	microglial	cells	which	are	
the	immune	cells	of	the	CNS	(1).	
	
	
Figure	2.	Neuroglial	cells.	Neurons	from	CNS	are	supported	by	glial	cells	of	three	different	types:	A)	Astrocytes;	
B)	Oligodendrocytes;	C)	Microglial	cells.	Adapted	from	(1).	
1.1.3.	Spinal	cord	features	
SC	extends	from	the	base	of	the	skull	to	the	first	lumbar	vertebra	and	connects	the	peripheral	
nerves	to	the	brain,	receiving	sensory	information	from	the	skin,	joints	and	muscles.	It	also	contains	
motor	neurons	responsible	for	both	voluntary	and	reflex	movements	(2).	
SC	 is	 divided	 in	 four	main	 regions:	 8	 cervical	 segments,	 12	 thoracic	 segments,	 5	 lumbar	
segments	 and	 5	 sacral	 segments	 (Figure	 3.C).	 Peripheral	 fibres	 that	 leave	 the	 spinal	 cord	 at	 the	
cervical	 level	are	 involved	 in	sensory	and	motor	activity	of	 the	back	of	 the	head,	neck	and	arms;	
nerves	at	the	thoracic	level	innervate	the	upper	trunk,	while	lumbar	and	sacral	regions	innervate	the	
lower	trunk,	back	and	legs	(Figure	3.C-E)	(2).	
Nerve	cell	bodies	form	the	gray	matter	of	SC,	that	is	divided	into	dorsal	and	ventral	horns.	
The	dorsal	horn	contains	sensory	neurons	that	receive	input	from	the	periphery,	while	the	ventral	
horn	is	filled	with	motor	nuclei	that	innervate	muscles.	Interneurons	of	different	typologies,	also	in	
the	 gray	matter,	 modulate	 sensory	 and	motor	 information.	 The	 white	matter	 consists	 of	 highly	
myelinated	axons	organized	in	longitudinal	parallel	tracts	that	make	part	of	the	ascending	sensory	
pathways	and	descending	motor	or	modulatory	pathways	that	bring	information	from	the	brain	(2).	
A	 B	 C	
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Figure	3.	Basic	structures	of	the	anatomy	of	the	nervous	system.	A)	Cross	section	of	the	spinal	cord;	B)	Anatomy	
of	the	vertebral	column;	C-E)	Organization	of	the	nerves	and	corresponding	innervated	region.	Adapted	from	
(4).	
1.2.	Spinal	Cord	Injury	
Spinal	cord	injury	(SCI)	is	divided	into	traumatic	and	non-traumatic	aetiologies.	Acute	SCI	is	
a	devastating	consequence	of	traumatic	episodes	that	affect	the	spinal	cord	and/or	the	vertebral	
column.	Consequences	of	this	trauma	can	lead	to	sensory	or	motor	disabilities	with	different	extents	
due	to	the	affected	region,	with	loss	of	neurological	function	below	the	vertebral	level	of	the	injury.	
The	 resultant	 pathology	 is	 caused	 by	 two	 distinct	 mechanisms:	 the	 primary	 injury	 damages	
(mechanical	injury)	and	secondary	injury	mechanisms.	The	latter	constitutes	the	main	reason	for	the	
morbidity	in	patients	that	suffered	SCI.	Finding	an	effective	therapeutic	intervention	target	directed	
to	the	secondary	injury	mechanisms	is	then	of	due	importance.	
	 	
A	 C	
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1.2.1.	Epidemiology	
Every	year,	around	the	world,	about	500,000	people	suffer	a	SCI,	according	to	a	World	Health	
Organization’s	report	(5).	SCI	has	a	worldwide	incidence	between	40	and	80	per	million	inhabitants	
per	 year	 (5).	 In	 the	 United	 States	 of	 America	 (USA)	 alone,	 there	 are	 about	 243,000	 to	 347,000	
persons	living	with	a	SCI	and	nearly	17,000	additional	people	suffer	SCI	every	year,	excluding	those	
who	died	at	the	scene	of	the	accident	(6).	The	SCI	incidence	is	the	highest	in	the	USA	when	compared	
to	the	rest	of	the	world,	with	54	cases	per	million	inhabitants	(6,7).	Data	on	the	magnitude	and	costs	
of	SCI	in	Europe	is	sparse	and	it	is	outdated	(7).	The	most	recent	data	on	the	epidemiology	of	SCI	in	
different	regions	of	the	world	refers	that	the	highest	incidence	of	SCI	in	Europe	was	in	Estonia(39.7	
per	million),	followed	by	Romania	(28.5	per	million),	Spain	(23.5	per	million),	and	France	(19.4	per	
million)	(7–10).	SCI	incidence	was	lower	than	20	per	million	in	Denmark	(9.2	per	million),	followed	
by	 the	 Netherlands,	 (11.7	 per	 million),	 Turkey	 (12.7	 per	 million),	 Ireland	 (13.1	 per	 million),	
Switzerland	(15	per	million),	Finland	(13.8	per	million),	and	Norway	(16.5	per	million)	(7,11–16).	In	
Portugal,	between	1986	and	1990,	the	annual	 incidence	of	SCI	was	58	per	million	population	but	
since	 this	 date,	 no	more	 epidemiologic	 data	 concerning	 SCI	 in	 Portugal	was	 published	 (17).	 The	
prevalence	of	SCI	in	Europe	goes	from	250	per	million	inhabitants	(Rhone-Alpes	Region,	France	1970-
1975)	to	526	per	million	inhabitants	(Iceland	1975-2009)	(7).	Traumatic	SCI	incidence	rates	are	higher	
in	young	adults	(around	40	years),	and	males	are	more	affected	(5,7).	Traffic	accidents	are	usually	
the	most	 common	cause	of	 traumatic	SCI,	 followed	by	 falls	 in	 the	elderly	population	and	acts	of	
violence	(5–7).	In	USA,	45%	of	lesions	lead	to	incomplete	tetraplegia,	21.3%	to	incomplete	paraplegia	
followed	by	complete	paraplegia,	and,	less	common,	complete	tetraplegia.	Less	than	1%	of	persons	
achieve	complete	neurological	 recovery	 (6).	 Injuries	 to	 the	cervical	 spine	 region	seems	 to	be	 the	
most	frequent	lesion	in	the	analysed	countries	(7).	
According	to	the	National	Spinal	Cord	Injury	Statistical	Center,	estimated	lifetime	costs	range	
between	1	million	and	4.5	million	dollars	per	person,	depending	on	age	at	injury	and	severity	of	injury	
(6).	Consequently,	with	aging	of	the	world	population,	health	care	systems	may	be	confronted	with	
an	increased	number	of	elderly	patients	with	SCI,	which	leads	to	a	higher	health	expenses’	weight	to	
the	government	or	to	the	patients	(18).	
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1.2.2.	Pathophysiology	
Traumatic	SCI	 is	pathophysiologically	and	temporarily	divided	 into	primary	and	secondary	
lesions	 and	 into	 acute	 (<48	 hours),	 subacute	 (48	 hours	 to	 14	 days),	 intermediate	 (14	 days	 to	 6	
months)	and	chronic	(>6	months)	phases	(4).	
1.2.2.1.	Primary	insult	–	Acute	injury	phase	
The	mechanical	impact	of	the	trauma	causes	the	disruption	and	dislocation	of	the	vertebral	
column	resulting	in	the	compression	or	transection	of	the	SC.	This	physical	damage	can	be	inflicted	
by	4	different	mechanisms:	1)	 cord	maceration,	 in	which	 the	morphology	of	 the	cord	 is	 severely	
destroyed;	2)	cord	lacerations	(gun	shot	or	knife	cuts);	3)	contusion	injury,	which	leads	to	a	central	
hematomyelia	that	may	evolve	to	syringomyelia;	and	4)	solid	cord	injury,	in	which	there	is	no	central	
focus	 of	 necrosis	 as	 in	 contusion	 injury	 (19).	When	 structural	 limits	 are	 surpassed,	 neurons	 and	
oligodendrocytes	are	directly	damaged	and	there	is	disruption	of	microvasculature	and	so,	of	blood-
spinal	cord	barrier.	The	trauma	in	spinal	cord	leads	to	severe	haemorrhages	specially	in	gray	matter	
with	subsequent	necrosis	and	oedema	at	the	site	of	injury	(20).	Right	after	SCI,	microcirculation	is	
destroyed	and	a	major	reduction	in	blood	flow	at	the	lesion	occurs	(21).	Spinal	shock,	vasospasm,	
ischemia,	plasma	membrane	compromise,	loss	of	ionic	homeostasis	and	accumulation	of	released	
neurotransmitters	from	death	cell	are	some	of	the	first	events	following	SCI	(22).	Neurogenic	shock	
happens	right	after	SCI	and	it	is	characterized	by	three	main	events:	hypotension,	bradycardia,	and	
hypothermia	 (23).	 The	hypotension	 is	 due	 to	 loss	of	 sympathetic	 tone	 and	decreased	peripheral	
vascular	 resistance	 (24).	 These	 primary	 injury	 mechanisms	 are	 responsible	 for	 the	 evolution	 to	
secondary	 injury	mechanisms.	Cell	permeabilization,	pro-apoptotic	signalling	and	 ischaemic	 injury	
cause	cell	dysfunction	and	thus	death	(4,25,26).	Haemorrhages	facilitate	the	access	of	inflammatory	
cells,	 cytokines	and	vasoactive	peptides	 to	 the	SC,	 recruiting	 inflammatory	cells	as	macrophages,	
neutrophils	and	lymphocytes	(27).	The	inflammatory	process	can	lead	to	spinal	cord	swelling	which	
can	be,	by	itself,	another	agent	of	mechanical	compression,	aggravating	the	initial	injury	(4).	
1.2.2.1.1.	Immune	system	in	SCI	
Injury	triggers	a	host	immune	response	that	releases	inflammatory	cytokines	as	Interleukin-
1	beta	(IL-1β),	Interleukin-6	(IL-6)	and	Tumour	necrosis	factor	alpha	(TNF-α)	and	chemoatractants,	
which	 initiate	 the	 recruitment	 of	 lymphocytes	 and	 neutrophils	 (28,29).	 These	 inflammatory	
substances	are	the	ones	that	enhance,	 in	endothelial	cells,	 the	expression	of	adhesion	molecules	
such	as	Intercellular	adhesion	molecule	1	(ICAM-1)	and	Vascular	cell	adhesion	molecule	1	(VCAM-1),	
Identification	and	characterization	of	potential	therapeutic	targets	for	spinal	cord	repair	
Department	of	Medical	Sciences	⎟	University	of	Aveiro	 9	
which	allows	neutrophils,	a	type	of	polymorphonuclear	leucocytes	(PMNs),	to	bind	and	to	migrate	
into	the	tissue	within	a	few	hours.	However,	the	influx	of	macrophages	is	more	delayed.	Neutrophils	
are	thus	the	first	immune	cells	to	infiltrate	the	lesion	and	persist	until	at	least	90	days	post-injury	
(dpi).	The	early	phase	of	cellular	inflammation	is	comprised	principally	of	neutrophils	(peaking	at	1	
dpi),	 macrophages/microglia	 (peaking	 at	 7	 dpi)	 and	 T	 cells	 (peaking	 at	 9	 dpi)	 (30,31).	 Activated	
macrophages,	PMNs	as	neutrophils,	and	lymphocytes	are	recruited	to	the	lesion	to	phagocyte	myelin	
debris,	which	in	turns	results	in	the	production	of	reactive	oxygen	species	(ROS)	due	to	oxidation.	
This	 oxidation	 worsen	 the	 inflammation,	 with	 the	 release	 of	 more	 free	 radicals	 (O2-,	 hydrogen	
peroxide	and	peroxynitrite)	that	have	a	damaging	effect	in	the	tissues,	inducing	lipid	peroxidation,	
Deoxyribonucleic	 acid	 (DNA)	 oxidative	 damage	 and	 protein	 oxidation,	 increasing	 necrosis	 events	
(32–34).	
Inflammation	and	 free	 radical	 formation	due	 to	ROS	play	an	 important	 role	 in	 secondary	
death	of	neurons	and	glia.	Necrosis	of	neuron	and	glia	releases	Adenosine	triphosphate	(ATP),	DNA	
and	potassium	that	activate	even	more	the	microglial	cells.	These	cells	infiltrate	the	injury	site	and	
propagate	the	initial	inflammatory	response	(35).	
1.2.2.2.	Subacute	injury	phase	-	Secondary	damage	
After	the	acute	phase,	subacute	injury	is	characterized	by	further	cell	death	and	apoptosis	
(36–38),	demyelination(39,40)	and	axonal	degeneration	(36,41,42).	In	this	phase,	the	area	of	trauma	
distinctly	enlarges	and	aggravates	 (22).	Electrolyte	shifts,	oedema,	 formation	of	 free	 radicals	and	
alterations	in	calcium	influx	are	some	of	the	main	events	in	this	phase	of	SCI	(22).	
Dying	neurons	and	astrocytes	release	high	levels	of	the	neurotransmitter	glutamate	that	is	
not	being	reabsorbed	efficiently	by	dying	astrocytes	(43,44).	Overactivation	of	N-methyl-D-aspartate	
(NMDA),	α-amino-3-hydroxy-5-methyl-4-isoxazole	proprionic	acid	(AMPA)	and	kainate	receptors	by	
glutamate	causes	sodium	intracellular	levels	deregulation	and	thus,	excitotoxicity	(45,46).	Glutamate	
excitotoxicity	also	triggers	oligodendrocytes	death	and	the	sequel	 to	 that	 is	 the	demyelination	of	
axons	that	had	survived	the	initial	trauma.	Without	myelin,	surviving	neurons	start	to	degenerate	
because	they	are	now,	exposed	to	damaging	factors	as	the	free	radicals	and	inflammatory	cytokines	
(22,47).	
As	mentioned	above,	 the	 formation	of	ROS	causes	 lipid	peroxidation	as	well	 as	oxidative	
damage	to	proteins	and	nucleic	acids	(48).	Free	radicals	invoke	some	damage	to	the	cytoskeleton	
and	organelles,	but	are	mainly	responsible	for	the	lysis	of	the	cell	membrane	since	peroxidated	lipids	
loose	stability,	leading	to	cell	death	by	necrosis.	In	animals,	the	loss	of	ionic	homeostasis	caused	by	
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ischemia	 and	 excitotoxicity,	 increases	 intracellular	 calcium	 levels.	 In	 addition,	 oxidative	 events	
damage	 mitochondria	 contributing	 to	 intracellular	 calcium	 increase	 which	 activates	 proteases	
(caspases	 and	 calpains)	 that	 break	 the	 cytoskeleton	 and	 deregulate	 mitochondrial	 function,	
triggering	cell	death	by	Wallerian	degeneration	(WD)	(49–51).	WD	of	the	axonal	stump	distal	to	the	
point	of	injury	was	first	described	by	Waller	in	degenerating	frog’s	peripheral	nerves.	WD	is	a	special	
type	of	programmed	cell	death,	only	observed	in	the	nervous	system	(52).	In	both	PNS	and	CNS,	the	
early	phase	of	WD	includes	the	granular	disintegration	of	the	cytoskeleton,	in	which	the	cytoskeletal	
proteins	of	the	axon,	such	as	microtubules	and	neurofilaments,	are	degraded	to	granular	debris	(53).	
Acute	and	subacute	events	are	summed	in	the	Figure	4.	
	
	
Figure	4.	Pathophysiology	evolution	of	traumatic	spinal	cord	injuries.	A)	acute	injury	phase;	B)	subacute	injury	
phase.	Adapted	from	(54).	
1.2.2.3.	Chronic	injury	phase	
This	phase	of	injury	is	marked	by	failed	attempts	at	remyelination,	vascular	reorganization,	
alterations	in	the	composition	of	the	extracellular	matrix	(ECM)	and	remodelling	of	neural	circuits	
(51).	Axons	continue	to	degenerate	in	the	particular	programed	cell	death	-	WD	-	and	an	astroglial	
scar,	containing	microglia	infiltrated	in	the	lesion	and	inhibitory	proteoglycans,	is	formed	around	the	
cystic	cavitation	(55).	The	massive	cell	death,	degeneration	and	inflammation	observed	in	the	acute	
phase	of	SCI	create	scar-encapsulated	spaces	in	the	lesion	site	due	to	loss	of	tissue	volume.	These	
spaces	are	then	filled	with	extracellular	fluid,	connective	tissue	and	macrophages,	forming	the	cystic	
cavities	that	represent	a	great	physical	barrier	to	axonal	regrowth	and	cell	migration.	The	physical	
process	of	cavitation	leads	to	loss	of	oligodendrocytes,	loss	of	neurite	stretching	and,	thus,	secondary	
injury	 (56–58).	 Animal	 models	 have	 shown	 a	 perilesional	 area	 around	 the	 cystic	 cavities,	 with	
enrichment	of	 reactive	astrocytes	and	activated	microglia.	 In	 this	area,	 there	 is	 secretion	of	ECM	
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proteins,	inhibitory	to	axonal	growth,	such	as	chondroitin	sulphate	proteoglicans	(CSPGs),	tenascin	
and	chondroitin	sulphate	proteoglycan	4	(NG2)	which,	together	with	astrocytes,	form	the	glial	scar	
(59).	
1.2.2.4.	Barriers	to	regeneration	
Axons	in	CNS	do	not	regenerate	spontaneously	after	SCI.	Both	intrinsic	and	extrinsic	factors	
are	responsible	for	the	regeneration	failure	(60).	Beyond	the	glial	scar,	Myelin-associated	proteins	
(MAPs),	such	as	NI-250	(NOGO-A),	Tenascin-R	(TNR),	Oligodendrocyte	myelin	glycoprotein	(OMGP)	
and	Myelin-Associated	glycoprotein	 (MAG),	have	been	shown	to	have	 inhibitory	effects	 in	axonal	
regrowth	in	the	CNS	(61–65).	These	proteins	can	all	bind	to	the	Nogo	receptor	p75	neurotrophin	
receptor	(p75NTR)	to	activate	RHOA	and	Rho-associate	protein	kinase	(ROCK),	which	causes	growth	
cone	collapse,	neurite	retraction	and	increases	the	probability	of	apoptosis	(66).	Together,	all	these	
factors	contribute	to	the	restriction	of	regeneration.	The	persistence	of	this	inhibitory	environment	
in	degenerating	 fibres	can	be	a	 factor	contributing	to	the	different	regenerative	outcomes	 in	 the	
lesioned	CNS	and	PNS.		
However,	CNS	has	endogenous	mechanisms	for	partial	regeneration:	synaptic	plasticity	of	
CNS	neurons	contributes	to	long-term	functional	recovery	(67);	neural	precursor	cell	pools,	found	in	
ependymal	 layers	of	 the	central	 canal	allow	the	differentiation	and	proliferation	of	new	glial	and	
support	cells	(68),	and	oligodendrocyte	precursor	cells	that	can	generate	neurons,	oligodendrocytes	
and	 astrocytes	 (including	 reactive	 astrocytes)	 (69).	 Barriers	 to	 complete	 regeneration	 still	 exist,	
which	means	that	therapies	to	eliminate	or	overcome	these	barriers	are	fundamental	(4).	
1.2.3.	Controlling	secondary	injury	
There	are	multiple	preclinical	strategies	aiming	the	recovery	of	SCI	in	rodent	models	but	few	
are	 already	 in	 the	 clinical	 studies	 phase.	 Clinically	 proven	 treatments	 available	 are	 restricted	 to	
decompressive	 surgery,	 control	 of	 blood	 pressure	 to	 ensure	 adequate	 SC	 reperfusion	 (4),	 and	
methylprednisolone	 as	 acute	 treatment,	 to	 control	 the	 secondary	 damages	 caused	 by	 the	
exacerbated	 inflammation.	 However,	 the	 latter	 is	 no	 longer	 recommended	 due	 to	 possible	 side	
effects	(70).	
Conceptually,	 a	 treatment	 that	 targets	 the	 secondary	 damage	 and	 thus	 preserve	 the	
functional	tissue	 is	considered	neuroprotection	(71).	Various	therapeutic	strategies	to	reduce	the	
extent	 of	 injury	 and	 thus	 increase	 the	 chances	 of	 recovery	 have	 been	 studied.	 These	 include	
approaches	that	alter	neuroinflammation:	reduce	free	radical	damage,	reduce	excitotoxic	damage	
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to	neurons,	improve	blood	flow;	cellular	therapeutic	interventions:	bridge	cysts	and	cavities,	replace	
dead	 cells,	 create	 a	 favourable	 environment	 for	 axon	 regeneration;	 molecular	 therapeutic	
interventions:	 protect	 neurons	 from	 secondary	 cell	 death,	 promote	 axonal	 growth	 and	 enhance	
conduction	 by	 neuroprotective	 therapies,	 delivery	 of	 growth	 factors,	 modulation	 with	 myelin	
inhibitors,	or	ECM	modification.	However,	none	of	these	strategies	are	clinically	validated.	Due	to	its	
complexity,	a	SCI	is	unlikely	to	be	cured	by	a	single	treatment.	An	ideal	therapy	for	SCI	would	be	a	
multimodal	treatment	combining	some	of	the	above	listed	approaches	(72).	
1.3.	Peripheral	nerve	injury	model	
In	 the	 lesioned	mammalian	 CNS,	 there	 is	 an	 initial	 attempt	 of	 transient,	 abortive	 axonal	
sprouting,	but	no	significant	or	effective	regeneration.	However,	in	the	lesioned	PNS,	degeneration	
after	 injury	may	be	followed	by	successful	axonal	regeneration	and	functional	recovery	when	the	
ideal	 permissive	 environment	 is	 set.	 Therefore,	 knowledge	 of	 the	 altered	 cellular	 and	molecular	
events	during	spontaneous	peripheral	nerve	regeneration	may	provide	insight	into	ways	to	improve	
both	PNS	and	CNS	repair	after	injury	(73,74).	
1.3.1.	Peripheral	nervous	system	cellular	components	
Peripheral	nerves	elongate	from	the	CNS	to	the	periphery,	transporting	motor,	secretory,	or	
sensorial	 electrical	 signals.	 The	afferent	 axons	are	 involved	by	 Schwann	cells,	which	produce	 the	
myelin	sheaths	(myelinated	fibres)	and	allow	also	the	depolarization	and	repolarization	of	the	axon	
through	nodes	of	Ranvier,	or	are	only	wrapped	by	 the	cytoplasmic	processes	of	non-myelinating	
Schwann	cell.	 In	 the	 central	branch,	 axons	are	 involved	by	oligodendrocytes	 that	 are	 the	 central	
neuroglial	cells	responsible	for	the	myelin	production	(1).	
The	myelin	sheaths	result	from	the	fusion	of	the	myelinating	Schwann	cells’	body	and	the	
plasma	 membrane	 of	 the	 axon.	 Peripheral	 nerve	 fibres	 are	 covered	 by	 surrounding	 layers:	 the	
endoneurium,	the	perineurium,	and	the	epineurium.	The	endoneurium	surrounds	myelinated	and	
unmyelinated	 axons,	 and	 consists	mainly	 of	 collagen	 fibres	 but	 is	 also	 composed	 of	 endoneurial	
fibroblast-like	 cells	 (EFLCs)	 (75,76).	 EFLCs	 differ	 from	 common	 fibroblasts,	 which	 have	 a	
mesenchymal	origin,	because	they	appear	to	derive	from	the	neural	crest	(77).	It	is	also	hypothesized	
that	a	portion	of	EFLCs	may	originate	from	the	bone	marrow	during	pathological	conditions	(78).	
EFLCs	express	cell	markers	not	typical	of		common	fibroblasts,	such	as	CD34	and	do	not	express	S100	
protein,	which	is	a	specific	marker	for	Schwann	cells	(78).	The	perineurium	covers	each	fascicle	and	
is	 structured	by	perineurial	 glial	 cells	 and	 collagen	 layers.	 Perineurial	 cells	 have	polygonal	 forms,	
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elongated	nuclei,	and	a	flat	cytoplasm.	These	cells	are	positive	to	claudin-1	and	epithelial	membrane	
antigen	(EMA),	for	example,	but	are	not	immunoreactive	to	S100	protein.	The	epineurium	forms	the	
tissue	that	surrounds	the	outer	surface	of	the	nerve	and	is	composed	mainly	of	collagenous	tissue.	
As	 it	 is	 described	 in	 Figure	5,	peripheral	 fibres	are	populated	by	other	 types	of	 cells:	 fibroblasts,	
pericytes,	mast	cells,	macrophages	and	satellite	glial	cells	which	are	glial	cells	that	cover	the	surface	
of	nerve	cell	bodies	in	sensory,	sympathetic	and	parasympathetic	ganglia	(75).		
	
Figure	5.	Peripheral	nerve	anatomy.	Perineurium	in	purple	is	enrolling	each	fascicle..	Myelinating	Schwann	cells	
(S),	in	green,	are	surrounding	the	yellow	axons.	Non-myelinating	Schwann	cells	(N)	are	surrounding	multiple	
axons.	Endoneurial	fibroblasts	(F;	pink	cells)	are	in	the	endoneurium,	and	pericytes	(P;	red	cells)	surround	small	
blood	vessels.	Adapted	from	(77).	
1.3.2.	Sensory	Dorsal	Root	Ganglia	and	Somatosensory	system	
The	 PNS	 represents	 the	 connection	 between	 peripheral	 structures	 and	 the	 CNS.	 The	
transmission	of	somatosensory	information	from	the	periphery	to	the	spinal	cord	and	brain	stem	is	
mediated	by	neurons	whose	cell	bodies	are	located	in	dorsal	root	and	cranial	nerve	sensory	ganglia	
(79).	 Sensory	Dorsal	 Root	Ganglia	 (DRG)	 localize	 immediately	 adjacent	 to	 the	 cord,	 inside	 of	 the	
vertebral	column.	These	neurons	are	pseudounipolar	neurons.	The	reason	why	this	structure	is	so	
interesting	 is	because	they	have	bifurcated	axons,	one	peripheral	branch	and	one	central	branch	
that	enters	the	spinal	cord	in	the	top	of	the	dorsal	horn	and	the	fibres	are	then	distributed	in	two	
branches,	one	ascends	to	the	junction	of	the	spinal	cord	with	the	medulla	and	carries	information	
and	the	other	stays	in	the	spinal	gray	matter	where	it	is	responsible	for	local	reflex	circuits	(2).	The	
same	neuron	has	a	regenerative	portion	–	PNS,	and	a	non-regenerative	portion	–	CNS	(80,81).		
In	a	histological	and	simplistic	perspective,	DRG	neurons	are	divided	in	“large	light”-type	A	
cells,	and	“small	dark”	–	type	B	cells	(79,82).	However,	size	is	not	enough	to	establish	a	classification	
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criterion.	Further	histochemical	and	 immunohistochemical	 studies	 led	 to	 the	 identification	of	 specific	
antigens	that	permit	the	distinction	between	different	subgroups.	
When	speaking	about	speed	of	conduction,	the	somatosensory	system	has	several	neuronal	
types	which	 includes	 large	myelinated	afferent	axons	(Aβ)	 that	are	associated	with	 low-threshold	
mechanoreceptors	and	express	tyrosine	receptor	kinase	B	(TrkB)	and/or	tyrosine	receptor	kinase	C	
(TrKC)	 (83),	 while	 non-myelinated	 (C)	 and	 thinly	 myelinated	 axons	 (Aδ)	 contain	 high-threshold	
receptors	 that	 transmit	 painful	 stimuli	 (nociceptors)	 (84–86).	 Tyrosine	 receptor	 kinase	 A	 (TrkA)-
immunostained	cells	are	mainly	of	small	diameter,	but	also	some	of	medium	size	(83).	Specific	DRG	
cell	populations	require	different	neurotrophins	for	their	phenotypic	maintenance,	this	is	the	reason	
why	they	express	different	neurotrophin	receptors.	Small	DRG	neurons	can	be	further	divided	into	
nerve	 growth	 factor	 (NGF)-dependent	 neurons	 and	 glial	 cell	 line-derived	 neurotrophic	 factor	
(GDNF)-dependent	neurons.	The	first	group	expresses	the	high-affinity	NGF	receptor	tyrosine	kinase	
A	and	contains	neuropeptides	such	as	Substance	P	(SP)	and	calcitonin-gene	related	neuropeptide	
(CGRP)	and	 the	other	group	has	 the	GDNF	 receptors	 such	as	RET,	GDNF	 family	 receptor	alpha-1	
(GFRα-1)	and	GDNF	 family	 receptor	alpha-2	 (GFRα-2)	but	 lacks	neuropeptides.	GDNF-dependent	
neurons	bind	to	the	plant	lectin,	Isolectin	B4	(IB4),	that	is	used	as	a	marker	for	this	group	of	cells	(87–
91).	
Peptidergic	CGRP-expressing	neurons	respond	to	stimuli	that	evoke	sensations	of	pain,	itch	
and	guard	hair	displacement,	depending	on	the	level	of	myelination	of	the	fibres.	Nonpeptidergic	
cells	are	involved	in	mechanosensation	(92).	
Neurofilament	 200	 (NF200)	 is	 a	 protein	 that	 is	 highly	 expressed	 in	 the	 cell	 body	 of	
proprioceptive	neurons	of	 large	diameter	and	tactile	neurons	of	mean	diameter,	and	so	it	can	be	
used	as	a	marker	in	immunostainings	for	this	groups	of	neurons	in	DRG	tissue	sections	(93).	
1.3.3.	Peripheral	Nerve	Regeneration	
Mechanical	 disruption	 of	 the	 axonal	 membrane	 causes	 the	 entry	 of	 extracellular	 ions	
resulting	 in	 depolarization,	 activation	 of	 calcium-sensitive	 proteases	 by	 calcium	 influx	 with	
remodelling	 of	 the	 cytoskeleton	 (73).	 These	 self-destructive	 events	 start	 the	 WD,	 probably	 via	
receptors	sensitive	to	tissue	damage	such	as	Toll-like	receptors	(TLRs)	(94),	and	occur	mainly	in	the	
lesion	 site	but	also	 in	 the	distal	nerve	 stump	 (95).	The	 first	events	of	peripheral	nerve	 injury	are	
similar	to	what	happens	in	CNS	axons	after	axotomy.	However,	the	following	steps	start	to	diverge	
and	 the	differential	 regeneration	observed	between	CNS	and	PNS	may	 reside	 in	 these	 facts.	The	
axonal	disintegration	and	fragmentation	triggers	the	activation	of	the	de-differentiation	of	Schwann	
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cells	via	tyrosine	kinase	receptor	ErbB2	activated	by	neuregulin	with	activation	of	mitogen-activated	
protein	kinase	(MAPK)	pathway.	Schwann	cells	are	the	larger	population	of	cells	in	the	injured	distal	
nerve	stump	and	change	their	phenotype	in	accordance	to	the	surrounding	conditions	(73,94,96).	
Two	 days	 after	 injury,	 Schwann	 cells	 initiate	 the	 fragmentation	 and	 degradation	 of	myelin	 from	
injured	 neurons	 (97).	 Is	 during	 this	 process	 that	 inhibitory	 molecules	 like	 MAG	 and	 OMGP	 are	
evacuated	from	the	lesion	site	(73).	Phagocytic	macrophages	are	recruited	after,	by	cytokines	and	
chemokines	produced	by	activated	Schwann	cells,	to	clean	the	remaining	myelin	fragments	together	
with	 resident	 endoneurial	macrophages	 (96,98).	 In	 addition	 to	 its	 involvement	 in	 destruction	 of	
myelin	debris,	Schwann	cells	in	the	distal	nerve	stump	de-differentiate,	proliferate	and	align	within	
basal	 lamina	 tubes,	 forming	 the	 bands	 of	 Büngner	 together	 with	 EFLCs.	 They	 express	 surface	
adhesion	molecules	and	neurotrophic	 factors	such	as	NGF,	BDNF,	and	Neurotrophin	4	(NT4)	that	
promote	and	guide	axonal	sprouting	through	the	distal	stump	to	achieve	target	connections	(97).	
PNS	ECM	also	suffers	some	remodelling	by	metalloproteinases,	and	has	a	relevant	role	 in	
the	 construction	 of	 a	 permissive	 growth	 environment.	 Laminin,	 by	 its	 connection	 to	 integrins,	
improves	neurite	outgrowth	and	mediates	Schwann	cells	migration,	proliferation	and	remyelination.	
Fibronectin	 and	 collagen	 also	 promote	 axonal	 outgrowth	 of	 adult	 peripheral	 neurons	 but	 less	
relevant	(99).	
In	the	adult	PNS,	axonal	regeneration	after	injury	depends	on	well-orchestrated	cellular	and	
molecular	processes	that	comprise	a	highly	reproducible	series	of	degenerative	reactions	distal	to	
the	site	of	injury	(73).	Successful	regeneration	is	a	consequence	of	efficient	clearance	of	neuronal	
debris,	and	the	creation	of	an	axonal	growth	friendly	environment,	especially	by	Schwann	cells	and	
macrophages.	
1.4.	Transcriptional	analyses	as	a	tool	to	understand	pathophysiologies	
Transcriptional	analyses	allow	the	study	of	the	transcriptome	which	is	the	complete	set	of	
transcripts	 in	 a	 cell.	 Various	 technologies	have	been	developed	 to	evaluate	 and	 characterize	 the	
transcriptome	 of	 a	 population	 of	 cells	 or	 tissues,	 including	 hybridization-based	 microarrays	 and	
Sanger	 sequencing-based	methods	 (100).	 Transcriptomic	 analyses	 are	 important	 to	 characterize	
expression	profiles	of	pathologies	or	physiological	conditions.	The	main	platform	used	for	expression	
data	analysis	has	been	the	DNA/RNA	microarrays;	however,	 the	development	of	RNA-sequencing	
(RNA-seq)	 technologies	 allowed	 for	 higher	 accuracy	 and	 to	 include	more	 transcript	 populations	
(101).	 These	 methods	 allow	 expression	 monitoring,	 in	 which	 the	 transcript	 levels	 of	 genes	 are	
measured	in	different	physiological	conditions	to	search	for	regulatory	expression	patterns.	
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The	main	application	of	DNA	microarrays	has	been	 the	quantification	of	gene	expression	
levels,	in	which	the	transcript	levels	of	genes	are	measured	in	different	physiological	conditions	in	
cultured	cells	or	tissues,	to	search	for	e.g.	regulatory	expression	patterns.	Microarrays	are	usually	
made	by	 the	 fixation	of	DNA	 spots	 on	 a	 surface	 like	 a	 coated	 glass	 platform.	 The	 fluorescent	 or	
biotinilated	labelled	RNA	or	DNA	are	then	hybridized	to	the	microarray,	and	the	signal	emitted	by	
each	spot	is	detected	(102,103).	
RNA-seq	 is	 based	 on	Next	 generation	 sequencing	 (NGS)	 and	 uses	 bridge	 amplification	 in	
Illumina	platforms.	RNA-seq	can	detect	transcripts’	levels,	and	can	also	reveal	splicing	isoforms	and	
expressed	polymorphisms	(104).	 	
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2.	Aims	
This	work	 aimed	 to	 find	 relevant	 targets	 for	 new	 therapeutic	 approaches	 for	 spinal	 cord	
regeneration	following	injury.	Two	paths	were	designed	to	achieve	this	goal:	a	bioinformatics	analysis	
to	 find	 putative	 genetic	 targets	 and	 an	 experimental	 study	 to	 characterize	 some	of	 the	 selected	
genes.	The	main	aims	of	this	study	were:	
• To	identify	transcriptomic	datasets	of	lesion	site	tissue	obtained	from	animal	models	with	
improved	spinal	cord	regeneration	and	functional	recovery	after	SCI;	
• To	 compare	 the	 lists	 of	 differential	 expressed	 genes	 (DEGs)	 of	 these	 studies,	 and	 find	
common	regulated	genes;	
• To	select	common	genes	with	relevance	for	the	nervous	system;	
• To	 analyse	 the	 regulation	 of	 the	 selected	 common	 genes	 in	 a	 peripheral	 nerve	 injury	
regenerative	model	by	q-RT-PCR,	and	verify	its	neuronal	distribution	by	histochemistry.	 	
	
	3.	Material	and	methods	 	
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3.1.	Bioinformatics	analysis	
This	analysis	had	some	transcriptomic	studies	of	SCI	as	a	starting	point,	 in	a	comparative	
analysis	to	find	common	regulated	genes	in	spinal	cord	regenerative	paradigms.	The	main	goal	of	
this	 bioinformatics	 analysis	was	 to	 identify	 transcriptomic	 datasets	 of	 RNA	 array-	 or	 sequencing-
based	experiments	of	tissue	at	the	SCI	lesion	site,	in	rodents	that	suffered	a	treatment	that	improved	
spinal	cord	regeneration	and	functional	recovery	after	SCI,	and	identify	common	regulated	genes.	
The	study	design	is	schematized	in	Figure	6.	
	
	
Figure	 6.	 Representative	 scheme	 of	 the	 bioinformatics	 study.	 DEGs,	 differential	 expressed	 genes;	 RAGs,	
regeneration	associated	genes.	
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3.1.1.	Selection	of	transcriptomic	studies	
The	 databases	 used	 for	 this	 search	were	 the	Gene	 Expression	Omnibus	 (GEO)	 database,	
Sequence	Read	Archive	(SRA),	Array	Express	and	Pubmed.	A	combination	of	the	following	keywords	
was	used:	“spinal	cord	injury”	OR	“spinal	cord	regeneration”	OR	“axon	regeneration”	with	filters	for	
Mus	musculus	or	Rattus	species.		
On	 the	 2nd	 of	 March	 of	 2017,	 a	 search	 was	 carried	 out	 on	 GEO.	 GEO	
(https://www.ncbi.nlm.nih.gov/geo/)	database	is	an	open-access	repository	of	functional	genomics	
where	scientific	community	can	deposit	array-	and	sequence-based	data	of	their	own	experiments.			
To	complement	this	search	with	RNA-sequencing	experiments,	on	the	2nd	of	March	of	2017,	
a	 search	 on	 SRA	 was	 performed	 with	 the	 same	 previous	 key	 words.	 SRA	
(https://www.ncbi.nlm.nih.gov/sra)	 is	 the	 database	 of	 the	 National	 Centre	 for	 Biotechnology	
Information	 (NCBI)	 where	 sequence	 data	 obtained	 from	 next	 generation	 sequencing	 (NGS)	
technology	is	stored	and	can	be	downloaded	for	further	analysis.	
In	 addition,	 on	 the	 5th	 of	 March	 of	 2017,	 a	 search	 on	 the	 Array	 Express	 platform	 was	
performed.	Array	express	from	EMBL	(https://www.ebi.ac.uk/arrayexpress/)	is	a	platform	similar	to	
GEO	where	it	is	possible	to	archive	array	experiments	or	sequencing	data	to	be	available	for	all	the	
scientific	community	(105).	
An	additional	search	on	the	6th	of	March	of	2017	was	performed	on	Pubmed	to	guaranty	
that	studies	where	the	expression	data	was	not	uploaded	to	the	transcription	databases	described,	
could	also	be	included.	
Studies	were	included	if	they	were	written	in	English	and	were	published	until	the	search	
date.	The	remaining	criteria	for	inclusion	and	exclusion	can	be	seen	in	Table	1.	
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Table	1.	Inclusion	and	exclusion	criteria	for	selection	of	studies	to	be	used	in	the	present	study.	
	 INCLUSION	CRITERIA	 EXCLUSION	CRITERIA	
POPULATION	AND	
CONDITION	
Rattus	or	Mus	musculus	with	
SCI	
Other	species;	embryonic	
studies	
TYPE	OF	INJURY	
Complete	
transection/hemisection	or	
contusion	models	
Compression	models	
INTERVENTIONS	
Pharmacological,	molecular	or	
genetic	interventions	that	
improve	SC	regeneration	and	
functional	recovery	
Cellular	treatments	
STUDY	DESIGN	
Compare	regenerative	
approach	with	injured	
controls.	
No	regenerative	treatment;	
only	analysis	of	injury	
transcriptome	
TYPE	OF	TRANSCRIPTOMIC	
ANALYSIS	
Genome	analysis	with	
MicroArray	or	RNA-seq	
MiRNA	
TISSUE	ANALYSED	 Spinal	cord	tissue	from	the	lesion	site	
Rostral	or	caudal	spinal	tissue	
and	cortex	tissue	
	
3.1.2.	Data	extraction	
The	 processed	 expression	 data	 files	 of	 the	 selected	 studies	 were	 extracted	 from	 the	
databases	mentioned	above.	
The	RNA-sequencing	expression	profile	GSE62760	based	on	HiSeq2000	(Illumina,	San	Diego,	
CA,	USA)	platform	was	obtained	from	the	GEO	database.	
The	microarray	expression	profile	GSE34430	based	on	Affymetrix	Mouse	All-Exon	ST	Array	
GeneChipsTM	(Santa	Clara,	California,	EUA)	platform	was	extracted	from	GEO.	
The	 microarray	 expression	 profile	 E-GEOD-69334	 based	 on	 Affymetrix	 GeneChip	 Rat	
Genome	 230	 2.0	 array	 (Santa	 Clara,	 California,	 EUA)	 platform	was	 obtained	 from	 Array	 Express	
database	from	EMBL.	
3.1.3.	Differential	expressed	genes	analysis	
Using	Microsoft®	 Excel	15.12.3	 (Microsoft	Corporation,	Redmond,	WA,	USA),	differential	
expressed	 genes	 (DEGs)	 were	 analysed	 by	 calculating	 the	 fold-change	 (FC)	 difference	 between	
injured	animals	that	received	a	regenerative	treatment	and	animals	with	injury,	but	no	intervention.	
A	threshold	of	1.2	FC	in	expression	was	established,	and	up	or	down-regulated	genes	were	separated	
in	two	distinct	groups	for	each	study	(106).	When	the	studies	presented	more	than	1	time-point,	the	
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DGEs	of	all	the	different	time	points	were	summed	and	analysed	as	a	group.	Several	bioinformatics	
tools	were	used	to	further	analysis	of	the	DEGs	lists.	
3.1.4.	Finding	Human	orthologs	
Due	to	the	different	animal	models	used	in	the	studies,	normalization	of	the	DEGs	to	human	
orthologs	was	performed	using	Biomart	from	Ensemble	(www.ensembl.org/biomart/martview/),	a	
web-based	tool	that	allows	normalization	of	data	with	different	identification	codes	as	well	as	the	
finding	of	homologue	or	ortholog	genes.	As	filters	input,	the	microarray	probes/probesets	ID	list	was	
uploaded	and	human	orthologs	were	selected	as	desired	output.	Only	genes	with	human	homology	
type	“one2one”	or	“one2many”	and	human	orthology	confidence	of	1	were	further	included	in	this	
study.	It	is	important	to	notice	that	this	conversion	can	be	introducing	some	bias	because	genes	with	
orthology	of	one2many	can	be	corresponding	to	more	than	one	human	gene.	
3.1.5.	Comparison	of	expression	profiles	
To	 compare	 the	 3	 selected	 datasets,	 Venn	 diagrams	 using	 the	 online	 tool	 Jvenn	
(jvenn.toulouse.inra.fr/)	were	plotted	for	the	resultant	3	groups	of	1.2	up-regulated	genes,	and	the	
3	groups	of	1.2	down-regulated	genes.	Groups	of	overlapping	DEGs	were	obtained.	
To	extract	some	functional	information	about	the	overlapping	genes	(107),	lists	were	upload	
to	 Uniprot	 (http://www.uniprot.org)	 and	 some	 information	 of	 interest	 as	 tissue	 specificity	 and	
involvement	 in	 disease,	 was	 retrieved	 from	 Pubmed	 publications,	 OMIM	 -	 Online	 Mendelian	
Inheritance	 in	 Man®	 database	 and	 MalaCards-	 The	 Human	 Disease	 Database	
(http://www.malacards.org/).	 This	 information	 was	 complemented	 with	 Nervous	 System	
Mammalian	 Phenotypes	 associated	 with	 mutant	 genotypes,	 searched	 in	 the	 Mouse	 Genome	
Informatics	(MGI)	(http://www.informatics.jax.org)	database.	Mouse	Genome	Database	(MGD)	is	a	
tool	 of	MGI	 that	 includes	data	 about	 the	 laboratory	mouse	as	phenotypes,	mutations	 and	other	
biological	data	to	facilitate	the	study	of	human	health	and	disease	(108).	
3.1.6.	Gene	Ontology	and	pathways	enrichment	analysis		
The	following	bioinformatics	tools	were	used	for	the	analysis	of	the	lists	of	overlapping	DEGs:	
The	 Database	 for	 Annotation,	 Visualization	 and	 Integrated	 Discovery	 6.8	 (DAVID)	
(https://david.ncifcrf.gov/home.jsp)	 is	 usually	 used	 for	 analysing	 large	 gene	 lists.	 This	 database	
organizes	interesting	genes	in	a	list	based	on	associated	biological	annotation	(e.g.,	gene	ontology	
terms,	 pathways),	 and	 then	 statistically	 highlight	 the	most	 overrepresented	 (enriched)	 biological	
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annotation.	 This	 allows	 the	 identification	 of	 biological	 processes	 most	 pertinent	 to	 the	 study	
(109,110).	
Gene	Ontology	(GO)	Consortium	(http://geneontology.org/)	creates	classes	to	describe	gene	
function.	 It	characterizes	genes	based	on	 three	main	specificities:	molecular	 function	 -	molecular	
activities	 of	 the	 gene	 products;	 cellular	 component	 -	 where	 the	 gene	 products	 are	 active;	 and	
biological	 process	 -	 pathways	 and	 larger	 processes	 made	 up	 of	 the	 activities	 of	 multiple	 gene	
products	(111).	
The	Kyoto	Encyclopedia	of	Genes	and	Genomes	(KEGG)		(http://www.genome.jp/kegg/)	is	a	
database	that	organizes	associated	gene	sets	into	pathways’	groups	(112).	
The	DEGs	common	to	at	least	2	of	the	3	datasets	were	submitted	to	DAVID.	Subsequently	
GO	 annotation	 terms	 and	 KEGG	 pathway	 enrichment	 analysis	 was	 performed	with	 a	 “Medium”	
classification	 stringency.	Gene	 counts	 ≥	 3	 and	Enrichment	 score	 ≥	 1.3	were	 set	 as	 the	 threshold	
values.	Only	the	5	first	clusters	for	each	analysis	are	here	presented. 
3.1.7.	PPI	network	analysis	
Protein-protein	interaction	(PPI)	network	of	the	common	DEGs	was	performed	on	the	online	
Search	Tool	 for	the	Retrieval	of	 Interacting	Genes/Proteins	database	(STRING	10.5,	https://string-
db.org/).	The	two	lists	(up-	or	down-regulated	genes)	were	uploaded	and	networks	expanded	to	the	
1st	shell	with	no	more	than	10	interactors	and	high	confidence	(0.7)	were	retrieved.	The	common	up	
and	down	PPI	networks	were	imported,	separately,	to	Cytoscape	3.4.0,	a	software	that	allows	the	
visualization	and	edition	of	complex	molecular	interaction	networks	and	pathways.		
Additionally,	to	find	possible	interconnections	between	up-	and	down-regulated	genes,	a	PPI	
network	 with	 the	 fusion	 of	 the	 two	 lists	 of	 the	 common	 DEGs	 was	 constructed	 with	 the	 same	
parameters	as	the	previous	ones.	This	network	was	also	edited	with	Cytoscape	software.	
3.1.8.	Human	Brain	Proteome	
Human	Protein	Atlas	(HPA)	(https://www.proteinatlas.org/)	is	a	public	database	with	the	aim	
to	 map	 all	 the	 human	 proteins	 in	 cells,	 tissues	 and	 organs	 using	 integration	 of	 various	 omics	
technologies,	 including	 antibody-based	 imaging,	 mass	 spectrometry-based	 proteomics,	
transcriptomics	 and	 systems	biology	 (113).	 In	 order	 to	 investigate	 if	 some	of	 the	 common	DEGs	
proteins	are	already	related	with	human	brain,	the	Human	Brain	Proteome	was	extracted	from	HPA		
and	was	compared	to	the	DEGs	lists	obtained	in	this	study.	Relevant	information	was	organized	on	a	
table.	
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3.1.9.	PPI-networks	between	common	DEGs	and	known	RAGs	
REGene	 (http://regene.bioinfo-minzhao.org/)	database	 is	a	comprehensive	gene	resource	
for	 regeneration,	 based	 on	 literature	 data,	 biological	 pathways,	 gene	 expression	 profiles	 and	
orthologs	 that	 gives	 the	 possibility	 of	 browsing	 genes	 by	 tissues/organs	 (114).	 Regeneration	
associated	 genes	 (RAGs),	 associated	 to	 nervous	 system	 or	 spinal	 cord	 regeneration,	 were	
downloaded	from	this	database.	
The	common	up	and	down	DEGs	and	nervous	associated	RAGs	were	imported	at	the	same	
time	to	Cytoscape,	an	expansion	to	known	interactions	was	performed;	interactors	with	at	least	2	
connections	were	included,	and	the	network	diagram	was	plotted.	 	
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3.2.	Experimental	studies	
3.2.1.	Animal	subjects	
Experiments	were	conducted	in	adult	Wistar	rats	(200-240	g)	in	compliance	with	the	German	
Animal	 Protection	 Law	 and	 were	 performed	 with	 the	 permission	 of	 the	 LANUV	 NRW	
(Recklinghausen,	Germany)	according	to	the	“Guidelines	for	good	scientific	practice	at	the	Heinrich-
Heine-University	(HHU)	Düsseldorf,	Germany”.	
3.2.2.	Sciatic	nerve	crush	model	
Sciatic	nerve	 injuries	of	anesthetized	rats	were	preceded	by	a	small	skin	 incision	over	the	
gluteal	 region.	The	 ischiocrural	musculature	was	 then	carefully	 spread	at	mid-thigh	with	minimal	
tissue	 damage	 to	 expose	 the	 sciatic	 nerve.	 Figure	 7	 represents	 the	 position	 and	 experimental	
methods	for	the	injury	of	the	sciatic	nerve.	
	
	
Figure	7.	Experimental	design	of	the	sciatic	nerve	lesion	in	a	rodent	model.	Lesions	were	performed	bilaterally	
in	the	thigh	of	the	rat.	Distal	and	proximal	stumps,	as	well	as	corresponding	DRG	were	collected	at	1,	2,	7,	14	
and	21	days	after	the	crush	or	transection	lesions.	DRG:	dorsal	root	ganglia;	dpi:	days	post	injury.	
For	 the	crush	 lesion,	5/45	 jewellery	 forceps	covered	with	graphite	powder,	were	used	to	
crush	the	sciatic	nerve	2	times	for	15	seconds	each	time.	Rat	sciatic	nerve	was	crushed	so	that	the	
continuity	of	Schwann	cells	basal	laminae	and	other	connective	structures	were	not	interrupted.	As	
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segments	distal	and	proximal	to	the	lesion	segments	remain	connected,	severed	axons	can	regrow	
completely	 and	 reach	 original	 innervation	 targets	 (115).	 This	 lesion	 model	 is	 schematically	
represented	in	Figure	8.	
	
Figure	 8.	 Representative	 scheme	 of	 the	 crush	 lesion	 paradigm.	 Crushed	 sciatic	 nerve	 has	 the	 ability	 to	
regenerate	within	few	weeks.	Blue	cells:	Schwann	cells;	red	fibres:	axons;	green:	nerve	fibre.	
3.2.3.	Sciatic	nerve	transection	
The	 same	 anaesthesia	 procedure	 was	 applied	 to	 these	 animals.	 To	 reproduce	 chronic	
denervation,	 the	 proximal	 stump	 of	 the	 sciatic	 nerve	 was	 ligated	 using	 6/0	 suture	 silk	 and	 the	
transection	of	the	sciatic	nerve	was	performed	right	after	the	knot	with	a	pair	of	micro-scissors.	Since	
rodent	models	have	a	much	more	pronounced	endogenous	axonal	regeneration	than	humans	and	
can	spontaneously	 reconnect	 fibres,	 the	suturing	of	 the	stumps	must	be	performed	to	avoid	 this	
(115).	 Total	 axotomy	 leads	 to	 irreversible	 interruption	 in	 the	 afferent	 and	 efferent	 transmission,	
without	regeneration	of	the	nerve	and	with	a	very	pronounced	WD.	The	lesion	model	is	schematically	
represented	in	Figure	9.	
	
Figure	 9.	 Representative	 scheme	 of	 the	 transection	 lesion	 paradigm.	 The	 distal	 stump	 suffers	 more	
degeneration	than	the	proximal	stump	and	thanks	to	the	suture	in	the	proximal	extremity,	axonal	regrowth	is	
blocked	and	Büngner	bands	are	 insufficient	 to	promote	 regeneration.	Blue	cells:	Schwann	cells;	 red	 fibres:	
axons;	green:	nerve	fibre.	
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3.2.4.	Spinal	cord	injury	
Spinal	cord	transection	at	thoracic	level	T8	was	performed	by	Doctor	Veronica	Estrada.	Rats	
were	anesthetized	with	Isoflurane	and	after	reaching	deep	anaesthesia,	the	animal	was	placed	onto	
a	heating	plate	with	constant	39°C,	and	cornea	gel	was	applied.	Following	laminectomy	at	T8/9,	and	
opening	of	the	dura	mater	via	a	 longitudinal	cut,	the	spinal	cord	was	slightly	 lifted	and	separated	
from	the	dura	with	a	spinal	cord	hook.	The	spinal	cord	was	completed	transected	by	a	transverse	cut	
with	a	pair	of	micro-scissors.		
3.2.5.	Tissue	preparation	
Injured	and	sham-operated	animals	were	sacrificed	by	cervical	dislocation	at	1	day,	2	days,	
7	days,	14	days	or	21	days	after	the	sciatic	nerve	lesion	(crush	or	transection),	at	the	same	period	of	
the	day	to	avoid	physiological	variations	due	to	the	circadian	cycle.	Sham	operated	animals	sacrificed	
in	 the	same	time	points	were	used	to	extract	control	 tissue.	The	proximal	and	distal	parts	of	 the	
sciatic	nerve	were	rapidly	but	carefully	dissected	as	also	the	corresponding	lumbar	DRGs	L4,	L5	and	
L6,	which	branch	to	this	nerve.	Tissue	samples	to	perform	further	immunohistochemistry	analysis	
were	fixated	in	4%	Formaldehyde	at	4°C	for	6	hours	(DRG)	or	24	hours	(nerves)	and	then	washed	3	
times	with	Phosphate-buffered	saline	(PBS),	and	stored	in	PBS	at	4°C	for	future	tissue	embedding.	
Nerves	were	wrapped	in	filter	paper	 in	order	to	preserve	their	shape.	Samples	to	perform	mRNA	
analysis	were	rapidly	frozen,	after	dissection,	and	stored	at	-30°C.	
3.2.6.	Quantitative	Real-Time	Polymerase	Chain	Reaction	(qRT-PCR)	
3.2.6.1.	Primer	design	
Messenger	RNA	 (mRNA)	sequences	of	 the	 target	genes	were	downloaded	 from	GenBank	
(https://www.ncbi.nlm.nih.gov/genbank/)	 (see	Table	2).	Primers	 for	qRT-PCR	were	calculated	and	
designed	using	Primer	Express	3.0	Software	(Applied	Biosystems).	
Primer	 design	 is	 performed	 accordingly	 to	 the	 follow	 ideal	 conditions:	 have	 20	 bases	 of	
length,	a	GC	content	between	20	and	80%,	repeating	sequences	must	be	avoided	and,	if	repeats	are	
present,	there	must	be	no	more	than	3	G	sequential	residues,	the	temperature	of	melt	must	be	kept	
between	58°-60°C,	the	last	5	nucleotides	at	the	3’end	can	not	have	more	than	2	G	and/or	C	bases,	
and	avoid	that	the	primer	forms	hairpin	because	of	being	homologous	to	itself.	 	
Identification	and	characterization	of	potential	therapeutic	targets	for	spinal	cord	repair	
	
	 	Patrícia	Maria	Dias	Correia	30	
Table	2.	mRNA	and	selected	primer	pair	sequences.	
Gene	 NCBI	Ref	Seq	 FWD	Seq	 REV	seq	
TNN	 NM_001107189.2	 GGGCAGCTGGATTTCTTCAA	 CAAGTCCAAGCCAGAACTCCTT	
MPP3	 NM_053668.1	 GCCAAATTCTGGCCCAATC	 CTGGGTGGCAGGGATGATC	
KIF4A	 XM_006257113.3	 TCCGGGAGGATCCTAAGGAA	 GTCCGAGGCAACTAGCACAGT	
	
3.2.6.2.	Total	RNA	isolation	
Total	RNA	extraction	was	performed	by	using	TRIzolTM	Reagent	(Invitrogen).	This	can	isolate	
high	quality	total	RNA,	as	well	as	DNA	and	proteins	from	cells	and	tissue	samples	of	human,	animals,	
plants	and	others.	
Frozen	nerves	were	homogenized	in	700	µl	of	TRIzolTM	Reagent	and	140	µl	of	Chloroform	
with	a	Homogenizer	PT	2100	(Kinematika).	Probes	should	not	become	warm	during	all	the	process	
of	extraction,	therefore	the	samples	were	maintained	in	ice	whenever	was	possible.	
All	centrifugation	steps	were	performed	using	Heraeus	Fresco	2	Centrifuge	(ThermoFischer)	
at	4	º	C.	DRGs	at	L4,	L5	and	L6	were	pooled	as	one	sample.	
Probes	were	incubated	on	ice	for	5	minutes	and	then	a	centrifugation	of	12000	rotations	per	
minute	(rpm)	for	20	min	was	performed.	The	homogenate	was	separated	into	a	clear	upper	aqueous	
phase,	containing	the	RNA,	an	interphase,	and	a	lower	pink	phase	containing	organic	components	as	
DNA	and	proteins.	The	upper	clear	phase	was	transferred	to	a	new	tube	and	500	µl	of	Isopropanol	
were	added	and	incubated	for	30	minutes	at	-20	º	C	to	precipitate	the	RNA	from	the	aqueous	layer.	
After	the	incubation,	a	new	centrifugation	was	made	at	13000	rpm	for	at	least	20	minutes.	Pellet	
was	collected	and	washed	with	100	µl	of	75%	EtOH	for	5	minutes.	Another	centrifugation	at	13000	
rpm	 during	 10	 minutes	 helped	 separating	 RNA	 from	 the	 supernatant.	 After	 discarding	 the	
supernatant,	the	pellet	was	dried	at	room	temperature	(RT)	for	5	minutes	and	then	dissolved	in	50	
µl	of	RNase	free	dH2O.	Total	RNA	samples	were	stored	at	-30ᵒC	for	further	purification.	
3.2.6.3.	RNA	clean-up	
Purification	 of	 extracted	 RNA	was	 performed	with	 RNeasy	 Columns	 (Qiagen)	 in	 order	 to	
remove	DNA	contamination	or	other	contaminants,	accordingly	to	RNeasy	Mini	HandBook	Standard	
Protocol.	 On-Column	 DNase	 digestion	 with	 the	 RNase-Free	 DNase	 Set	 (Qiagen)	 was	 performed	
during	RNA	purification.	Biological	samples	were	first	lysed	and	homogenized	in	the	presence	of	a	
highly	denaturant	buffer,	which	inactivates	RNases	to	ensure	purification	of	intact	RNA.	Ethanol	is	
added	to	provide	appropriate	binding	conditions,	and	then	the	samples	were	applied	to	a	RNeasy	
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silica	membrane	 (700	 µl	 is	 the	maximum	 column´s	 capacity),	 to	 which	 the	 total	 RNA	 binds	 and	
contaminants	are	efficiently	washed	away.	These	columns	provide	an	enrichment	for	mRNA	because	
they	retain	RNA	molecules	longer	than	200	nucleotides	and	5.8S	ribosomal	ribonucleic	acid	(rRNA),	
5S	 rRNA,	 transfer	 ribonucleic	 acid	 (tRNA)	 have	 less	 than	 200	 nucleotides	 of	 length	 and	 are	
consequently	washed	away.	
3.2.6.4.	Combination	of	TRIzolTM	Reagent	and	RNeasy	columns	
As	 DRG	 samples	 were	 smaller	 in	 terms	 of	 mass,	 the	 following	 alternative	 protocol	 of	
extraction	and	purification	of	total	RNA	was	performed	to	make	ensure	that	a	greater	percentage	of	
RNA	 probes	was	 collected.	 Tissue	was	 homogenized	 in	 500	 µl	 of	 Trizol	 Reagent	with	 a	 Polytron	
Homogenizer	(Kinematika)	centrifuged	at	12000xg	for	10	minutes	at	4ᵒC	and	then	the	supernatant	
was	 transferred	 to	 a	 new	 tube.	 This	 step	 reduces	 possible	 debris	 caused	 by	 fat	 tissue.	 The	
homogenized	solution	was	left	to	incubate	for	5	minutes	at	room	temperature.	100	µl	of	Chloroform	
were	added	and	the	mixture	was	vortexed.	After	2	minutes	of	incubation,	a	centrifugation	at	12,000	
xg	for	15	minutes	at	4ºC	was	performed.	The	transparent	upper	phase,	containing	RNA,	was	collected	
to	 a	 new	 tube	 and	 300	 µl	 of	 70%	 EtOH	 were	 added.	 After	 mixing	 well,	 the	 homogenate	 was	
transferred	to	a	RNeasy	Mini	Spin	Column	(Qiagen)	to	a	maximum	of	700	µl	of	volume	per	column.	
From	here,	standard	protocol	for	RNeasy	columns	was	applied,	starting	in	the	step	of	washing	the	
column	with	RW1	buffer.	DNase	treatment	with	RNase-Free	DNase	Set	(Qiagen)	was	also	applied.	
3.2.6.5.	RNA	concentration	measurement	
RNA	yield	was	determined	using	a	spectrophotometer	ND	1000	(PeqLab,	Biotechnologie).	A	
drop	of	1	µl	was	applied	 in	 the	equipment	and	RNA	absorbance	values	were	measured.	Through	
measurement	of	absorbance	of	the	sample,	Nanodrop	makes	a	correlation	between	absorbance	and	
concentration	using	the	Beer-Lambert	law:	
A	=	a(	)	*	b	*	c	
where	 A	 is	 the	 measured	 absorbance,	 a(	 )	 is	 a	 wavelength-dependent	 absorptivity	
coefficient,	b	is	the	path	length,	and	c	is	the	sample	concentration.	
Nucleic	acids	have	an	absorbance	peak	of	UV	light	at	260	nm,	proteins	and	phenolic	acids	
have	a	strong	absorbance	at	280	nm	and	organic	compounds	as	Trizol,	around	230	nm.	For	pure	
RNA,	A260/A280	ratios	should	be	between	2.1	and	1.8,	and	the	ratio	A260/A230	should	be	close	to	
2.0.	This	is	crucial	for	the	success	of	the	next	steps.	
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3.2.6.6.	Complementary	DNA	(cDNA)	synthesis	
Reverse	transcription	(RT)	of	total	RNA	to	single-stranded	cDNA	was	performed	using	the	
High	Capacity	cDNA	Reverse	Transcription	Kit	(Thermo	Fischer).	This	kit	includes	10x	RT	buffer,	10x	
RT	 Random	primers,	Deoxynucleotide	 (dNTP)	Mix,	MultiScribe	 Transcriptase	 and	RNase	 Inhibitor	
(sometimes	not	included	in	the	kit).	The	master	mix	was	prepared	following	the	recipe	below,	in	a	
PCR	tube	of	0.1	ml	(Biozym):	
	
Volumes	per	reaction:	
3	µl	of	10x	RT-buffer;	
3	µl	of	10x	RT	Random	Primers;	
1.2	µl	of	dNTPs	(100M);	
1.5	µl	of	RNase	Inhibitor;	
1.5	µl	of	MultiScribe	Reverse	Transcriptase	(50	U/µl).	
	
For	DRG	samples,	a	volume	corresponding	 to	300	ng	of	extracted	RNA	was	added	to	 the	
reaction,	while	with	nerves,	100	ng	of	extracted	RNA	used	as	template.	RNase	free	water	was	added	
in	the	end	until	30	µl	of	the	reaction	volume.	Samples	were	mixed	and	centrifuged	before	the	PCR	
reaction.	The	reaction	was	performed	with	the	Fast	Thermal	Cycler	(Applied	Biosystems)	with	the	
following	conditions:	
Table	3.	PCR	protocol.	
	 Incubation	
Reverse	
Transcription	
MultiScribe	
inactivation	
Maintenance	
Temperature	(ºC)	 25	 37	 85	 4	
Time	(minutes)	 10	 120	 5	 ∝	
	
In	the	end	of	the	amplification,	samples	were	diluted	to	further	quantitative	RT-PCR	analysis	
or	were	stored	at	-30ºC.	
3.2.6.7.	Quantitative	RT-PCR	
To	quantify	the	relative	amount	of	mRNA	in	the	samples,	a	real-time	PCR	was	performed.	
Alterations	in	the	expression	profile	of	the	target	genes	were	analysed	in	the	different	paradigms	
and	time	points	in	the	distal	parts	of	sciatic	nerves	and	in	their	correspondent	DRG.	For	the	sham	
sample,	a	pool	of	the	sham	animals’	tissues	was	performed	at	each	time	point.		
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Gene	 expression	 can	 be	 indirectly	 measured	 by	 quantification	 of	 the	 cDNA	 that	 was	
previously	converted	from	the	messenger	RNA.	By	using	a	specific	primer-pair,	it	is	possible	to	target	
the	gene	sequence	of	interest	and	amplify	it	exponentially.	In	this	study,	KIF4A,	MPP3	and	TNN	genes	
were	the	target	genes.	TNN	was	further	abandoned	since	we	were	not	able	to	amplify	it,	even	after	
testing	3	different	primer-pairs,	probably	due	to	 its	 low	expression	levels.	Functional	primer	pairs	
were	 designed	 for	 the	 other	 two	 gene	 targets.	 A	 calibrator	 sample	 is	 needed	 as	 a	 physiological	
reference	to	compare	the	fold	increase	of	these	targets.	The	calibrator	samples	in	this	study	were	
the	sham	operated	animals	that	permitted	to	calculate	the	fold	increase	of	the	target	genes	in	the	
lesioned	animals.	The	expression	levels	of	MPP3	and	KIF4A	in	lesioned	animals	were	thus	compared	
to	their	expression	in	the	sham	operated	animals.	All	quantifications	needed	also	to	be	normalized	
to	an	endogenous	control,	 to	account	 for	variability	 in	 the	 initial	amount	of	 total	RNA	and	 in	 the	
reverse	transcription	reaction.	Ornithine	Decarboxylase	(ODC)	was	the	house	keeping	gene	and	it	
was	 used	 as	 an	 endogenous	 control	 since	 it	 showed	 an	 invariant,	 constitutive	 expression	 in	 the	
different	time	points	and	conditions.	
qRT-PCR	quantification	is	based	on	the	measurement	of	the	fluorescence	emitted	by	a	dye	
when	 it	 is	 incorporated	 in	 double	 stranded	 DNA.	 2x	 Power	 SYBR	 Green	 Master	 Mix	 (Applied	
Biosystems)	 was	 used,	 containing	 all	 the	 components	 needed	 for	 the	 PCR	 reaction	 and	 the	
fluorescence	emission,	including	Taq	DNA	Polymerase,	RT	buffer,	nucleotides,	Mg2+	and	Uracil-DNA-
Glycosylase	(UNG).		
The	protocol	was	performed	accordingly	to	the	SYBR	Green	manufacturer´s	guidelines.	
	
Primer-dependent	reaction	mix	for	a	final	volume	of	20	µl:	
Primer	forward	(5	µM)	à	1.2	µl	
Primer	reverse	(µM)	à	1.2	µl	
ddH2O	à	4.2	µl	
SYBR	Green	Master	Mix	(2x)	à	10	µl	
cDNA	à	3	µl	
	
The	reaction	mixes	and	cDNA	were	loaded	in	Reaction	Plates	of	0.1	mL	MicroAmp	Fast	96-
well	 (Applied	 Biosystems)	 and	 the	 quantification	 performed	 by	 a	 7900HT	 Fast	 in	 Real-Time	 PCR	
System	(Applied	Biosystems)	using	the	protocol	described	in	Table	4,	with	40	repeat	cycles.	 	
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Table	4.	RT-PCR	protocol.	
	 Step	1	 Step	2	 Step	3	 Step	4	
Temperature	(ºC)	 50	 95	 95	 60	
Time	(minutes)	 2	 10	 0.15	 1	
	
The	Real-time	Thermal	cycler	is	capable	of	detecting	this	fluorescence	levels	(ΔRn)	emitted	
in	each	cycle	of	DNA	generation	and	uses	them	to	construct	a	graphic	of	amplification	(Figure	10).	A	
threshold,	a	value	within	 the	exponential	growth	region	of	 the	amplification	curve,	 is	established	
manually	or	automatically.	This	value	is	used	to	calculate	the	Threshold	Cycle	(Ct)	value	which	is	the	
cycle	number	where	the	fluorescence	passes	the	threshold	(116).	All	measurements	were	performed	
with	duplicate	technical	replicas,	and	the	mean	of	Ct	value	per	condition	was	calculated	for	further	
analysis.	A	total	of	3	animals	per	condition	and	time	point	were	analysed	separately	and	graphics	
with	the	mean	values	and	standard	deviations	were	plotted.	
	
	
Figure	 10.	 Representative	 scheme	 of	 an	 amplification	 plot.	ΔRn:	 normalized	 reporter	 value.	 Adapted	 from	
(116).	
To	calculate	the	fold	change	using	the	Ct	values:	2^-
ΔΔCt	
Where	ΔCt=	Ct	target	gene	–	Ct	endogen	control	and	ΔΔCt	=	ΔCt	probe	-	ΔCt	calibrator.	
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3.2.6.8.	Dissociation	curve	protocol	
To	help	ensure	specificity	of	 the	selected	primers,	 the	dissociation	curve	of	 the	amplified	
product	 can	be	 constructed	 in	 the	end	of	 the	qRT-PCR	program,	 to	determine	 the	melting	point	
(Figure	11).	A	single,	sharp	peak	indicates	that	a	unique	specific	PCR	product	was	generated	with	the	
selected	set	of	primers,	but,	if	there	are	more	than	one	peak,	it	suggests	that	the	amplification	was	
not	specific	for	a	single	DNA	target	(116).	
	
													 	
	
Figure	11.	Representative	scheme	of	a	dissociation	curve	analysis.	A)	Normal	dissociation	curve;	B)	Example	of	
a	dissociation	curve	with	two	peaks	indicating	that	primer	pairs	are	not	specific	for	the	amplicon.	Adapted	from	
(116).	
3.2.6.9.	Statistical	Analysis	
Data	 is	 expressed	 as	 mean	 ±	 standard	 deviation	 of	 3	 biological	 replicates.	 Statistical	
significance	was	analysed	using	 the	one-sample	Student’s	T-Test	 in	GraphPad	Prism	 (version	5.0,	
GraphPad	Software,	Inc.).	Results	were	considered	statistically	significant	at	p<0.05.	 	
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3.2.7.	Immunohistochemical	analysis	
qRT-PCR	 analysis	 revealed	 that	 candidate	 genes	 expression	 is	 regulated	 in	 the	 analysed	
samples	but	the	extracted	tissue	can	possibly	be	contaminated	with	tissues	rather	that	the	nerve	
because	during	the	extraction	there	 is	always	other	structures	that	come	attached	to	the	nerves.	
Thus,	in	order	to	find	if	our	two	candidate	genes	are	neuronal	specific,	free	floating	cryosections	of	
the	SC	of	a	sham	animal	and	of	a	long	time	point	(weeks)	injured	animal,	with	50	µm,	were	provided	
by	Doctor	Veronica	Estrada	from	Molecular	Neurobiology	Laboratory	of	Heinrich	Heine	University	in	
Düsseldorf,	to	perform	immunohistochemistry.	A	SC	with	a	lumbar	lesion	from	an	animal	sacrificed	
3	days	after	transection	was	also	provided	for	further	cryopreservation	and	sectioning.		
Several	 rats	 were	 operated	 by	 Doctor	 Frank	 Bosse	 from	 the	 Molecular	 Neurobiology	
Laboratory	of	Heinrich	Heine	University	 in	Düsseldorf,	 receiving	peripheral	nerve	 lesion	 (crush	or	
transection	of	sciatic	nerve)	or	just	a	wound	to	be	used	as	sham	animals.	Collection	of	sciatic	nerves	
and	DRG	from	sacrificed	animals	was	performed	also	by	Doctor	Frank	Bosse,	with	my	help,	when	
possible.	
3.2.7.1.	Tissue	embedding	and	sectioning	
Free-floating	spinal	cord	cryo-sections:	To	avoid	crystallization	during	the	process	of	cryo-
embedding,	the	spinal	cord	of	a	lesioned	animal,	sacrificed	3	days	after	lesion,	was	immersed	in	30%	
sucrose	solution	for	48	hours,	until	the	water	in	the	tissue	was	completely	replaced	by	the	sucrose	
solution.	 Using	 a	 freezing	microtome,	 tissue	 was	 frozen	 in	 sucrose	 solution,	 and	 50	µm	 sagittal	
sections	were	cut,	transferred	to	a	multi-well	plate,	and	stored	in	PBS	at	4°C.	
Sciatic	nerve	and	DRG	cryo-sections	on	slides:	Tissues	were	immersed,	first	in	a	10%	sucrose	
in	PBS	solution	during	6-8	hours	and	then	transferred	to	a	30%	sucrose	solution	during	24	hours	to	
remove	all	the	water	of	the	tissue	and	avoid	destruction	of	the	normal	structure	by	crystallization.	
Using	a	Cryostat	(CM	3050	S,	Leica),	nerves	and	DRG	were	embedded	in	OCT	Compound	medium	
(Tissue	 TEK,	 Sakura),	 and	 10	 µm	 cross	 sections	 were	 made	 and	 transferred	 to	 Silane	 Treated	
Microscope	Slides	 (Marienfeld).	Before	storage,	slides	were	 left	 to	dry	at	RT	 for	30	min	and	then	
stored	at	-30°C.	
3.2.7.2.	Fluorescent	immunostaining	
All	 staining	 procedures	 were	 carried	 out	 according	 to	 the	 following	 general	 protocols.	
Different	antibodies	and	dilutions	were	applied	as	described	in	Table	5.	DAPI	(Roche)	was	used	to	
stain	the	nuclei.	During	stain	procedures	slides	were	kept	in	dark	humidified	chambers	to	prevent	
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dehydration	of	 the	 tissue	sections	and	 fluorochrome	 fading	of	 the	 secondary	antibodies.	Donkey	
serum	(DS,	Sigma-Aldrich)	was	diluted	in	PBS	1x	to	make	blocking	solution	and	primary	antibodies	
were	 incubated	 in	 this	solution,	while	secondary	antibodies	 incubation	was	performed	 in	DS-free	
PBS	1x.	Negative	controls	were	based	on	the	replacement	of	the	incubation	with	primary	antibodies	
by	incubation	with	blocking	solution	only,	to	test	the	reactivity	of	secondary	antibodies	and	check	
non-specific	binding.	
To	wash	out	all	sucrose	residues,	free	floating	sections	were	first	washed	in	PBS	1x	3	times	
during	 10	minutes	with	 agitation.	 A	 blocking	 step	was	 performed	 to	 avoid	 unspecific	 binding	 of	
antibodies,	with	5	%	DS	 for	1	hour	at	 room	temperature	with	agitation.	Primary	antibodies	were	
incubated	for	around	24	hours	(over	night)	at	4°C,	also	with	agitation.	Primary	antibodies	must	be	
well	 washed	 to	 prevent	 the	 accumulation	 of	 non-specific	 binding	 antibodies	 so,	 before	 the	
incubation	with	secondary	antibodies,	sections	were	washed	3	times,	during	5	minutes	each,	with	
PBS.	 To	 perform	 double	 staining,	 Donkey	 Alexa	 Anti-rabbit	 594	 (A21207;	 Thermo	 Scientific)	 and	
Donkey	Alexa	Anti-mouse	488	 (A21202;	Thermo	Scientific),	or	Donkey	Alexa	Anti-rat	488	 (A21208;	
Thermo	 Scientific),	 or	 Donkey	 Alexa	 Anti-goat	 488	 (A11055;	 Thermo	 Scientific),	 antibodies	 were	
incubated	simultaneously	with	a	working	dilution	of	1:500,	combined	with	DAPI	(1:10)	(Roche)	for	1	
hour	at	room	temperature.	After	washing	3	times	for	5	minutes,	tissues	were	immersed	in	70%	EtOH	
for	5	minutes	and	then	transferred	to	Sudanblack	0,3%	(Sigma-Aldrich)	for	7	minutes,	as	an	attempt	
to	reduce	background	fluorescence.	To	wash	excess	of	Sudanblack,	tissues	were	rinsed	around	10	
times	in	70%	EtOH	and	then	washed	3	times	for	5	minutes	each	wash	with	distilled	water.	Sections	
were	transferred	to	Glass	Microscope	Slides	(Mattrand)	and	let	dry	at	room	temperature	overnight.	
To	mount	the	coverslip	Immu-MountTM	(Thermo	Fisher)	was	used	as	mounting	medium.	
The	protocol	for	cryo-sections	in	slide	is	slightly	different.	Before	starting	the	staining,	slides	
needed	to	dry	 for	10	minutes	at	RT.	A	hydrophobic	PAP	Pen	(Abcam)	was	used	to	delimitate	the	
different	 sections	 in	 the	 same	slide.	To	hydrate	 the	 tissue	and	 remove	 the	OCT	cutting	medium,	
tissue	was	covered	with	PBS	for	10	minutes	and	then	rinsed	in	PBS	to	remove	the	remaining	medium.	
Before	starting	the	incubation	with	antibodies,	all	epitopes	on	the	sample	were	blocked	to	prevent	
the	nonspecific	bindings	of	the	antibodies,	with	a	blocking	solution	of	10%	DS/PBS	1x,	for	1	hour	at	
RT.	After	blocking,	incubation	with	primary	and	secondary	antibodies	was	performed	as	previously	
described.	After	washing	secondary	antibodies	that	did	not	bind	specifically	to	the	tissue,	a	last	wash	
step	was	made	with	 distilled	water	 and	 slides	were	 left	 to	 dry	 over	 night,	 before	mounting	 the	
coverslips	with	Fluoromount	G®	(Southern	Biotech).	
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Various	antibodies	(described	in	Table	5)	were	used	against	known	neuronal	or	glial	markers.	
PAN	is	a	neurofilament	marker	for	axons;	MBP	is	a	myelin	marker,	S100	is	a	protein	characteristic	of	
Schwann	 cells,	 glial	 cells	 and	 satellite	 cells;	 PDGFR-α	 is	 a	 receptor	 present	 in	 oligodendrocytes,	
astrocytes,	 Schwann	 cells,	 platelets	 and	 fibroblasts;	 GFAP	 is	 expressed	 by	 glial	 cells;	 NF200	 is	 a	
neurofilament	and	is	also	distributed	in	the	cell	bodies	of	bigger	DRG	cells;	and	IB4	is	a	lectin	that	
binds	to	smaller	DRG	neurons.	
Table	5.	Description	of	primary	antibodies	or	dies,	and	working	solutions.	
ANTIBODY/DYE	 PROTEIN	 SUPPLIER	 CATALOGUE	#	 HOST/ISOTYPE	
WORKING	
DILUTION	
ANTI-KIF4A	
Kinesin	Family	
Member	4A	 MyBioSource	 MBS2518989	
Rabbit	IgG	
polyclonal	
1:700	
	
ANTI-MPP3	
Membrane	
Palmitoylated	
Protein	3	
ProteinTech	 14650-1-AP	 Rabbit	IgG	
polyclonal	
1:60	
ANTI-PAN	(SMI	
312)	
Neurofilament	 Covance	 SMI-312R	
Mouse	IgG1	
monoclonal	
1:1000	
ANTI-MBP	
Myelin	Basic	
Protein BioRad	 Aa82-87	
Rat	IgG2a	
monoclonal	
1:250	
ANTI-S100	
[B32.1]	
S100	Calcium	
Binding	Protein	
A1	
Abcam	 Ab7852	
Mouse	IgG1	
monoclonal	 1:200	
ANTI-PDGFR-α	
Platelet-
derived	
growth	factor	
receptor	alpha	
Neuromics	 GT15150	 Goat	IgG	 1:250	
ANTI-GFAP	
Glial	fibrillary	
acidic	protein	
Chemicon	 MAB3402	
Mouse	IgG1	
monoclonal	
1:1000	
ANTI-NF200	
[N52]	
Neurofilament	
200	 Sigma-Aldrich	 N0142	
Mouse	IgG1	
monoclonal	 1:50	
IB4	(LECTIN)	 Isolectin	B4	 Sigma-Aldrich	 L	2895	 Isolectin	B4	 1:20	
	
3.2.7.3.	Microscopy	analysis	
Fluorescent	 labelling	 was	 analysed	 in	 a	 fluorescence	microscope	 Axioplan	 2	 (Zeiss)	 with	
AxioVision	 Rel	 4.8	 software	 (Zeiss)	 or	 by	 confocal	 microscopy	 with	 LSM	 510	 Meta	 confocal	
microscope	(Carl	Zeiss);	40x	oil	objective.	Images	were	analysed	and	edited	using	ImageJ	2.0.0.	(NIH).	
	 	
	4.	Results	 	
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4.1.	Bioinformatics	analysis	
This	subsection	describes	the	bioinformatics	analysis	performed	in	this	study	and	its	main	
results.	This	analysis	had	a	 few	transcriptomic	studies	of	SCI	as	a	starting	point,	 in	a	comparative	
analysis	to	find	common	regulated	genes	in	spinal	cord	partial	regenerative	paradigms.		
4.1.1.	Selection	of	transcription	studies	
The	main	aim	of	this	first	analysis	was	to	identify	putative	RAGs,	genes	whose	expression	is	
consistently	regulated	during	spinal	cord	injury	events.	For	that,	studies	of	animal	models	of	spinal	
cord	 injury,	 where	 a	 regenerative	 approach	 was	 applied	 with	 at	 least	 partial	 success,	 and	 a	
transcription	study	of	the	expression	pattern	of	all	genome	at	the	lesion	site	was	performed,	were	
selected.	These	genome	wide	expression	(GWE)	studies	have	been	performed	with	microarray	or	
RNA-sequencing	technology.	Common	DEGs	-	putative	RAG	genes	-	were	investigated.	
A	search	using	the	keywords	“spinal	cord	 injury”	OR	“spinal	cord	regeneration”	OR	“axon	
regeneration”,	with	filter	for	rattus	and	mus	muscullus	species,	resulted	in	36	studies	in	GEO,	Array	
Express	and	SRA	databases,	and	an	additional	research	in	Pubmed	retrieved	33	results	(Figure	12).		
A	 selection	based	on	 inclusion	and	exclusion	 criteria	was	 applied,	 and	only	 three	 studies	
revealed	to	fulfil	the	purpose	of	this	work.	The	search	strategy	is	described	in	Figure	12	and	selected	
studies	are	described	in	Table	6.	
	
Figure	12.	Flow	chart	displaying	the	search	strategy.	Studies	with	analysis	of	the	entire	genome	of	rats	or	mices	
with	spinal	cord	injury	and	where	a	regenerative	approach	was	applied,	were	selected	for	further	analysis	and	
comparison.	After	screening,	three	studies	were	included	in	this	bioinformatics	study.	
Additional	records	
(PubMed)	
Total:33	
Records	identified	through	
transcriptomic	databases	
(GEO;	Array	Express;	SRA)	
Total:	36	
	
Records	screened	for	
eligibility	
Records	excluded	
Not	eligible	
Not	available	
Not	classifiable	
Total:66	
Datasets	included	in	this	
comparative	study	
Total:	3	
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Table	6	–	Datasets’	characteristics	and	information	of	the	selected	studies.	
Author(s)	 Year	 Dataset	title	 Dataset	ID	 Database	
Duan	H,	Ge	W,	Zhang	A,	Xi	Y,	
Chen	Z,	Luo	D,	Cheng	Y,	Fan	
KS,	Horvath	S,	Sofroniew	MV,	
Cheng	L,	Yang	Z,	Sun	YE,	Li	X.	
2015	 Expression	data	from	adult	Wistar	
female	rat	5mm	spinal	cord	tissue	
E-GEOD-
69334	
Array	
Express	
Munro	KM,	Perreau	VM,	
Turnley	AM.	 2012	
Differential	Response	Following	
Spinal	Cord	Injury	in	EphA4	
Knockout	
E-GEOD-
34430	
Array	
Express	
Satzer	D,	Miller	C,	Maxon	J,	
Voth	J,	DiBartolomeo	C,	
Mahoney	R,	Dutton	JR,	Low	
WC,	Parr	AM	
2015	
T	Cell	Deficiency	in	Spinal	Cord	
Injury:	Altered	Locomotor	Recovery	
and	Whole-Genome	
Transcriptional	Analysis	
GSE62760	 GEO	
	
The	 expression	 profile	 study	 E-GEOD-69334,	 deposited	 by	 Xiaoguang	 Li	 and	 Yi	 E	 Sun,	
analysed	tissue	of	animals	that	received	a	Neurotrophin-3	(NT3)-loaded	chitosan	in	the	empty	lesion	
site	after	a	complete	spinal	cord	transection	in	the	thoracic	spinal	tract.	Other	interventions	were	
performed	 but	 they	 had	 no	 interest	 to	 this	 study.	 At	 1,	 3,	 10,	 20,	 30,	 60,	 90	 dpi,	 animals	were	
sacrificed	and	lesion	site	tissue	of	treated	animals	and	injured	animals	without	treatment	was	used	
to	 make	 the	 transcriptomic	 analysis.	 The	 authors	 described	 that	 the	 treated	 animal	 group	
demonstrated	better	functional	recovery	after	SCI	(117).	
The	expression	profile	E-GEOD-34430,	deposited	by	Ann	M.	Turnley,	Kathryn	M.	Munro	and	
Victoria	M	Perreau,	analysed	mice	lacking	the	developmental	axon	guidance	molecule	Ephrin	type-
A	 receptor	4	 (EphA4).	Previously	has	been	 shown	 that	blocking	of	 the	EphA4	 receptor	promotes	
axonal	 regeneration	 and	 functional	 recovery	 following	 SCI.	 These	 authors	 have	 performed	 a	
microarray	analysis	of	spinal	cord	tissue	from	the	lesion	site	of	mice	with	spinal	cord	injury	and	sham	
injured	 controls.	 Mice	 were	 sacrificed	 four	 days	 after	 a	 complete	 hemisection	 injury.	 Axonal	
regeneration	and	functional	recovery	was	observed	 in	these	EphA4	knockout	(KO)	mice	following	
injury.	Comparison	was	made	between	gene	expression	of	injured	KO	animals	and	of	injured	wild-
type	animals	(106).	
The	transcription	study	GSE62760,	deposited	by	Ann	Margaret	Parr,	analysed	T-cell	deficient	
athymic	nude	(AN)	rats	that	recovered	better	than	immunocompetent	control	Sprague-Dawley	(SD)	
rats	following	spinal	cord	transection.	In	this	study,	the	authors	evaluated	locomotor	recovery	in	SD	
and	 AN	 rats	 following	moderate	 spinal	 cord	 contusion.	 To	 understand	 this	 differential	 recovery,	
whole-genome	expression	was	accessed	using	Ribonucleic	acid	(RNA)	sequencing,	 in	the	acute	(1	
wpi)	and	chronic	(8	wpi)	phases	of	recovery.	AN	rats	demonstrated	greater	locomotor	function	than	
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SD	rats	only	at	1-wpi,	coinciding	with	the	peak	of	T	cell	infiltration	in	immunocompetent	rats.	For	this	
reason,	only	the	data	from	the	1-week	time-point	was	included	in	the	study	here	presented	(118).	
Selected	 studies	 presented	 different	 types	 of	 spinal	 cord	 lesion,	 different	 regenerative	
attempt	treatments	and	2	different	but	similar	rodent	models,	but	they	share	similar	lesion	sites	and	
they	 all	 affirm	 that	 the	 regenerative	 genetic	 or	 scaffold	 and	 chemical	 strategies	 have	 improved	
recovery	after	lesion,	in	the	treated	animals.	The	selected	studies	and	their	characteristics	can	be	
seen	in	Table	7.	
Table	7	-	Characteristics	of	selected	gene-expression	studies	of	spinal	cord	injury	with	regenerative	
approaches.	
	
4.1.2.	Data	extraction	
Files	of	samples	of	interest	were	downloaded	from	the	transcriptomic	databases	mentioned	
or	from	supplementary	information	of	the	scientific	paper	reporting	the	study.	
From	transcriptomic	study	E-GEOD-69334,	datasets	of	3	samples	for	each	condition	were	
extracted.	Data	from	tissue	of	non	injured	animal,	from	the	lesion	site	of	injured	animals	at	3,	10,	20,	
30,	60,	90	dpi	time-points	of	NT3	treated	animals,	and	from	lesion	control	animals,	was	extracted.	A	
total	of	39	expression	profiles	of	this	study	were	downloaded.	Mean	expression	values	of	the	three	
samples	(biological	replicates)	per	condition	were	calculated	before	any	further	analysis.	Lesioned	
animals	that	did	not	receive	treatment	were	here	used	as	control	samples.	
Study	 Species	 Injury	
site	
Animals	
genre	
and	age	
Tissue	
examined	
Time	
points	
Type	of	
injury	
Treatment	 Analysis	
Hongmei	
Duan	
	
E-GEOD-
69334	
Rattus	
norvegicus	
T7-T8	 Females	
6-	to	8-
wk-old	
	
Lesion	site	
Caudal	
Rostral	
1dpi,	
3dpi,	
10dpi,	
20dpi,	
30dpi,	
60dpi,	
90dpi	
Complete	
transection	
NT3	
treatment	
with		chitosan	
tubular	
scaffold	
Affymetrix	
GeneChip	(Rat	
Genome	230)	
2.0	
Kathryn	
M.	Munro	
	
E-GEOD-
34430	
Mus	
musculus	
T13-L1	 Mix	
10-	to	14-
wk-old	
Lesion	site	 4dpi	 Left	
hemisection	
with	
complete	
transaction	
	
EphA4	
knockout	rats	
Affymetrix	
Mouse	All-
Exon	ST	Array	
GeneChipsTM	
David	
Satzer	
	
GSE62760	
Rattus	
norvegicus	
T8-T9	 Females	
16-to	18-	
wk-old	
Lesion	site	
Caudal	
Rostral	
1wpi,	
8wpi	(no	
improved	
recovery	
observed)	
Contusion	
at	a	force	of	
200	kdyn	
T-cell	
deficient	
athymic	nude	
rats	
HiSeq	2000	
(Illumina)	
Dpi:	days	post-injury;	wpi:	weeks	post-injury;	wk:	week;	NT3:	neurotrophin	3;	EphA4:	Ephrin	Type-A	
Receptor	4.	
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In	 the	 transcription	 study	 E-GEOD-34430,	 6	 datasets	 were	 of	 interest	 for	 this	 study,	
corresponding	to	3	wild-type	animals	that	received	injury	and	3	knockout	animals	that	also	suffered	
injury.	Knockout	animals	were	used	as	control	values	in	this	study.	
From	the	transcription	study	GSE62760,	3	samples	per	group	were	extracted.	The	datasets	
of	interest	were	from	Acute	SD	group	and	Acute	AN	group,	being	SD	rats	the	control	group.	
4.1.3.	Data	pre-processing	and	DEGs	screening	
Using	 Excel,	 mean	 values	 for	 each	 condition	 were	 calculated	 and	 fold	 increases	 were	
calculated	by	comparing	 treated	 injured	animals	with	non	treated	animals,	at	each	specific	 time-
point.	A	fold-change	of	1.2	was	set	as	threshold	value.	The	DEGs	obtained	were	the	following:	
In	the	E-GEOD-34430	study,	2,003	microarray	codes	were	up-regulated	while	1,821	were	
down-regulated.	
In	 GSE62760,	 2,924	 transcripts	 presented	 a	 positive	 fold-increase	 and	 4,520	were	 down	
regulated	when	compared	to	the	non	treated	control.	
In	the	E-GEOD-69334	study,	the	data	from	the	different	time-points	was	assembled	together	
and	1,267	probes	were	identified	as	up-regulated,	while	679	had	lower	expression	values	than	the	
control	ones.	
4.1.4.	Conversion	to	human	orthologs	
In	an	attempt	to	normalize	the	data	used	in	this	master	thesis	and	make,	at	the	same	time,	
the	conversion	of	the	microarray	codes	to	the	gene	names,	the	six	DEGs	lists	were	uploaded	to	the	
Biomart	online	tool	and	human	orthologs	were	retrieved	(see	Supplementary	Table	1.	in	appendix).	
Orthology	conversion	can	lead	to	a	larger	number	of	DEGs	in	the	end	of	the	analysis	because	some	
rat	 or	mice	 genes	 can	 be	 converted	 in	more	 than	 one	 human	 gene,	 by	 human	 homology	 ‘type	
one2many’.	 Results	 for	 ‘many2many’	 homology	 were	 excluded,	 as	 well	 as	 genes	 with	 human	
orthology	confidence	of	0.	
For	 the	 E-GEOD-34430	 study,	 after	 cleaning	 the	 results	 according	 to	 the	 parameters	
established,	 1,689	 of	 the	 up-regulated	 ones	 were	 retrieved	 (84.3%)	 and	 1,550	 down-regulated	
(85.1%).	 In	 the	GSE	62760	study,	2,340	up-regulated	human	orthologs	were	 identified	 (80%)	and	
3,814	of	the	down-regulated	ones	(84%)	were	obtained,	and	for	the	E-GEOD-69334	study,	1,086	up-
regulated	genes	were	converted	(86%)	and	866	of	the	down-regulated	genes	(126%)	have	a	human	
ortholog.	
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4.1.5.	Comparison	of	expression	profiles	
Venn	diagrams	were	constructed	to	assess	overlaps	of	DEGs	between	the	three	studies.	In	
the	down-regulated	DEGs	(Figure	13.A.),	31	genes	are	common	to	the	three	studies	and	in	the	up-
regulated	 group	 (Figure	 13.B.),	 38	 genes	 are	 differential	 expressed	 in	 the	 three	 studies.	 A	 great	
overlap	 is	 also	 observed	 when	 comparing	 groups	 two	 by	 two.	 The	 complete	 table	 with	 the	
intersections	 between	 the	 three	 studies	 of	 up-	 and	 down-regulated	 genes	 can	 be	 consulted,	 in	
Appendix,	Supplementary	Table	2.	
	
	
Figure	13.	Comparison	of	expression	profiles	of	the	three	analysed	studies.	A)	Venn	diagram	of	down-regulated	
DEGs	 in	 the	three	analysed	datasets:	31	differential	expressed	genes	are	commonly	down-regulated	 in	the	
three	studies;	B)	Venn	diagram	of	up-regulated	DEGs	in	the	three	analysed	datasets:	38	of	the	down-regulated	
genes	were	found	to	be	common	to	the	three	studies.	KO:	knock	out;	Mo:	mouse;	NT3:	Neurotrophin	3;	EphA4:	
Ephrin	Type-A	Receptor	4.	
The	 two	 lists	 of	 common	 DEGs	 were	 uploaded	 to	 UniProtKB	 database	 and	 some	 useful	
information	 regarding	 biological	 function	 was	 retrieved.	 In	 Table	 8	 are	 presented	 the	 down-
regulated	common	genes	and	in	Table	9	are	presented	the	up-regulated	common	genes.	With	this	
analysis	it	was	possible	to	see	that	some	of	the	genes	found	to	be	commonly	regulated	in	the	three	
analysed	 studies	 are	 related	 with	 neuronal	 pathologies,	 neuronal	 tissue	 expression	 and	 some	
phenotypes	of	interest,	like	axonal	and	brain	development.	This	was	a	starting	point	to	select	specific	
genes	for	further	experimental	testing.	 	
A. B.
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Table	8.	UniProtKB	retrieved	information,	reviewed	by	Swiss	Prot	of	common	down-regulated	genes.	
	
Gene	name Uniprot	 Protein	name Tissue	specificity Mamalian	Phenotype	by	MGI	database
NAT8 Q9UHE5 N-acetyltransferase	8
Preferentially	expressed	in	liver	and	kidney.	
Also	detected	in	brain	(at	protein	level).	
PubMed:22267734,	PubMed:9852678.
GPC3 P51654 Glypican-3	(GTR2-2) Highly	expressed	in	lung,	liver	and	kidney.
HCAR3 P49019
Hydroxycarboxylic	acid	
receptor	3
Expression	largely	restricted	to	adipose	
tissue	and	spleen.	PubMed:12522134.
HCAR2 Q8TDS4
Hydroxycarboxylic	acid	
receptor	2
Expression	largely	restricted	to	adipose	
tissue	and	spleen.	Expressed	on	mature	
neutrophils	but	not	on	immature	neutrophils	
or	eosinophils.	PubMed:12522134,	
TP53BP2 Q13625
Apoptosis-stimulating	of	
p53	protein	2	
Widely	expressed.	Expressed	in	spleen,	
thymus,	prostate,	testis,	ovary,	small	
intestine,	colon	and	peripheral	blood	
leukocyte.	Reduced	expression	in	breast	
carcinomas	expressing	a	wild-type	TP53	
protein.	Overexpressed	in	lung	cancer	cell	
lines.	PubMed:10498867,	
PubMed:10631318,	PubMed:11684014.
Abnormal	brain	morphology	(MP:0002152);	abnormal	
cerebral	cortex	morphology	(MP:0000788);	abnormal	
cortical	plate	morphology	(MP:0008439);	abnormal	
cortical	ventricular	zone	morphology	(MP:0008458);	
abnormal	embryonic	neuroepithelial	cell	proliferation	
(MP:0012704);	abnormal	embryonic	neuroepithelium	
morphology	(MP:0004261);	abnormal	neuronal	
migration	(MP:0006009);	abnormal	neuronal	
precursor	proliferation	(MP:0004948);	abnormal	
neuron	differentiation	(MP:0009937);	abnormal	retina	
morphology	(MP:0001325);	abnormal	stratification	in	
cerebral	cortex	(MP:0000790);	dilated	brain	ventricles	
(MP:0012676);	hydroencephaly	(MP:0001891);	
increased	embryonic	neuroepithelial	cell	proliferation	
(MP:0012705);	increased	neuronal	precursor	cell	
PCDHB4 Q9Y5E5 Protocadherin	beta-4
CTNNAL1 Q9UBT7
Alpha-catulin	(Catenin	
alpha-like	protein	1)
Widely	expressed.	Expressed	at	lower	level	
in	neural	tissues	and	at	the	highest	level	in	
the	adrenal	gland.	PubMed:10542337,	
PubMed:12270917,	PubMed:9806841.
RPRM Q9NS64 Protein	reprimo
PCDH8 O95206 Protocadherin-8	
KCNK2 O95069
Potassium	channel	
subfamily	K	member	2
Isoform	4	is	detected	in	kidney,	adrenal	gland	
and	brain	where	it	is	preferentially	expressed	
in	the	amygdala	but	not	found	in	thalamus,	
hypothalamus,	hippocampus	or	substantia	
KCNAB2	
KCNK2
Q13303
Voltage-gated	potassium	
channel	subunit	beta-2	
Detected	in	myelinated	nerve	fibers	in	the	
spinal	cord,	in	the	juxtaparanodal	region	of	
the	nodes	of	Ranvier,	but	also	in	the	
paranodal	region.	PubMed:11086297.	
Detected	in	hippocampus	(at	protein	level)	
PubMed:21357749.	Detected	in	
Abnormal	learning/memory/conditioning	
(MP:0002063);	abnormal	nervous	system	
electrophysiology	(MP:0002272);	
behavior/neurological	phenotype	(MP:0005386).
PKHD1L1 Q86WI1
Fibrocystin-L		(PKHD1-
like	protein	1)
Ubiquitous.	Expressed	in	spleen	and	thymus	
as	well	as	in	activated	T-cells	and	B-
lymphoblasts.	PubMed:12620974.
PAX8 Q06710 Paired	box	protein	Pax-8
Expressed	in	the	excretory	system,	thyroid	
gland	and	Wilms	tumors.
SLCO1A2	 P46721
Solute	carrier	organic	
anion	transporter	family	
member	1A2
LTB Q06643 Lymphotoxin-beta Spleen	and	thymus.
TMEM215 Q68D42 Transmembrane	protein	
EPHA4 P54764 Ephrin	type-A	receptor	4 Ubiquitous.
Abnormal	axon	guidance	(MP:0002961);	abnormal	
axon	morphology	(MP:0005404);	abnormal	barrel	
cortex	morphology	(MP:0003989);	abnormal	
corticospinal	tract	morphology	(MP:0002878);	
abnormal	innervation	(MP:0002184);	abnormal	
innervation	pattern	to	muscle	(MP:0001052);	
abnormal	motor	neuron	innervation	pattern	
(MP:0000940);	abnormal	nerve	fiber	response	
(MP:0003477);	abnormal	primary	somatosensory	
cortex	morphology	(MP:0000860);	abnormal	spinal	
cord	dorsal	column	morphology	(MP:0009677);	
abnormal	spinal	cord	morphology	(MP:0000955);	
abnormal	thalamus	morphology	(MP:0000832);	
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EPHA4 P54764 Ephrin	type-A	receptor	4 Ubiquitous.
Abnormal	axon	guidance	(MP:0002961);	abnormal	
axon	morphology	(MP:0005404);	abnormal	barrel	
cortex	morphology	(MP:0003989);	abnormal	
corticospinal	tract	morphology	(MP:0002878);	
abnormal	innervation	(MP:0002184);	abnormal	
innervation	pattern	to	muscle	(MP:0001052);	
abnormal	motor	neuron	innervation	pattern	
(MP:0000940);	abnormal	nerv 	fiber	response	
(MP:0003477);	abnormal	primary	somatosensory	
cortex	morphology	(MP:0000860);	abnormal	spinal	
cord	dorsal	column	morphology	(MP:0009677);	
abnormal	spinal	cord	morphology	(MP:0000955);	
abnormal	thalamus	morphology	(MP:0000832);	
Gene	name Uniprot	 Protein	name Tissue	specificity Mamalian	Phenotype	by	MGI	database
DYNC1	I	1 O14576
Cytoplasmic	dynein	1	
intermediate	chain	1
IGSF1 Q8N6C5
Immunoglobulin	
superfamily	member	1	
Highly	expressed	in	pancreas,	testis	and	fetal	
liver.	Moderately	expressed	in	heart,	prostate	
and	small	intestine.	Expressed	at	very	low	
levels	in	brain,	thymus,	ovary,	colon,	fetal	
lung	and	fetal	kidney.	Expressed	in	muscle.	
Isoform	3	is	expressed	in	pituitary	gland.	
PubMed:11854097,	PubMed:23143598,	
Abnormal	pituitary	gland	morphology	(MP:0000633).
CYP2J2 P51589 Cytochrome	P450	2J2	
Highly	expressed	in	heart,	present	at	lower	
levels	in	liver,	ileum,	jejunum,	colon,	and	
KLHL23 Q8NBE8 Kelch-like	protein	23
AOX1 Q06278 Aldehyde	oxidase	1
Abundant	in	liver,	expressed	in	adipose	
tissue	and	at	lower	levels	in	lung,	skeletal	
muscle,	pancreas.	In	contrast	to	mice,	no	
significant	gender	difference	in	AOX1	
expression	level	(at	protein	level).	
PubMed:18066686,	PubMed:18671973,	
PubMed:20444863,	PubMed:22031625,	
MTMR11 A4FU01
Myotubularin-related	
protein	11	
Expressed	in	bone	marrow,	spleen	and	
thymus.	PubMed:17498563.
RAMP1 O60894
Receptor	activity-
modifying	protein	1
Expressed	in	many	tissues	including	the	
uterus,	bladder,	brain,	pancreas	and	gastro-
intestinal	tract.	PubMed:9620797.
RET P07949
Proto-oncogene	tyrosine-
protein	kinase	receptor	
Ret
Abnormal	innervation	(MP:0002184);	abnormal	
innervation	pattern	to	muscle	(MP:0001052);	
abnormal	motor	neuron	innervation	pattern	
(MP:0000940);	abnormal	neuromuscular	synapse	
morphology	(MP:0001053);	abnormal	neuron	
differentiation	(MP:0009937);	abnormal	neuron	
morphology	(MP:0002882);	abnormal	
neurotransmitter	secretion	(MP:0005445);	abnormal	
parasympathetic	postganglionic	fiber	morphology	
(MP:0008313);	abnormal	prevertebral	ganglion	
morphology	(MP:0008316);	abnormal	sympathetic	
ganglion	morphology	(MP:0001008);	abnormal	
sympathetic	neuron	morphology	(MP:0001025);	
decreased	motor	neuron	number	(MP:0000939);	
ALPL P05186
Alkaline	phosphatase,	
tissue-nonspecific	
Abnormal	spinal	nerve	morphology	(MP:0001077)
CEMIP Q8WUJ3
Cell	migration-inducing	
and	hyaluronan-binding	
protein	
Expressed	in	dermal	and	in	synovial	
fibroblasts.	Strongly	expressed	in	gastric	
cancers	compared	with	the	paired	normal	
tissues.	Strongly	expressed	in	both	ductal	
carcinoma	and	invasive	breast	cancer	cells	
compared	with	benign	epithelial	cells	(at	
protein	level).	Strongly	expressed	in	brain,	
placenta,	prostate,	breast,	lung	and	testis.	
Expressed	in	fibroblasts,	epithelial	cells	and	
cancer	cells.	In	ear,	it	is	specifically	
expressed	in	inner	ear.	Expressed	in	cochlea	
and	vestibule	tissues.	Strongly	expressed	in	
gastric	cancers	compared	with	the	paired	
normal	tissues.	Strongly	expressed	in	colon	
adenocarcinomas	compared	with	normal	
colonic	mucosas.	Strongly	expressed	in	
breast	cancer	as	compared	to	normal	breast	
TIAM1 Q13009
T-lymphoma	invasion	and	
metastasis-inducing	
protein	1
Found	in	virtually	all	analyzed	tumor	cell	lines	
including	B-	and	T-lymphomas,	
neuroblastomas,	melanomas	and	
Abnormal	diencephalon	morphology	(MP:0000830);	
abnormal	forebrain	morphology	(MP:0000783);	
anencephaly	(MP:0001890);	exencephaly	
GZMB P10144 Granzyme	B
COL2A1 P02458
Collagen	alpha-1(II)	chain	
(Alpha-1	type	II	collagen)
Isoform	2	is	highly	expressed	in	juvenile	
chondrocyte	and	low	in	fetal	chondrocyte.	
PubMed:2355003.
Abnormal	brain	development	(MP:0000913);	
abnormal	forebrain	development	(MP:0003232);	
abnormal	forebrain	morphology	(MP:0000783);	
PPL	 O60437 Periplakin	
Expressed	in	stratified	squamous	epithelia	
and	in	some	other	epithelia.	
ABLIM3 O94929
Actin-binding	LIM	protein	
3
Expressed	predominantly	in	heart	and	brain.	
PubMed:17194709.
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Table	9.	UniProtKB	retrieved	information,	reviewed	by	Swiss	Prot	of	common	up-regulated	genes.	
	
Gene	
name
Uniprot	
Entry
Protein	name Tissue	specificity Involvement	in	disease
Mammalian	Phenotype	by	MGI	
database
TIMELESS Q9UNS1
Protein	timeless	
homolog
Expressed	in	all	tissues	examined	including	brain,	heart,	
lung,	liver,	skeletal	muscle,	kidney,	placenta,	pancreas,	
spleen,	thymus	and	testis.	Highest	levels	of	expression	in	
placenta,	pancreas,	thymus	and	testis.	PubMed:9856465,	
PubMed:9891984.
POLE Q07864
DNA	polymerase	
epsilon	catalytic	
subunit	A
IL1RL1 Q01638
Interleukin-1	
receptor-like	1
Highly	expressed	in	kidney,	lung,	placenta,	stomach,	skeletal	
muscle,	colon	and	small	intestine.	Isoform	A	is	prevalently	
expressed	in	the	lung,	testis,	placenta,	stomach	and	colon.	
Isoform	B	is	more	abundant	in	the	brain,	kidney	and	the	
liver.	Isoform	C	is	not	detected	in	brain,	heart,	liver,	kidney	
and	skeletal	muscle.	Expressed	on	T-cells	in	fibrotic	liver;	at	
protein	level.	Overexpressed	in	fibrotic	and	cirrhotic	liver.	
PubMed:11478810,	PubMed:19508382.
SRPX2 O60687
Sushi	repeat-
containing	protein	
SRPX2
Expressed	in	neurons	of	the	rolandic	area	of	the	brain	(at	
protein	level).	Highly	expressed	in	the	brain,	placenta,	lung,	
trachea,	uterus,	adrenal	gland,	heart,	ovary	and	placenta.	
Weakly	expressed	in	the	peripheral	blood,	brain	and	bone	
marrow.	Expressed	in	numerous	cancer	cell	lines	and	in	
gastrointestinal	cancer	cells.	Higher	levels	found	in	colorectal	
cancers	than	in	normal	colonic	mucosa.	PubMed:16497722,	
PubMed:18718938,	PubMed:19065654,	PubMed:22242148,	
PubMed:9864177.
	Rolandic	epilepsy	with	speech	dyspraxia	
and	mental	retardation	X-linked	(RESDX)	
[MIM:300643]:	A	condition	
characterized	by	the	association	of	
rolandic	seizures	with	oral	and	speech	
dyspraxia,	and	mental	retardation.	
PubMed:16497722.
NCAPG2 Q86XI2
Condensin-2	
complex	subunit	G2	
MMS22L Q6ZRQ5
Protein	MMS22-like	
(Methyl	
methanesulfonate-
sensitivity	protein	22-
like)
BRCA1 P38398
Breast	cancer	type	1	
susceptibility	protein	
Isoform	1	and	isoform	3	are	widely	expressed.	Isoform	3	is	
reduced	or	absent	in	several	breast	and	ovarian	cancer	cell	
lines.
Abnormal	embryonic	
neuroepithelial	layer	
differentiation	(MP:0000786);	
abnormal	nervous	system	
morphology	(MP:0003632);	
exencephaly	(MP:0000914).
CA9 Q16790
Carbonic	anhydrase	
9	
Expressed	primarily	in	carcinoma	cells	lines.	Expression	is	
restricted	to	very	few	normal	tissues	and	the	most	abundant	
expression	is	found	in	the	epithelial	cells	of	gastric	mucosa.
SLC10A7 Q0GE19
Sodium/bile	acid	
cotransporter	7	
CD163 Q86VB7
Scavenger	receptor	
cysteine-rich	type	1	
protein	M130
Expressed	in	monocytes	and	mature	macrophages	such	as	
Kupffer	cells	in	the	liver,	red	pulp	macrophages	in	the	
spleen,	cortical	macrophages	in	the	thymus,	resident	bone	
marrow	macrophages	and	meningeal	macrophages	of	the	
central	nervous	system.	Expressed	also	in	blood.	Isoform	1	is	
the	lowest	abundant	in	the	blood.	Isoform	2	is	the	lowest	
abundant	in	the	liver	and	the	spleen.	Isoform	3	is	the	
predominant	isoform	detected	in	the	blood.	
PubMed:10577520,	PubMed:11196644,	PubMed:16434690.
TC2N Q8N9U0
Tandem	C2	domains	
nuclear	protein
DSCC1 Q9BVC3
Sister	chromatid	
cohesion	protein	
DCC1
CENPI Q92674 Centromere	protein	I
FCRLA Q7L513 Fc	receptor-like	A
Expressed	specifically	in	primary	and	secondary	lymphoid	
tissues	like	lymph	node,	spleen	and	tonsil.	Specifically	
expressed	in	B-cells	with	a	high	level	in	normal	germinal	
center	B-cells,	centroblasts	and	in	a	subset	of	diffuse	large	B-
cell	lymphomas.	Highly	expressed	in	bone	marrow	B-cells	
and	weakly	in	earlier	B	lineage	cells.	Expressed	in	pre-
germinal	and	germinal	center	B-cells	in	secondary	lymphoid	
tissues.	Also	expressed	in	melanoma	and	melanocytes.	
PubMed:11754007,	PubMed:11891275,	PubMed:12202404,	
PubMed:15551350.
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FCRLA Q7L513 Fc	receptor-like	A
Expressed	specifically	in	primary	and	secondary	lymphoid	
tissues	like	lymph	node,	spleen	and	tonsil.	Specifically	
expressed	in	B-cells	with	a	high	level	in	normal	germinal	
center	B-cells,	centroblasts	and	in	a	subset	of	diffuse	large	B-
cell	lymphomas.	Highly	expressed	in	bone	marrow	B-cells	
and	weakly	in	earlier	B	lineage	cells.	Expressed	in	pre-
germinal	and	germinal	center	B-cells	in	secondary	lymphoid	
tissues.	Also	expressed	in	melanoma	and	melanocytes.	
PubMed:11754007,	PubMed:11891275,	PubMed:12202404,	
PubMed:15551350.
Gene	
name
Uniprot	
Entry
Protein	name Tissue	specificity Involvement	in	disease
Mammalian	Phenotype	by	MGI	
database
MPP3 Q13368
MAGUK	p55	
subfamily	member	3
Abnormal	cerebral	cortex	
morphology	(MP:0000788);	
abnormal	neuronal	migration	
(MP:0006009);	abnormal	retina	
morphology	(MP:0001325);	
retinal	degeneration	
(MP:0001326).
PRC1 O43663
Protein	regulator	of	
cytokinesis	1
Overexpressed	in	bladder	cancer	cells	PubMed:17409436,	
PubMed:17409436.
TNN Q9UQP3 Tenascin-N
Not	detected	in	normal	adult	mammary	tissues	or	brain	but	
expressed	in	most	breast	tumors	and	brain	tumors,	such	as	
glioblastomas,	astrocytomas	and	oligodendrogliomas,	tested	
PubMed:17909022,	PubMed:19884327.	In	brain	tumors,	
detected	around	the	endothelial	cell	layer	of	the	clood	
vessels	PubMed:19884327,	PubMed:17909022,	
PubMed:19884327.
CAPN3 P20807 Calpain-3 Isoform	I	is	skeletal	muscle	specific.
	Limb-girdle	muscular	dystrophy	2A	
(LGMD2A)	[MIM:253600]:	An	autosomal	
recessive	degenerative	myopathy.	
PubMed:27020652,	PubMed:27234031,	
PubMed:7720071,	PubMed:8624690,	
PubMed:9150160,	PubMed:9266733,	
PubMed:9452114,	PubMed:9655129,	
PubMed:9762961,	PubMed:9771675.
CHAF1B Q13112
Chromatin	assembly	
factor	1	subunit	B
CENPT Q96BT3
Centromere	protein	
T
MMP13 P45452 Collagenase	3
Detected	in	fetal	cartilage	and	calvaria,	in	chondrocytes	of	
hypertrophic	cartilage	in	vertebrae	and	in	the	dorsal	end	of	
ribs	undergoing	ossification,	as	well	as	in	osteoblasts	and	
periosteal	cells	below	the	inner	periosteal	region	of	ossified	
ribs.	Detected	in	chondrocytes	from	in	joint	cartilage	that	
have	been	treated	with	TNF	and	IL1B,	but	not	in	untreated	
chondrocytes.	Detected	in	T	lymphocytes.	Detected	in	breast	
carcinoma	tissue.	PubMed:8207000,	PubMed:8798568,	
PubMed:9056642,	PubMed:9562863.
Delayed	wound	healing	
(MP:0002908)
MBNL3 Q9NUK0
Muscleblind-like	
protein	3	
Highly	expressed	in	the	placenta.	PubMed:11929853.
RASGRP2 Q7LDG7
RAS	guanyl-releasing	
protein	2	
Detected	in	platelets,	neutrophils	and	T	lymphocytes	(at	
protein	level).	Expressed	in	brain	where	it	is	enriched	in	the	
striatum.	Also	expressed	in	the	hematopoietic	system.	
Detected	in	heart,	brain,	lung,	placenta,	liver,	skeletal	muscle	
and	kidney.	PubMed:10918068,	PubMed:17576779,	
PubMed:17702895,	PubMed:9341881,	PubMed:9789079.
BLM	 P54132
Bloom	syndrome	
protein	
FGR P09769
Tyrosine-protein	
kinase	Fgr	
Detected	in	neutrophils,	monocytes	and	natural	killer	cells	
(at	protein	level).	Detected	in	monocytes	and	large	
lymphocytes.	PubMed:11078731,	PubMed:2181286,	
PubMed:8327512.
KCNN4 O15554
Intermediate	
conductance	calcium-
activated	potassium	
channel	protein	4	
Widely	expressed	in	non-excitable	tissues.
BRCA2 P51587
Breast	cancer	type	2	
susceptibility	protein
Highest	levels	of	expression	in	breast	and	thymus,	with	
slightly	lower	levels	in	lung,	ovary	and	spleen.
Abnormal	motor	
capabilities/coordination/movem
ent	(MP:0002066);	nervous	
system	phenotype	(MP:0003631);	
open	neural	tube	(MP:0000929).
ITGB6 P18564 Integrin	beta-6
CCDC93 Q567U6
Coiled-coil	domain-
containing	protein	93
KIF4A O95239
Chromosome-
associated	kinesin	
KIF4A	
Highly	expressed	in	hematopoietic	tissues,	fetal	liver,	spleen,	
thymus	and	adult	thymus	and	bone	marrow.	Lower	levels	
are	found	in	heart,	testis,	kidney,	colon	and	lung.	
PubMed:10978527.
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4.1.6.	Gene	Ontology	and	pathways	enrichment	analysis		
To	compare	the	DEGs	lists	and	have	an	idea	of	the	pathways	and	GO	terms	enriched	in	each	
group	(up-	or	down-regulated	genes),	a	cluster	analysis	of	up-	and	down-regulated	genes	present	in	
at	 least	two	of	the	three	studies	was	performed	using	the	online	tool	DAVID.	Only	the	first,	more	
abundant,	 5	 clusters	 for	 each	 group	 are	 here	 presented	 (see	 entire	 table	 in	 appendix	 –
Supplementary	Table	3).	
Results	of	the	down-regulated	genes	demonstrated	that	there	are	14	significantly	enriched	
clusters	 fulfilling	 the	 threshold	 parameters	 (Table	 10).	 GO	 terms	 and	 KEGG	 pathways	 of	 down-
regulated	 genes	 were	 predominantly	 associated	 with	 axon	 development,	 cardiomyopathy,	
inflammatory	response,	sodium/potassium	transport,	sperm	motility,	and	calcium	channel	complex.	
Up-regulated	common	genes	were	enriched	in	14	significantly	established	clusters	(Table	11).	The	
main	 terms	presented	 in	 these	groups	were	cell	 cycle	 regulation	of	DNA	 replication,	DNA	 repair,	
cardiomyopathy,	 wound-healing	 signalling	 pathways,	 and	 neurotransmitter	 transmembrane	
transport.		
Overall,	 common	 DEGs	 were	 predominantly	 associated	 with	 pathways	 of	 DNA	 repair,	
development,	and	inflammation,	and	with	GO	terms	of	cardiomyopathy,	neurotransmitter	transport,	
DNA	replication,	and	healing.	
KIF4A O95239
Chromosome-
associated	kinesin	
KIF4A	
Highly	expressed	in	hematopoietic	tissues,	fetal	liver,	spleen,	
thymus	and	adult	thymus	and	bone	marrow.	Lower	levels	
are	found	in	heart,	testis,	kidney,	colon	and	lung.	
PubMed:10978527.
Gene	
name
Uniprot	
Entry
Protein	name Tissue	specificity Involvement	in	disease
Mammalian	Phenotype	by	MGI	
database
MYO1G B0I1T2
Unconventional	
myosin-Ig	
Specifically	expressed	in	hematopoietic	cells.	
PubMed:11544309,	PubMed:20071333.
SASS6 Q6UVJ0
Spindle	assembly	
abnormal	protein	6	
homolog
	Microcephaly	14,	primary,	autosomal	
recessive	(MCPH14)	[MIM:616402]:	A	
form	of	microcephal.	
PubMed:24951542.
PKMYT1 Q99640
Membrane-
associated	tyrosine-	
and	threonine-
specific	cdc2-
inhibitory	kinase
SLC38A4 Q969I6
Sodium-coupled	
neutral	amino	acid	
transporter	4
Detected	in	embryonic	and	adult	liver,	and	at	lower	levels	in	
adult	muscle,	kidney	and	pancreas.	Detected	in	placenta	
syncytiotrophoblasts	throughout	gestation.	Detected	in	fetal	
blood	vessels.	PubMed:11342143,	PubMed:11414754,	
PubMed:16148032.
KIF11 P52732
Kinesin-like	protein	
KIF11	
	Microcephaly	with	or	without	
chorioretinopathy,	lymphedema,	or	
mental	retardation	(MCLMR)	
[MIM:152950]:	An	autosomal	dominant	
disorder	that	involves	an	overlapping	
but	variable	spectrum	of	central	nervous	
system	and	ocular	developmental	
anomalies.	PubMed:22284827.
ERO1A Q96HE7
ERO1-like	protein	
alpha	
Widely	expressed	at	low	level.	Expressed	at	high	level	in	
upper	digestive	tract.	Highly	expressed	in	esophagus.	Weakly	
expressed	in	stomach	and	duodenum.	PubMed:10818100.
EPHA3 P29320
Ephrin	type-A	
receptor	3
Widely	expressed.	Highest	level	in	placenta.
KIF20A O95235
Kinesin-like	protein	
KIF20A	
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Table	10.	GO	and	KEGG	pathway	enrichment	analysis	by	DAVID	of	down-regulated	genes	common	to	at	least	
two	of	the	three	analysed	studies.	Only	the	first	5	clusters	are	presented.	Count:	number	of	genes	enriched	in	
each	term;	%:	percentage	of	genes	in	the	group	comparing	to	the	total	list	of	genes	analysed.	
	 	
Term Description Count % P-value
	Cluster	1 Enrichment	Score:	2.86
hsa04060 Cytokine-cytokine	receptor	interaction 23 3.36 6.05E-05
GO:0070098 Chemokine-mediated	signaling	pathway 10 1.46 1.09E-03
GO:0006954 Inflammatory	response 22 3.22 3.95E-02
	Cluster	2 Enrichment	Score:	2.38
GO:0031402 Sodium	ion	binding 5 0.73 6.88E-04
GO:0030955 Potassium	ion	binding 5 0.73 1.31E-03
GO:0006813 Potassium	ion	transport 7 1.02 7.95E-02
	Cluster	3 Enrichment	Score:	2.22
GO:0035725 Sodium	ion	transmembrane	transport 10 1.46 0.00
GO:0086010 Membrane	depolarization	during	action	potential 6 0.88 0.00
GO:0005248 Voltage-gated	sodium	channel	activity 5 0.73 0.01
GO:0034765 Regulation	of	ion	transmembrane	transport 11 1.61 0.01
GO:0060078 Regulation	of	postsynaptic	membrane	potential 5 0.73 0.01
GO:0001518 Voltage-gated	sodium	channel	complex 4 0.58 0.01
GO:0019228 Neuronal	action	potential 5 0.73 0.02
	Cluster	4 Enrichment	Score:	2.12
GO:0030049 Muscle	filament	sliding 8 1.17 3.97E-04
GO:0060048 Cardiac	muscle	contraction 8 1.17 1.14E-03
GO:0005861 Troponin	complex 3 0.44 3.14E-02
GO:0055010 Ventricular	cardiac	muscle	tissue	morphogenesis 3 0.44 2.32E-01
	Cluster	5 Enrichment	Score:	2.11
GO:1903779 Regulation	of	cardiac	conduction 12 1.75 4.76E-06
hsa04970 Salivary	secretion 12 1.75 3.94E-04
GO:0005890 Sodium:potassium-exchanging	ATPase	complex 5 0.73 4.48E-04
hsa04974 Protein	digestion	and	absorption 12 1.75 4.82E-04
GO:0060048 Cardiac	muscle	contraction 8 1.17 1.14E-03
hsa04261 Adrenergic	signaling	in	cardiomyocytes 14 2.05 3.73E-03
GO:0006883 Cellular	sodium	ion	homeostasis 5 0.73 4.43E-03
GO:0005391 Sodium:potassium-exchanging	ATPase	activity 4 0.58 4.79E-03
GO:0036376 Sodium	ion	export	from	cell 4 0.58 4.82E-03
hsa04973 Carbohydrate	digestion	and	absorption 7 1.02 4.84E-03
hsa04971 Gastric	acid	secretion 9 1.32 6.39E-03
GO:0030007 Cellular	potassium	ion	homeostasis 4 0.58 8.36E-03
hsa04024 cAMP	signaling	pathway 16 2.34 8.59E-03
hsa04964 Proximal	tubule	bicarbonate	reclamation 5 0.73 1.04E-02
GO:0086064 Cell	communication	by	electrical	coupling	involved	in	cardiac	conduction4 0.58 1.06E-02
GO:0010248 Establishment	or	maintenance	of	transmembrane	electrochemical	gradient4 0.58 1.06E-02
hsa04022 cGMP-PKG	signaling	pathway 14 2.05 1.08E-02
hsa04919 Thyroid	hormone	signaling	pathway 11 1.61 1.15E-02
hsa04976 Bile	secretion 8 1.17 1.57E-02
hsa04918 Thyroid	hormone	synthesis 8 1.17 1.69E-02
hsa04260 Cardiac	muscle	contraction 8 1.17 2.38E-02
hsa04961 Endocrine	and	other	factor-regulated	calcium	reabsorption 6 0.88 2.75E-02
hsa04978 Mineral	absorption 6 0.88 3.00E-02
GO:1903561 Extracellular	vesicle 6 0.88 3.33E-02
GO:0086009 Membrane	repolarization 3 0.44 4.05E-02
hsa04911 Insulin	secretion 8 1.17 4.31E-02
hsa04960 Aldosterone-regulated	sodium	reabsorption 5 0.73 6.02E-02
hsa04972 Pancreatic	secretion 8 1.17 6.43E-02
GO:0006813 Potassium	ion	transport 7 1.02 7.95E-02
GO:0010107 Potassium	ion	import 4 0.58 8.11E-02
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Table	11.	GO	and	KEGG	pathway	enrichment	analysis	by	DAVID	of	up-regulated	genes	common	to	at	least	two	
of	the	three	analysed	studies.	Only	the	first	5	clusters	are	presented.	Count:	number	of	genes	enriched	in	each	
term;	%:	percentage	of	genes	in	the	group	comparing	to	the	total	list	of	genes	analysed.	
	
4.1.7.	PPI	network	analysis		
String's	 undirected	 protein-protein	 interaction	 networks	 based	 on	 ‘Experiments’,	
‘Databases’	and	‘Co-expression’	data,	with	connection	interaction	scores	of	at	least	0.7,	of	common	
down-regulated	 genes	 and	 up-regulated	 genes,	 expanded	 to	 first	 shell,	 with	 no	 more	 than	 10	
interactors,	were	retrieved.	In	Figure	14,	network	B,	nodes	are	sized	accordingly	to	the	degree	of	
connection	to	other	proteins,	with	bigger	circles	representing	a	higher	degree.	Only	the	proteins	that	
showed	some	interaction	were	included	in	these	networks.	
Down-regulated	DEGs	show	few	PPI	between	them	(Figure	14.A).	The	retrieved	PPI	network	
presents	19	protein	nodes.	
The	 PPI	 network	 of	 up-regulated	 DEGs	 (Figure	 14.B)	 consisted	 of	 29	 protein	 nodes.	 14	
(BRCA1,	BRCA2,	TIMELESS,	POLE,	DSCC1,	CHAF1B,	CENPT,	CENPI,	PKMYT1,	PRC1,	NCAPG2,	KIF4A,	
KIF11	and	KIF20A)	of	 the	38	up-regulated	genes	are	connected	direct	or	 indirectly	 in	an	 intricate	
network.	Top	hub	genes	(genes	with	high	degree	of	connection)	are	MCM4,	CDK1,	PCNA	and	POLE2.	
Term Description Count % P-value
	Cluster	1 Enrichment	Score:	8.14
GO0007062 Sister	chromatid	cohesion 22 3.71 1.73E-11
GO0000776 Kinetochore 16 2.70 3.56E-08
GO0000777 Condensed	chromosome	kinetochore 15 2.53 6.21E-07
	Cluster	2 Enrichment	Score:	3.89
GO0006270 DNA	replication	initiation 11 1.85 4.72E-08
GO0042555 MCM	complex 6 1.01 3.70E-06
hsa03030 DNA	replication 8 1.35 2.24E-04
GO0000784 Nuclear	chromosome,	telomeric	region 10 1.69 2.37E-02
GO0003678 DNA	helicase	activity 4 0.67 4.08E-02
	Cluster	3 Enrichment	Score:	3.82
hsa04110 Cell	cycle 20 3.37 5.70E-08
hsa04114 Oocyte	meiosis 11 1.85 5.11E-03
hsa04914 Progesterone-mediated	oocyte	maturation 9 1.52 1.16E-02
Cluster	4 Enrichment	Score:	3.43
hsa04974 Protein	digestion	and	absorption 14 2.36 1.14E-05
GO0005581 Collagen	trimer 12 2.02 1.66E-04
GO0030574 Collagen	catabolic	process 9 1.52 1.16E-03
GO0005788 Endoplasmic	reticulum	lumen 14 2.36 8.87E-03
	Cluster	5 Enrichment	Score:	2.21
GO0000732 Strand	displacement 7 1.18 1.64E-04
GO0000729 DNA	double-strand	break	processing 4 0.67 1.21E-02
GO1901796 Regulation	of	signal	transduction	by	p53	class	mediator 8 1.35 1.16E-01
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A	network	with	the	combination	of	up-	and	down-regulated	genes	was	also	elaborated	to	
find	possible	common	interactions	and	pathways	(see	Figure	15).	EPHA4,	TIAM1	and	DYNC1⎥1	are	
down-regulated	genes	that	interact	with	networks	of	up-regulated	genes.	
	
	
Figure	 14.	 Networks	 of	 protein	 interactions	 between	 down-regulated	 common	 genes	 and	 between	 up-
regulated	common	genes.	String's	protein-protein	interaction	network	based	on	Experiments,	Databases	and	
Co-expression	data,	with	connection	interaction	scores	of	at	least	0.7.	Undirected	network	of	common	down-
regulated	genes	(red	nodes	in	figure	A)	and	up-regulated	(blue	nodes	in	B),	expanded	to	first	shell	(grey	nodes)	
with	no	more	than	10	interactors.	In	network	B,	nodes	are	sized	accordingly	to	the	degree	of	connection	to	
other	proteins,	 bigger	 circles	 represent	higher	degree.	Only	 the	DEGs	 that	 showed	 some	 interaction	were	
included	in	these	networks.	Edited	on	Cytoscape.	
A.
B.
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Figure	15.	Network	of	protein	interactions	between	up-	and	down-regulated	genes.	String's	protein-protein	
interaction	network	based	on	Experiments,	Databases	and	Co-expression	data,	with	connection	 interaction	
scores	of	at	least	0.7,	of	common	up-regulated	(blue	nodes)	and	down-regulated	genes	(pink	nodes),	expanded	
to	 first	 shell	 (grey	nodes)	with	no	more	 than	10	 interactors.	Nodes	are	 sized	accordingly	 to	 the	degree	of	
connection	 to	 other	 proteins,	 bigger	 circles	 represent	 higher	 degree.	 Only	 the	 DEGs	 that	 showed	 some	
interaction	were	included	in	this	network.	Edited	on	Cytoscape.	
4.1.8.	REGene	database	and	Human	Brain	Proteome	
REGene	 database	 allows	 the	 download	 of	 lists	 of	 genes	 that	 are	 already	 associated	 to	
regeneration	 (114).	 RAGs	 associated	 to	 nervous	 system	 or	 spinal	 cord	 regeneration,	 were	
downloaded	from	this	database.	A	comparison	between	this	list,	and	our	list	of	DEGs	was	made,	and	
common	genes	can	be	seen	in	Table	12.	Some	of	the	down-regulated	genes	are	already	correlated	
with	regeneration	of	nervous	system	components,	such	as	EPHA4	and	RET.		
From	the	Human	Brain	Atlas,	a	list	of	1437	genes	whose	expression	levels	are	known	to	be	
high	in	the	brain,	was	also	downloaded	and	compared	to	the	common	DEGs	of	this	study.	Also	in	the	
group	of	the	down-expressed	genes,	SLCO1A2,	EPHA4,	RPRM,	DYNC1I1	are	known	to	be	enriched	in	
normal	brain	tissue.	PCDH8	is	a	brain	specific	gene,	meaning	that	it	is	only	expressed	in	brain	and	
not	in	another	human	tissue	or	organ.	 	
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Table	12	 -	List	of	 the	genes	down-regulated	common	to	 the	 three	datasets	analysed,	already	known	to	be	
involved	in	regeneration	of	the	nervous	system	(in	the	REGene	database),	or	brain	enriched/specific	(in	Human	
Brain	Proteome).	HPA:	Human	Protein	Atlas.	
Gene	name	
Human	brain	
proteome	by	HPA	
REGene	
nervous	
PCDH8	 +	 	
SLCO1A2	 +	 	
EPHA4	 +	 +	
DYNC1I1	 +	 	
RPRM	 +	 	
RET	 	 +	
	
4.1.9.	PPI	network	between	RAGs	and	common	DEGs	
Using	the	online	protein-protein	interaction	database	String,	a	PPI	network	was	constructed	
(see	Figure	16)	with	the	common	up-	and	down-regulated	genes	and	their	interactors	that	are	known	
regeneration	 associated	 genes	 of	 the	 nervous	 system	 and	 spinal	 cord	 (described	 in	 REGene	
database).	The	network	has	18	nodes	of	the	up-regulated	genes,	14	nodes	of	the	down-regulated	
ones,	202	genes	associated	with	regeneration	of	the	nervous	system	and	16	nodes	of	genes	related	
to	regeneration	of	the	spinal	cord.	Only	protein	products	of	DEGs	with	interactions	are	shown	in	the	
figure	and	no	expansion	was	performed.	This	analysis	revealed	a	big	main	network	where	some	of	
these	proteins	interact	with	known	RAGs,	and	also	two	smaller	ones.	
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4.1.10.	Selection	of	putative	RAGs	
This	bioinformatics	study	led	to	a	list	of	putative	regeneration	associated	genes	that	may	be	
in	the	future	relevant	targets	for	the	treatment	of	the	secondary	injury	after	spinal	cord	traumas.	
Kinesin	Family	Member	4A	(KIF4A),	Tenascin	N	(TNN)	and	Membrane	Palmitoylated	Protein	3	(MPP3)	
were	three	selected	genes	for	further	analysis	in	a	peripheral	injury	rodent	model,	well	established	
as	a	regenerative	model.	
MPP3		
MPP3	is	an	integral	component	of	plasma	membrane	(GO:	0005887),	involved	in	coupling	
the	cytoskeleton	to	the	cell	membrane,	but	can	also	be	distributed	in	the	cytoplasm	or	in	the	nucleus	
of	 cells.	 This	 gene	 product	 is	 a	 member	 of	 a	 family	 of	 membrane-associated	 proteins	 termed	
MAGUKs	 (membrane-associated	 guanylate	 kinase	 homologs).	 MAGUKs	 interact	 with	 the	
cytoskeleton	and	 regulate	 cell	 proliferation,	 signalling	pathways,	 and	 intracellular	 junctions	 (119)	
This	protein	contains	a	conserved	sequence,	called	the	SH3	(src	homology	3)	motif,	responsible	for	
its	 association	 with	 the	 cytoskeleton.	 It	 is	 thought	 that	 MPP3	 plays	 an	 important	 role	 in	 signal	
transduction	 (GO:0007165),	 and	 is	 also	 involved	 in	 GDP-mannose	 pyrophosphorylase	 (GMP)	
(GO:0046037)	 and	GDP	metabolic	 processes	 (GO:0046710).	 It	 is	 related	with	Chromosome	3q29	
Deletion	Syndrome	causing	microcephaly	and	Allan-Herndon-Dudley	Syndrome	that	causes	mental	
retardation.	This	gene’s	mRNA	is	overexpressed	in	brain:	cerebellar	hemisphere	and	cerebellum,	and	
in	 heart:	 atrial	 appendage	 and	 left	 ventricle,	 according	 to	 the	 GTEx	 database	
(https://www.gtexportal.org/home/),	and	its	protein	is	highly	expressed	in	fetal	brain,	frontal	cortex	
and	 fetal	 heart	 according	 to	 ProteomicsDB	 (https://www.proteomicsdb.org),	 PaxDb	 (http://pax-
db.org/),	 and	 MOPED	 –	 Multi-Omics	 Profilling	 Expression	 databases	
(https://www.proteinspire.org/MOPED).	According	to	LifeMap	Discovery	-	Embryonic	Development	
&	 Stem	 Cell	 Compendium	 (https://discovery.lifemapsc.com),	 MPP3	 mRNA	 expression	 is	 up-
regulated	in	adult	dopaminergic	neurons.	MPP3	protein	interacts	directly	with	a	group	of	proteins	
(LIN7A,	LIN7B	and	LIN7C)	involved	in	the	distribution	of	channels	and	receptors	at	the	cell	membrane	
in	the	brain	(120).	
KIF4A	
The	encoded	protein	by	KIF4A	is	an	ATP-dependent	microtubule-based	motor	protein	that	
is	involved	in	the	intracellular	transport	of	membranous	organelles.	This	protein	also	associates	with	
condensed	chromosome	arms,	is	involved	in	maintaining	chromosome	integrity	during	mitosis,	and	
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may	be	involved	in	the	organization	of	the	central	spindle	prior	to	cytokinesis.	Human	phenotypes	
associated	 with	 KIF4A,	 according	 to	 Malacards	 (http://www.malacards.org/),	 are	 cognitive	
phenotypes	like	Mental	Retardation	X-Linked	100	(HP:0001419),	intellectual	disability	(HP:0001249),	
abnormality	 of	 higher	 mental	 function	 (HP:0011446),	 seizures	 (HP:0001250),	 and	 poor	 speech	
(HP:0002465).	KEGG	pathways	database	retrieved	its	related	pathways’	terms:	endocytic	trafficking,	
EGFR	 signalling	 and	 innate	 immune	 system.	GO	 annotations	 related	 to	 this	 gene	 include	ATPase	
activity	 (GO:0005524),	 microtubule-based	 movement	 (GO:0007018)	 and	 anterograde	 axonal	
transport	 (GO:0008089).	 KIF4A	 is	 also	 involved	 in	 the	 pathway	 R-HSA-422475,	 of	 axon	 guidance	
according	to	Reactome.	The	most	probable	subcellular	locations	according	to	UniProtKB/Swiss-Prot	
are	 the	 nucleus	 matrix,	 cytoplasm	 (cytoskeleton,	 spindle),	 midbody	 (during	 cytokinesis)	 and	
chromosome.	
TNN	
TNN	is	an	extracellular	matrix	protein	 involved	 in	neurite	outgrowth	and	cell	migration	 in	
hippocampal	explants.	In	tumours	it	stimulates	angiogenesis	by	elongation,	migration,	and	sprouting	
of	endothelial	cells	(121).	It	is	associated	to	integrin	binding	(GO:0005178),	focal	adhesion,	PI3K-AKT	
signalling	pathway,	and	ECM-receptor	interaction,	by	KEGG	pathways.	TNN	is	involved	in	biological	
processes	 of	 axonogenesis	 (GO:0007409),	 cell	 migration	 (GO:0016477),	 and	 cell	 growth	
(GO:0016049).	 The	 subcellular	 locations	 described	 by	 UniprotKB/Swiss-Prot	 are	 the	 extracellular	
space	(secreted)	and	extracellular	matrix.	It	is	not	detected	in	normal	adult	mammary	tissues	or	brain	
but	 is	 expressed	 in	 most	 breast	 and	 brain	 tumours,	 such	 as	 glioblastomas,	 astrocytomas,	 and	
oligodendrogliomas	(glial	tumours).	
Based	on	these	characteristics,	these	three	genes	seemed	to	have	potential	relevance	in	the	
nervous	system	development	and/or	regeneration	processes	and	so,	could	be	potential	targets	that	
needed	to	be	investigated.	Two	different	peripheral	injury	rodent	models	were	further	used	to	study	
the	behaviour	and	distribution	of	these	genes,	in	a	regenerative	paradigm:	the	crushed	sciatic	nerve,	
and	 a	 not	 so	 regenerative	model:	 the	 transected	 sciatic	 nerve.	 There	 are	 also	many	 other	DEGs	
whose	 functions	 in	 SCI	 have	 not	 been	 well	 studied	 and	 characterized	 yet	 and	 could	 be	 further	
investigated.	
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4.2.	Experimental	studies	
4.2.1.	Gene	expression	analysis	by	real-time	PCR	
The	levels	of	the	three	target	DEGs	in	rat	tissue	under	normal	or	lesioned	conditions	were	
further	analysed	by	qRT-PCR.	First,	different	primer	pairs	were	tested	for	the	selected	target	genes,	
until	a	good	dissociation	curve	and	amplification	curve	were	obtained.	For	the	TNN	gene,	no	good	
primer-pair	was	found.	After	testing	three	different	primer-pairs,	the	dissociation	graphics	in	some	
time	points	still	presented	two	peaks	which	can	indicate	that	the	primer-pair	is	not	amplifying	TNN	
gene	specifically	or	that	the	amounts	of	this	transcript	are	very	low.	The	amplification	curves	were	
also	atypical	in	some	time-points.		
For	the	MPP3	and	KIF4A	DEGs,	the	second	primer-pairs	tested	were	selected	because	they	
presented	the	best	amplification	curves	and	only	one	peak	in	the	dissociation	curve.	Selected	primer-
pairs	are	described	in	Table	2	of	the	Materials	and	Methods	chapter.	
In	order	to	understand	how	the	regulation	of	expression	of	the	three	chosen	genes	alters	in	
response	to	a	lesion	in	PNS	fibres,	we	evaluated	by	qRT-PCR,	the	expression	levels	of	the	target	genes	
in	the	distal	stumps	of	lesioned	sciatic	nerves	and	its	corresponding	DRG,	of	rats	that	received	crush	
or	 transection	nerve	 lesions	of	 the	sciatic	nerve.	DRG	analysis	allowed	the	understanding	of	how	
these	genes	are	being	regulated	by	the	cell	bodie,	while	in	the	distal	stumps,	it	is	possible	to	conclude	
about	the	degeneration/regeneration	environment.	Tissues	were	collected	in	different	time	points	
after	the	lesion	(1,	2,	7,	14	and	21dpi)	and	tissues	from	sham-operated	animals	were	used	for	control	
levels.	 For	 each	 condition,	 three	biological	 replicates	were	used.	 Replicates	 show	great	 standard	
deviation	because	there	is	a	high	level	of	inner	variability	for	each	animal.	Nevertheless,	although	
the	 absolute	 values	 show	 some	 discrepancy,	 the	 pattern	 of	 the	 expression	 profiles	 between	
replicates	are	similar.	
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4.2.1.1.	KIF4A	is	highly	expressed	upon	axonal	injury	
In	the	analysis	of	the	distal	stumps	of	the	sciatic	nerves	(see	Figure	17),	only	time	point	1dpi	
did	not	show	a	differential	expression	of	KIF4A	when	compared	to	the	sham	control	animal.	KIF4A	
showed	 an	 increased	 expression	 in	 the	 distal	 stump	 of	 the	 sciatic	 nerves	 either	 of	 animals	 that	
suffered	nerve	crush	or	of	animals	that	had	their	sciatic	nerve	fully	transected.	7dpi	is	the	time	point	
when	this	gene	reaches	the	greater	peak	of	expression,	with	fold	increase	values	of	more	than	15	
times	over	the	control	sham-operated	animal.	Crush	paradigm	shows	a	higher	up-regulation	of	this	
gene	across	the	different	time-points.	With	the	progression	of	time,	KIF4A	seems	to	tend	to	achieve	
the	 basal	 initial	 value.	 The	 crush	 paradigm	 shows,	 in	 general,	 higher	 levels	 than	 the	 transected	
animals	but	both	have	a	similar	expression	profile.	As	axons	are	not	connected	in	the	transection	
paradigm	and	at	7dpi	axon	is	almost	completely	lost,	this	similar	pattern	can	give	us	a	clue	of	the	
hypothetical	importance	of	supporting	neuronal	cells	in	this	panorama.	
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Figure	17.	Gene	expression	analysis	of	KIF4A	in	the	distal	part	of	the	sciatic	nerve	in	different	lesion	paradigms	
comparing	to	control	sham-operated	animal.	In	blue	is	represented	the	profile	of	the	transected	animals	and	
in	pink	is	the	profile	of	the	animals	that	suffered	a	crush	of	the	sciatic	nerve.	The	crush	paradigm	shows,	in	
general	higher	levels	than	the	transected	animals	but	both	have	a	similar	expression	profile.	N=3;	one-sample	
T-test;	*p	≤0.05.	Dpi,	days	post-injury.	
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DRG	analysis	(see	Figure	18)	allowed	to	understand	how	genes	are	being	regulated	in	the	
cell	 bodies	 of	 the	 affected	 axons.	 At	 2dpi	 it	 is	 visible	 a	 highly	 significant	 (**	 P-value	≤0.01)	 up-
regulation	of	almost	2	fold	increase,	in	the	crush	paradigm.	For	the	transection	paradigm	KIF4A	at	
2dpi	and	7dpi	shows	also	a	tendency	to	be	up-regulated,	with	higher	but	not	significant	values.	The	
remaining	time-points	did	not	show	differences	from	the	control	sham-operated	animal.	
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Figure	18.	Gene	expression	analysis	of	KIF4A	 in	sciatic	nerve	corresponding	sensory	DRG	in	different	 lesion	
paradigms	compared	to	control	sham-operated	animal.	 In	blue	 is	represented	the	profile	of	the	transected	
animals	and	in	pink	is	the	profile	of	the	animals	that	suffered	a	crush	of	the	sciatic	nerve.	At	2	dpi	of	crush	
paradigm,	KIF4A	is	significantly	different	from	the	control	but	in	the	transection,	despite	the	non-significance,	
is	also	observed	a	tendency	for	the	up-regulation	of	this	gene	in	DRG.	N=3;	one-sample	T-test;	**p	≤0.01.	Dpi,	
days	post-injury.	
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4.2.1.2.	MPP3	is	not	regulated	in	the	axon	after	a	lesion	
MPP3	revealed	a	lower	increasing	of	expression	in	the	distal	stump	of	the	lesioned	sciatic	
nerves	 (Figure	 19)	 and	 a	 great	 standard	 deviation,	meaning	 that	 each	 animal	 had	 very	 different	
expression	patterns	with	high	variability	of	the	expression	of	this	gene.	
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Figure	 19.	Gene	 expression	 analysis	 of	 MPP3	 in	 distal	 part	 of	 sciatic	 nerve	 in	 different	 lesion	 paradigms	
compared	to	control	sham-operated	animal.	In	blue	is	represented	the	profile	of	the	transected	animals	and	
in	pink	is	the	profile	of	the	animals	that	suffered	a	crush	of	the	sciatic	nerve.	In	the	analysis	of	the	distal	stump	
of	sciatic	nerve,	no	significant	differences	were	observed	when	compared	to	the	control.	N=3;	one-sample	T-
test;	*p	≤0.05.	Dpi,	days	post-injury.	
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In	DRG,	MPP3	has	a	clearer	expression	profile	(see	Figure	20)	with	very	similarities	between	
lesion	 paradigms,	 and	 has	 its	 expression	 increased	 with	 progression	 of	 time	 after	 the	 lesion.	
Although,	in	the	first	2	days	after	the	crush	paradigm	lesion,	MPP3	showed	a	significantly	(*	p-value	
≤0.05)	under-expression	(~0.7x)	when	compared	to	the	control	sham-operated	animal.	
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Figure	20.	Gene	expression	analysis	of	MPP3	in	sciatic	nerve’s	corresponding	sensory	DRGs,	in	different	lesion	
paradigms	compared	to	control	sham-operated	animal.	 In	blue	 is	represented	the	profile	of	the	transected	
animals	and	in	pink	is	the	profile	of	the	animals	that	suffered	a	crush	of	the	sciatic	nerve.	The	crush	paradigm	
shows	more	significant	regulation	of	MPP3.	N=3;	one-sample	T-test;	*p	≤0.05.	Dpi,	days	post-injury.	
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4.2.2.	Protein	distribution	is	nervous	system	tissues	
Anderson	 and	 Seilhamer	 showed	 that	 mRNA	 and	 protein	 levels,	 in	 human	 liver,	 do	 not	
directly	correlated	(122).	As	this	can	happen	in	other	organs,	it	was	important	to	test	the	distribution	
of	 the	 candidates	 in	 neuronal	 tissue	 to	 complement	 the	 expression	 analyses.	 To	 validate	 the	
expression	 of	 the	 studied	 genes	 in	 neuronal	 tissue	 intact	 or	 lesioned,	 immunostainings	 of	
cryosections	 of	 spinal	 cord,	 DRG	 and	 sciatic	 nerve	 tissues	 were	 made.	 Tissues	 analysed	 were	
extracted	from	sham-operated	or	lesioned	animals.	Time-points	analysed	were	selected	based	on	
the	 expression	 analysis	 results:	 the	 time	 points	where	 the	 genes	 showed	more	 expression	were	
selected,	as	the	probability	of	finding	the	proteins	in	the	stainings	was	higher.	
4.2.2.1.	KIF4A	distribution	pattern	in	spinal	cord	cryo-sections	
KIF4A-positive	 structures	 are	present	 in	both	gray	 (cell	 bodies)	 and	white	matter	 (axonal	
pattern)	of	spinal	cord	tissue.	In	sagittal	sections,	double	labelling	with	PAN	312,	an	axonal	marker,	
showed	partial	overlapping	and	confirmed	the	neuronal	distribution	of	this	protein,	with	an	axonal	
pattern.	MBP	marker	was	used	to	stain	CNS	myelin	and	no	overlapping	was	observed	between	MBP	
staining	and	KIF4A,	whose	positive	staining	seemed	to	be	within	the	myelin	sheaths,	reinforcing	the	
idea	that	KIF4A	is,	at	least,	partially	expressed	in	the	axons	of	the	spinal	cord	(see	Figure	21.	A-C).	
Co-labelling	with	GFAP,	a	glial	marker,	did	not	not	show	KIF4A/GFAP	overlapping	in	the	intact	spinal	
cord	section	(see	Figure	21).	 	
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Figure	21.	Fluorescent	microscopy	analysis	of	KIF4A	immunostaining	of	sagittal	cuts	with	50	µm	of	an	intact	
spinal	 cord.	 A)	 KIF4A-positive	 structures	 are	 present	 in	 both	 gray	 (cell	 bodies)	 and	 white	 matter	 (axonal	
pattern);	B)	Colabelling	with	PAN	312,	an	axonal	marker,	shows	partial	overlapping	(arrows);	C)	MBP	marker	
was	used	to	stain	Myelin	and	no	overlapping	was	observed	with	KIF4A;	D)	Staining	with	GFAP,	a	glial	marker,	
shows	 different	 KIF4A-positive	 (arrows)	 and	 GFAP-positive	 (arrow-heads)	 structures.	 DAPI	 is	 marking	 the	
nucleus.	
In	sagittal	sections	of	lesioned	spinal	cord	was	possible	to	observe	that	KIF4A	still	overlapped	
with	PAN	312,	which	means	that	it	does	not	loose	the	axonal	distribution	after	lesion	(Figure	22).	To	
investigate	if	KIF4A	was	present	in	glial	cells,	a	double	labelling	with	GFAP	was	performed	and	again	
this	analysis	did	not	show	overlapping	of	GFAP	stained	cells	with	KIF4A-positive	structures	(data	not	
shown).	
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Figure	22.	Fluorescent	microscopy	analysis	of	KIF4A	immunostaining	of	sagittal	cuts	with	50	µm	of	a	transected	
spinal	cord	3	days	after	 lesion.	A)	KIF4A	 is	present	near	 the	 lesion	site	 (asterisk)	 in	PAN-positive	structures	
(white	arrows).	B)	Axonal	staining	indicates	that	axons	are	more	disorganized,	not	so	parallel	and	straight	due	
to	the	lesion	degeneration	but	there	is	still	co-localization	of	KIF4A	with	PAN.	DAPI	is	marking	the	nucleus.	
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4.2.2.2.	KIF4A	distribution	pattern	in	Dorsal	Root	Ganglia	
KIF4A	antibody	appears	to	mark	the	nucleus	of	various	neurons	of	the	DRG.	When	IB4,	a	dye	
that	stains	the	smaller	neurons	in	DRG,	was	used,	we	could	confirm	that	KIF4A	stained	what	appears	
to	be	 the	nucleus	of	 these	 smaller	neurons.	Anti-KIF4A	antibody	 seemed	 to	be	also	marking	 the	
nucleus	of	bigger	neurons	(see	Figure	23).	The	analysis	of	the	DRG	of	the	three	paradigms	–	sham	
animal;	two-day	transected	animal	and	two-day	crushed	animal	–	shows	slightly	differences.	In	the	
crush	condition,	nuclei	of	IB4-positive	cells	seemed	to	express	higher	amounts	of	KIF4A	(although	
immunohistochemistry	is	not	the	best	technique	to	conclude	this	because	it	only	allows	a	qualitative	
analysis)	(Figure	23.C).	In	the	transection	paradigm,	it	also	seems	to	exist	a	slight	up-regulation	of	
the	KIF4A	signal	but	there	is	a	clear	degeneration	of	DRG	cell	bodies	that	difficult	this	analysis	(Figure	
23.B).	Satellite	cells	are	surrounding	the	cells	bodies	of	DRG	neurons	and	also	seem	to	express	KIF4A.	
	
	
Figure	23.	Fluorescent	microscopy	analysis	of	KIF4A	immunostaining	of	cross	cuts	with	10	µm	of	DRG.	KIF4A-
positive	 structures	 seem	to	be	 the	nucleus	of	 the	neurons	of	 the	DRG.	 IB4	 is	a	dye	 that	 stains	 the	smaller	
neurons	in	DRG.	The	nucleus	of	these	smaller	neurons	are	KIF4A-positive	(arrows).	A-C)	Anti-KIF4A	antibody	is	
also	marking	the	nucleus	of	bigger	neurons	(arrow	heads);	The	analysis	of	DRGs	of	the	three	paradigms	–	sham	
animal	(A);	2	day	transected	animal	(B)	and	2	day	crushed	animal	(C)	–	shows	slightly	differences;	C)	In	the	
crush	 condition,	 nucleus	 of	 IB4-positive	 cells	 seem	 to	 express	 higher	 amounts	 of	 KIF4A	 but	
immunohistochemistry	is	not	enough	to	prove	this;	In	the	transection	paradigm,	the	degeneration	of	DRG	cells	
is	clear	(B).	It	is	also	possible	to	observe	that	satellite	cells	are	surrounding	the	cell	bodies	of	DRG	neurons	and	
express	KIF4A.	DAPI	is	marking	the	nucleus.	
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Anti-KIF4A	antibody	seemed	to	also	mark	the	nucleus	of	bigger	neurons.	This	was	shown	by	
using	NF200	to	mark	the	bigger	neurons	(Figure	24).	The	immunostaining	of	a	DRG	section	of	a	2-
day	 transected	animal	 also	 showed	 the	degeneration	 that	 these	neurons	 suffer	when	 the	 sciatic	
nerve	is	transected.	
	
Figure	24.	Fluorescent	microscopy	of	KIF4A	immunostaining	of	10	µm	cross	sections	of	DRG	cells.	A)	NF200	
marks	the	bigger	neurons	and	KIF4A	is	staining	the	nucleus	of	these	bigger	neurons;	in	the	zoomed	picture,	is	
clear	that	the	nuclei	of	the	NF200-positive	cells	are	KIF4A-positive	(arrows);	B)	The	immunostaining	of	a	section	
of	a	2-day	transected	animal	also	shows	the	degeneration	that	these	neurons	suffer	when	the	sciatic	nerve	is	
transected	(also	shown	in	IB4	co-labelling	staining).	DAPI	is	marking	the	nucleus.	
	 	
Identification	and	characterization	of	potential	therapeutic	targets	for	spinal	cord	repair	
Department	of	Medical	Sciences	⎟	University	of	Aveiro	 69	
4.2.2.3.	KIF4A	distribution	pattern	in	sciatic	nerve	
Double	labelling	of	cross	sections	of	intact	sciatic	nerve	with	KIF4A	and	PAN	312,	an	axonal	
marker,	 showed	various	 tubular	 structures	 that	were	positive	 for	both	KIF4A	and	PAN	312,	most	
possibly	the	axons	in	the	nerve	(see	Figure	25.A).	Other	cellular	components	between	axons	are	also	
KIF4A-positive	but	not	PAN-positive.	S-100	protein,	a	Schwann	cells’	marker,	was	used	to	confirm	if	
the	extra-axonal	structures	were	Schwann	cells	(see	Figure	25.B).	The	double	labelling	showed	partial	
overlapping	of	KIF4A	and	S100,	indicating	that	KIF4A	is	also	expressed	in	Schwann	cells,	but	there	
were	also	some	structures	that	did	not	have	axonal	pattern	nor	are	S100-positive.	While	in	the	spinal	
cord,	KIF4A	was	not	present	in	glial	or	support	cells,	 in	the	nerve,	KIF4A	is	expressed	by	Schwann	
cells	and	other	unidentified	cells.	
	
	
Figure	25.	Fluorescent	microscopy	analyses	of	10	µm	cross	cryosections	of	sciatic	nerve	from	a	sham	animal	
with	KIF4A	immunostaining.	A)	Double	labelling	was	performed	with	PAN,	an	axonal	marker,	and	it	is	possible	
to	 observe	 some	 structures	 that	 are	 positive	 for	 both	 KIF4A	 and	 PAN	 (arrows)	 but	 also	 some	 cellular	
components	are	KIF4A-positive	but	not	PAN-positive	(arrow-head);	B)	S100,	a	Schwann	cells’	marker,	was	used	
to	confirm	if	the	extra-axonal	structures	were	Schwann	cells’	cell	bodies	wrapping	the	neurons.	The	double	
labelling	showed	partial	overlapping	of	KIF4A	and	S100	(arrows)	but	also	some	structures	that	do	not	have	
axonal	pattern	nor	are	S100-positive	(arrow-head).	DAPI	is	marking	the	nucleus.	
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In	KIF4A	imunnolabelling	of	10	µm	sagittal	sections	of	a	proximal	stump	of	a	lesioned	sciatic	
nerve	which	resembles	the	normal	tissue	because	the	main	degeneration	is	observed	in	the	distal	
stump,	S100	marked	the	Schwann	cells	and	the	co-labelling	with	KIF4A	confirms	the	previous	results,	
it	is	observed	partial	overlapping	of	the	S100-	and	KIF4A-positive	structures,	and	there	are	various	
tubular	structures	that	are	KIF4A-positive	but	negative	to	S100	protein,	that	appear	to	be	the	axons	
in	the	nerve	enclosed	by	the	Schwann	cells.	Despite	this,	there	is	still	some	non-tubular	structures	
enclosed	 between	 Schwann	 cells	 that	 are	 negative	 for	 S100	 but	 positive	 for	 KIF4A,	 with	 a	 an	
extended	cytoplasm	(Figure	26),	these	can	be	perineurial	glia	or	endoneurial	fibroblast-like	cells.	
	
	
Figure	26.	KIF4A	immunolabelling	in	10	µm	sagittal	sections	of	a	proximal	stump	of	a	transected	sciatic	nerve	
(mimics	 the	 normal	 tissue	 because	 the	main	 degeneration	 is	 observed	more	 in	 the	 distal	 stump).	 S100	 is	
marking	the	Schwann	Cells	and	the	double	labelling	with	KIF4A	confirms	the	previous	results,	it	 is	observed	
partial	overlapping	of	the	S100-positive	cells	and	KIF4A	positive	structures	(arrows).	Despite	this,	there	is	still	
some	structures	that	are	negative	for	S100	but	positive	for	KIF4A	(arrow-heads).	DAPI	is	marking	the	nucleus.	
Analysis	 of	 a	 sagittal	 section	 of	 the	 distal	 part	 of	 the	 nerve	 at	 7	 dpi	 of	 the	 transection	
paradigm,	revealed	lost	of	PAN	labelling	due	to	Wallerian	Degeneration	(data	not	shown),	which	was	
to	expect.	The	KIF4A	signal	was	also	low	but	there	were	still	KIF4A-positive	and	PAN-negative	cellular	
structures.	
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Immunostaining	of	cross	sections	of	the	distal	stump	of	a	transected	nerve	collected	21	days	
after	 the	 lesion,	 confirmed	 the	 previous	 results:	 the	 signal	 of	 the	 axonal	 marker	 PAN	 was	 low,	
revealing	that	 there	were	 few	axons	 in	 this	area,	but	 there	were	KIF4A-positive	structures	 in	 this	
region	 at	 this	 time	 point	 (Figure	 27.A).	 Double	 labelling	 with	 KIF4A	 and	 PDGFR-α,	 a	 glial	 and	
endothelial	marker	showed	that	positive	cells	for	PDGFR-α	had	their	inner	structures	also	stained	for	
KIF4A	 but	 there	were	 some	 KIF4A-positive	 cells	 that	were	 not	 positive	 for	 the	 PDGF-α	 receptor	
marker	(see	Figure	27.B).	
	
	
Figure	27.	Fluorescent	microscopy	analysis	of	KIF4A	distribution	in	a	10	µm	cross	section	of	the	distal	stump	of	
a	transected	sciatic	nerve	collected	21	days	after	lesion.	A)	Immunostaining	confirmed	the	previous	results,	in	
the	distal	 stump	of	a	 transected	nerve,	axonal	marker	PAN	 is	not	 labelling	 the	axons,	but	 there	are	KIF4A-
positive	structures	(arrow-heads);	B)	Double	 labelling	with	KIF4A	and	PDGFR-α	shows	that	positive	cells	 for	
PDGFR-α	have	 their	 inner	 structures	 also	 stained	 for	 KIF4A	 (arrows)	 but	 some	KIF4A-positive	 cells	 are	 not	
positive	for	the	receptor	marker	(arrow-heads).	DAPI	is	marking	the	nucleus.	
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In	crushed	sciatic	nerve	sagittal	sections,	collected	7	days	after	being	crushed,	the	expression	
pattern	of	KIF4A	 seemed	 to	be	 similar	 to	 the	normal	 tissue.	There	were	KIF4A-positive	 cells	 also	
PDGFR-α-positive	but	some	of	the	KIF4A-positive	cells	exhibited	no	co-labelling	with	this	receptor	
staining	(Figure	28).	These	cells	can	be	fibroblasts	or	other	types	of	endoneurial	cells	but	they	were	
not	identified	in	this	study.	KIF4A	seemed	to	be	distributed	in	the	nucleus	periphery	and	also	in	the	
membrane	of	the	positive	cells.	
	
	
Figure	28.	Fluorescent	microscopy	analysis	of	KIF4A	distribution	in	a	10	µm	sagittal	section	of	the	lesion	site	of	
a	crushed	sciatic	nerve	collected	7	days	after	lesion.	In	the	crush	paradigm	the	pattern	of	expression	of	KIF4A	
seems	to	be	similar	to	the	normal	tissue;	there	is	KIF4A-positive	cells	that	are	also	pdgfr-α-positive	(arrows)	
but	some	of	the	KIF4A-positive	cells	exhibit	no	co-labelling	with	the	receptor	marker	(arrow-heads).	These	cells	
can	be	fibroblasts	or	other	types	of	endoneurial	cells	but	they	were	not	identified	in	this	study.	KIF4A	seems	
to	be	distributed	in	the	nucleus	perifery	and	also	in	the	membrane	of	the	positive	cells.	DAPI	is	marking	the	
nucleus.	
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4.2.2.4.	MPP3	distribution	pattern	in	the	spinal	cord	
The	 immunohistochemistry	 analysis	 of	MPP3	distribution	 in	 an	 intact	 spinal	 cord	 sagittal	
section	 showed	 that	MPP3	 was	 clearly	marking	 PAN-positive	 axonal-like	 structures	 in	 the	 white	
matter	and	some	cell	bodies	in	the	gray	matter	(Figure	29.A).	Co-localization	of	MPP3	with	the	axonal	
marker,	PAN,	 is	clear	 (Figure	29.B).	To	confirm	the	axonal	distribution,	double	 labelling	with	anti-
MBP	antibodies	allowed	to	see	MPP3-positive	structures	enclosed	between	myelin	sheaths	(Figure	
29.C).	
	
	
Figure	29.	Fluorescent	microscopy	analysis	of	MPP3	distribution	in	a	50	µm	sagittal	section	of	an	intact	spinal	
cord.	A)	MPP3	is	marking	axonal-like	structures	in	the	white	matter	(arrows)	and	some	cell	bodies	in	the	gray	
matter	 (asterisk).	B)	Zoomed	picture	of	 the	white	matter	of	 the	spinal	cord,	 showing	 the	co-localization	of	
MPP3	 with	 the	 axonal	 marker,	 PAN.	 C)	 Double	 labelling	 with	 MBP	 marker	 confirms	 that	 MPP3-positive	
structures	are	enclosed	between	myelin	sheaths	(arrow-heads).	DAPI	is	marking	the	nucleus.	
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When	a	section	of	a	lesioned	spinal	cord	was	stained	for	the	glial	marker	GFAP	MPP3-positive	
structures	in	the	white	matter	were	also	found	to	be	positive	for	GFAP,	showing	an	astrocyte-like	
appearance	(Figure	30).	This	indicates	that	not	only	axonal	structures	were	expressing	MPP3	but	also	
gial	cells.	As	this	 is	a	 lesioned	tissue,	these	cells	can	be	activated	astrocytes	but	a	specific	marker	
would	have	to	be	used	to	confirm	this	assumption.	
	
	
Figure	30.	Fluorescent	microscopy	analysis	of	MPP3	distribution	in	a	50	µm	sagittal	section	of	a	lesioned	spinal	
cord.	GFAP	is	marking	glial	cells.	In	the	white	matter	of	a	transected	spinal	cord,	MPP3-positive	structures	are	
also	positive	for	GFAP,	having	an	astrocyte-like	appearance	(arrows).	DAPI	is	marking	the	nucleus.	
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4.2.2.5.	MPP3	distribution	pattern	in	DRG	
In	 the	 analysis	 of	 DRG	 sections	 of	 a	 control	 sham-operated	 animal,	 MPP3	 showed	 a	
cytoplasmic	distribution	in	NF200-positive	cell	bodies	(larger	neurons)	but	also	in	cell	bodies	of	the	
smaller	neurons.	Co-labelling	with	IB4	confirmed	that	smaller	neurons	are	also	MPP3-positive.	MPP3	
has	a	cytoplasmic	distribution	in	the	cell	bodies	of	these	neurons	(Figure	31-Figure	32).	
	
	
Figure	31.	Microscopy	analysis	of	MPP3	distribution	in	a	10	µm	cross	section	of	DRG	cell	bodies	of	a	sham-
operated	animal.	A)	Fluorescence	picture	of	an	overview	of	DRG	cells	stained	for	MPP3	and	IB4.	B)	Confocal	
microscopy	analysis.	MPP3	shows	a	cytoplasmic	distribution	in	IB4-positive	cell	bodies	(arrows)	but	also	in	cell	
bodies	of	bigger	neurons	(arrow-heads).	DAPI	is	marking	the	nucleus.	
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Figure	32.	Microscopy	analysis	of	MPP3	distribution	 in	a	10	µm	cross	section	of	DRG	cell	bodies	of	a	sham	
animal.	 A)	 Labelling	of	MPP3	and	NF200	of	DRG	 cells	 of	 a	 sham-operated	 animal;	 B)	 Confocal	microscopy	
analysis.	MPP3	shows	a	cytoplasmic	distribution	in	NF200-positive	cell	bodies	(arrows)	but	also	in	cell	bodies	
of	smaller	neurons	(arrow-heads).	DAPI	is	marking	the	nucleus.	
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4.2.2.6.	MPP3	distribution	pattern	in	sciatic	nerve	
MPP3	 labelling	 of	 cross	 sections	 of	 an	 intact	 sciatic	 nerve	 from	 a	 sham-operated	 animal	
showed	an	axonal	distribution,	highly	co-localizing	with	the	PAN	axonal	marker	 (Figure	33.A).	Co-
labelling	with	the	S100	Schwann	cell	marker	did	not	show	co-localization	of	MPP3-positive	structures	
with	Schwann	cells,	in	this	basal	condition.	Some	structures	with	a	distribution	pattern	different	from	
Schwann	cells	or	axons	were	also	positive	 for	MPP3	but	were	not	 identified	 in	 this	 study	 (Figure	
33.B).	
	
	
Figure	33.	Fluorescent	microscopy	analysis	of	MPP3	distribution	in	a	10	µm	cross	section	of	an	intact	sciatic	
nerve.	A)	MPP3	shows	an	axonal	distribution,	co-localizing	with	PAN	axonal	marker	(arrows).	B)	S100	(Schwann	
cell	 marker)	 co-labelling	 shows	 no	 co-localization	 of	MPP3-positive	 structures	 with	 Schwann	 cells	 (arrow-
heads).	Some	structures	with	a	distribution	pattern	different	from	Schwann	cells	or	axons	are	also	positive	for	
MPP3	(asterisks).	DAPI	is	marking	the	nucleus.	
To	 study	 the	 distribution	 pattern	 of	 MPP3	 in	 the	 distal	 degenerative	 part	 of	 the	 nerve	
following	 21	 days	 after	 transection,	 confocal	microscopy	 analysis	 of	 cross	 sections	 of	 the	 tissue	
adjacent	to	the	acute	lesion	of	a	transected	sciatic	nerve	was	performed.	Labelling	with	anti-MPP3	
antibody	showed	that,	following	injury	and	at	this	time	point,	there	was	co-localization	of	MPP3	with	
S100-positive	cellular	structures,	and	also	 in	non-identified	cells	 (Figure	34.A).	MPP3	staining	was	
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not	being	caused	by	macrophages	because	the	analysis	did	not	show	co-localization	with	ED1	(data	
not	shown);	this	would	not	be	an	axonal	labelling	either	since	axons	are	almost	all	lost	in	the	distal	
stump,	and	so	the	axonal	distribution	of	MPP3	was	also	lost	in	the	distal	stump	of	lesioned	nerve	The	
staining	of	sagittal	sections	of	a	nerve	collected	7	days	after	transection	lesion	showed	that	MPP3	is	
cytoplasmically	distributed	in	S100-positive	structures	and	also	in	non-identified	cells	(Figure	34.B).	
It	was	not	possible	to	assess	differences	in	the	level	of	protein	expression	of	MPP3	between	different	
time	points	after	lesion.	
 
	
Figure	34.	Confocal	microscopy	analysis	of	MPP3	distribution	in	a	10	µm	cross	section	of	the	distal	stump	of	a	
transected	sciatic	nerve.	A)	Cross	section	of	a	nerve	collected	21	days	after	lesion.	MPP3	is	present	in	S100-
positive	structures	(arrow-heads)	but	also	in	non-identified	cells	(arrow-head).	MPP3	staining	is	not	caused	by	
macrophages	because	did	not	show	co-localization	with	ED1	and	axons	are	almost	all	lost	in	the	distal	stump	
so	the	axonal	distribution	of	MPP3	is	lost	in	the	distal	stump	of	lesioned	nerve	(data	not	shown).	B)	Sagittal	
section	of	a	nerve	collected	7	days	after	 lesion.	MPP3	is	cytoplasmic	distributed	in	S100-positive	structures	
(arrow-heads)	and	also	in	non-identified	cells	(arrow-head).	DAPI	is	marking	the	nucleus.	
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MPP3	and	KIF4A	protein	distribution	in	tissues	ended	up	being	very	similar.	In	intact	sciatic	
nerve	 and	 spinal	 cord	 tissues,	 were	 both	 staining	 axons	 of	 the	 sciatic	 nerve,	 and	 KIF4A	 is	 also	
expressed	in	Schwann	Cells.	When	looking	to	DRG,	both	big	and	small	neurons	are	MPP3-	and	KIF4A-
positive	but	with	different	subcellular	localizations,	KIF4A	is	preferentially	expressed	in	the	nucleus,	
while	MPP3	 seemed	 to	 be	more	 cytoplasmically	 distributed.	 In	 the	 immunostainings	 of	 lesioned	
tissue,	both	genes	were	being	expressed	in	Schwann	cells	and	other	glial	or	fibroblastic	cells	and.	
KIF4A	showed	to	be	highly	up-regulated	in	the	distal	stump	of	the	lesioned	sciatic	nerves	which	can	
indicate	that	the	distribution	of	these	proteins	in	the	non-neuronal	cells	present	in	the	lesion	may	
have	 an	 important	 role	 in	 the	 creation	 of	 the,	 already	 described,	 regenerative	 favourable	
environment.	MPP3	is	not	so	regulated	in	the	distal	stump	but	more	up-regulated	in	the	cell	bodies	
of	DRG	neurons,	specially	in	the	crush	(regenerative)	paradigm,	meaning	that	if	this	gene	has	a	role	
in	the	PNS	regeneration,	its	action	may	be	more	to	the	axon	by	itself	and	not	so	much	in	the	neuron-
supporting	cells.	
	 	
	
	5.	Discussion	 	
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In	the	present	work	we	first	used	transcriptomic	data	 from	apparent	partial	 regenerating	
spinal	cords	of	rodents,	as	a	starting	point	to	look	for	potential	key	genes	or	pathways	involved	in	
the	observed	 improved	functional	recovery.	The	bioinformatics	analysis	was	an	 important	tool	 to	
unveil	 the	more	relevant	pathways	altered	 in	 the	regenerative	approaches	used	 in	 these	studies,	
when	compared	to	the	non-regenerative	lesion-only	animals.	Previous	transcriptomic	studies	of	SCI	
in	rodents,	from	other	authors,	allowed	the	characterization	of	the	transcriptome	of	this	pathology	
(123,124).	In	transcriptomic	studies	of	SCI	rodent	models,	up-regulated	DEGs	mainly	participated	in	
cell	cycle,	lysosome	activity,	oxidative	phosphorylation,	nervous	system	development	and	immune-
related	 pathways;	 while	 down-regulated	 DEGs	 were	 involved	 in	 oxidative	 phosphorylation	 and	
central	 nervous	 system	 disease	 signalling	 pathways	 (117,123,124).	 However,	 our	 particular	
comparative	study	is	somewhat	innovative	as	it	is	an	attempt	of	finding	common	robust	pathways	
that	 are	 regulated	 when	 a	 non-endogenous	 partial	 regeneration	 occurs.	 This	 is	 the	 reason	 why	
injured	animals	without	treatment	were	used	as	controls,	instead	of	sham-operated	animals.	
In	 the	bioinformatics	 comparative	analysis,	 a	 group	of	 genes	was	 found	 to	be	commonly	
regulated	in	the	three	analysed	studies,	which	means	that	they	may	have	some	key	functions	in	the	
differential	 regeneration	outcomes	observed	 (106,117,118).	 The	 clustering	 analysis	 based	on	GO	
terms	and	KEGG	pathways	of	the	down-regulated	genes	common	to	at	least	two	studies,	revealed	
an	enrichment	in	processes	like	inflammatory	response,	sodium/potassium	transport,	ATPases	and	
neuronal	action	potential,	troponin	complex,	and	cAMP/cGMP-PKG-signalling	pathway.	The	down-
regulation	of	these	processes	might	be	happening	to	avoid	the	secondary	mechanisms	of	SCI;	the	
inflammatory	response	is	decreased,	and	the	action	potentials	are	also	down-regulated.	We	could	
think	that	this	is	deleterious	but,	under	an	injury	context,	this	down-regulation	might	be	important	
to	prevent	the	previously	described	damage	caused	by	the	inflammatory	cells	and	the	excitotoxicity	
of	glutamate	(45,46).	Considering	the	up-regulated	events,	an	enrichment	in	processes	such	as	of	
DNA	replication	and	cell	cycle	regulation,	and	DNA	repair,	can	be	related	with	the	attempt	to	correct	
damages	arising	from	the	oxidative	stress	triggered	by	ROS.	Neurotransmitter	transport	processes	
are	also	up-regulated	and	may	be	 indicating	the	promotion	of	neuronal	plasticity.	The	process	of	
collagen	degradation	is	also	up-regulated	and	may	be	involved	in	an	attempt	to	destroy	or	reduce	
the	formation	of	an	ECM	scar	around	the	cystic	cavities,	which	may	be	related	to	the	promotion	of	
regeneration.	 In	 favour	of	this	hypothesis	 is	a	study	where	the	 inhibition	of	collagen	biosynthesis	
resulted	 in	 a	 partial	 recovery	 of	 the	 injured	 spinal	 cord	 (125).	 Signal	 transduction	 by	 p53	 is	 also	
altered,	possible	due	to	the	activation	of	some	promoters	of	this	pathway	by	ROS	produced	during	
SCI	(126).	
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To	better	understand	how	the	genes	involved	in	these	processes	could	be	interacting,	and	if	
up-	 and	down-regulated	 genes	 are	working	 together	 for	 the	 same	pathways,	 a	 PPI	 network	was	
constructed	and	allowed	to	better	understand	how	the	genes	could	be	interacting	with	each	other.	
A	relatively	big	group	of	genes	has	shown	to	interact	with	each	other:	DYNC1⎟1,	PRC1,	KIF11,	KIF4A,	
KIF20A,	NCAPG2,	PKMYT1,	CENPT,	CENPI,	DSCC1,	BRCA2,	BRCA1,	BLM,	POLE,	TIMELESS	and	CHAF1B.	
These	proteins	are	involved	in	processes	of	cytokinesis,	cell	cycle,	nuclear	division,	sister	chromatid	
segregation	and	microtubule	cytoskeleton	organization	(Table	8	and	Table	9).	
When	exploring	 the	Human	Protein	Atlas,	 some	of	 the	common	regulated	DEGs	 (PCDH8,	
SLCO1A2,	EPHA4,	DYNC1⎟1	and	RPRM)	were	 found	 to	make	part	of	 the	Human	Brain	Proteome,	
meaning	that	in	healthy	situations,	these	genes	are	highly	expressed	in	neuronal	tissue.	However,	in	
the	context	of	the	analysed	transcriptomes,	these	genes	are	down-regulated	after	injury.	
To	 find	 putative	 connections	 of	 the	 identified	 DEGs	 with	 already	 known	 regeneration	
pathways,	 the	 lists	 of	 our	 common	 genes	 were	 compared	with	 genes	 already	 known	 to	 have	 a	
function	in	the	regenerative	processes	of	the	nervous	system,	including	the	spinal	cord,	retrieved	
from	the	REgene	database.	RET	gene	was	found	to	have	a	neuroregenerative	effect	in	Parkinson’s	
Disease	 (127)	 and	 EPHA4	was	 already	 connected	 to	 neurite	 outgrowth	 in	 the	 SC	 (128).	 The	 PPI	
network	with	known	RAGs	and	our	common	up-	and	down-regulated	genes	that	interact,	shows	a	
dense	net	of	connections,	unveiling	possible	relationships	between	the	genes	in	study	and	the	genes	
associated	 to	 regeneration,	which	 can	 indicate	 that	 they	 are	 involved	 in	 regeneration	 networks,	
direct	or	indirectly.	
This	comparative	SCI	transcriptomic	analysis	led	to	interesting	results	that	could	be	used	as	
a	starting	point	to	further	experimental	studies	in	rodent	models.	To	that	end,	common	DEGs	were	
chosen	for	the	following	characteristics:	role	in	neuronal	migration	or	proliferation,	involvement	in	
nervous	system	diseases	or	phenotypes,	and/or	already	known	expression	 in	brain	 tissues.	Three	
genes	were	thus	selected:	TNN,	MPP3	and	KIF4A.	Due	to	failed	quantifications	of	TNN	expression,	as	
in	healthy	brains	its	expression	is	low	(121),	and	it	is	a	secreted	protein,	the	study	of	this	gene	was	
abandoned.	For	these	follow-up	studies,	two	models	of	nerve	injury	were	used.	The	rodent	model	
of	crushed	sciatic	nerve	is	commonly	used	as	a	regenerative	model	of	the	nervous	system	tissue,	in	
contrast	with	the	transection	model	that	does	not	allow	the	reconnection	of	the	nervous	fibres	(115).	
In	this	study,	this	model	was	used	to	evaluate	if	the	target	genes	are	regulated	in	case	of	nervous	
tissue	 lesion	 and	 further	 endogenous	 regeneration	 by	 the	 analysis	 of	 the	 distal	 stumps	 of	
degenerative	 sciatic	 nerves,	 and	 its	 corresponding	 DRG,	 by	 quantitative	 real-time	 PCR	 and	
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immunohistochemistry	 techniques.	 The	 protein	 distribution	 of	 these	 genes	was	 also	 analysed	 in	
lesioned	and	intact	spinal	cord	tissue.	
The	bioinformatics	analysis	of	transcriptomic	studies	on	partial	regenerative	model	animals	
revealed	an	 increase	 in	MPP3	 levels	 relatively	to	the	 injury	condition	alone,	with	a	peak	at	seven	
days.	Its	levels	continue	to	decrease	and	go	bellow	sham	animal	levels	after	10	dpi,	stabilizing	in	a	
negative	fold	change	thereafter	(until	the	last	time	point	analysed,	90	dpi).	
The	expression	analysis	of	this	gene	revealed	that	in	the	distal	part	of	a	lesioned	peripheral	
nerve,	MPP3	expression	is	barely	altered.	The	MPP3	staining	study	showed	that	MPP3	is	expressed	
in	the	axons	of	intact	spinal	cord	and	of	intact	sciatic	nerves,	and	in	the	cytoplasm	of	DRG	cells	from	
sham	and	lesioned	animals.	However,	while	in	the	lesioned	spinal	cord	MPP3	stains	astrocytes,	in	
intact	spinal	cord	sections	this	protein	is	not	observed	in	this	cell	type.	After	lesion,	astrocytes	modify	
their	phenotype,	becoming	activated	spinal	astrocytes,	known	to	have	a	deleterious	role	in	the	CNS	
lesion	 recovery	 (59).	 The	 hypothesis	 that	 derived	 from	 this	 results	 was	 that	 astrocytes	 start	 to	
express	MPP3	after	lesion	as	activated	astrocytes	in	SCI,	which	may	have	then	a	possible	deleterious	
role	in	the	lesion.	In	the	PNS,	this	protein	is	also	not	expressed	in	glial	cells	such	as	Schwann	cells	in	
intact	sciatic	nerve	tissue	but,	after	a	transection	lesion,	axonal	staining	is	lost	and	MPP3	appears	
now	to	be	present	although	not	very	abundantly	in	Schwann	cells.	Indeed,	the	fluorescence	intensity	
of	the	distal	sciatic	nerve	stainings	is	relatively	low,	preventing	an	undoubted	characterization	of	the	
distal	stump	of	the	transection	lesion.	When	looking	to	the	qRT-PCR	expression	data	of	MPP3	in	the	
distal	stump,	the	doubt	is	not	clarified	because	of	its	not	variable	levels.		
When	looking	to	expression	analysis	of	MPP3	in	DRG,	there	is	a	small	(~1.5x)	up-regulation	
of	this	protein’s	expression	at	7-14	days	following	sciatic	nerve	lesion	that	is	maintained	at	least	until	
3	weeks	post-injury,	with	the	crush	paradigm	showing	slightly	higher	expression	levels.	MPP3	protein	
is	 being	 expressed	 in	 both	 bigger	 and	 smaller	 DRG	 neurons	 so,	 if	 this	 gene	 has	 a	 protective	 or	
promoting	role,	it	is	affecting	all	different	types	of	sensory	neurons.	
MPP3	 is	 a	 membrane-associated	 protein	 and	 has	 been	 related	 to	 actin	 cytoskeleton	
reorganization	by	connecting	CADM1	with	the	p85	portion	of	PI3K,	forming	a	multi-protein	complex	
at	the	periphery	of	cells	which	activates	the	PI3K	pathway	to	reorganize	the	actin	cytoskeleton	and	
act	 on	 cell	 morphology	 and	 differentiation	 (e.g.	 promotes	 the	 acquisition	 of	 an	 epithelial	 cell	
structure	 in	MDCK	 cells)	 (129).	 PI3K	 has	 also	 already	 been	 related	with	 neurogenesis	 during	 the	
embryonic	development	(130).	In	studies	where	MPP3	was	overexpressed,	this	protein	was	shown	
to	enhance	cell	migration	by	up-regulating	the	matrix	metalloproteinase	1	(MMP1)	(132).	Also	during	
development,	MPP3	 is	 required	 for	 the	maintenance	of	migration-related	 structures	 such	as	 the	
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apical	protein	complex,	adherens	 junctions,	and	for	stratification	and	proper	migration	of	cortical	
neurons	(119).		
MPP3	is	a	also	a	PDZ	protein	and	so,	it	interacts	with	Serotonin	5-Hydroxytryptamine2C	(5HT-
2C)	receptors,	and	recruits	these	receptors	to	the	plasma	membrane	in	cortical	neurons	(132).	This	
gene	 can	 also	 be	 recruiting	 other	 receptors	 and	 molecules	 to	 the	 membrane,	 supporting	 the	
processes	of	axonal	extension.	This	would	make	sense	if	the	major	responsible	for	the	expression	of	
MPP3	was	the	axon,	meaning	that	when	axons	are	absent	e.g.	in	the	distal	stump	of	the	transected	
sciatic	nerves,	the	levels	of	MPP3	slightly	decrease	comparing	to	the	intact	nerve.	Conversely,	in	the	
crush	paradigm,	the	neuronal	MPP3	levels	also	decrease	in	the	first	days	but	will	be	restored	and	
start	to	be	up-regulated	at	7	days	after	the	injury,	when	regenerating	axons	start	to	sprout.	
The	 other	 common	 DEG	 chosen	 to	 analyse	 by	 qPCR	 and	 IHC	 means	 was	 KIF4.	 In	 the	
bioinformatics	analysis	of	the	transcriptomes	of	partially	SCI	recovering	paradigms	in	rodents,	KIF4A	
was	observed	to	be	up-regulated	 in	 the	 first	7	days,	above	the	 injury	alone	condition,	and	 in	 the	
following	days	to	behave	like	injury,	slowly	decreasing	to	normal	levels	from	10	to	90	days	post	injury.	
In	the	follow	up	experiments,	KIF4A	revealed	to	have	interesting	features	and	to	be	a	good	
candidate	for	further	studies.	Its	mRNA	expression	is	up-regulated	in	the	distal	stump	both	in	crushed	
and	transected	nerves,	meaning	that	the	expression	is	local	and	not	occurring	in	the	neuronal	cell	
body	and	brought	by	the	axon,	or	occurring	in	response	to	a	neuronal	cell	body	signal,	because	the	
suture	of	 transection	does	not	allow	this	communication	between	 the	distal	part	of	 the	 lesioned	
nerve	and	its	cell	body.	The	immunostaining	results	in	intact	and	lesioned	sciatic	nerve	support	this	
hypothesis,	 since	 Schwann	 cells	 and	 other	 support	 cells	 in	 the	 distal	 lesion	 nerve	 section	 were	
observed	 to	 be	 KIF4A-positive	 and	 can	 be	 responsible	 for	 the	 highly	 increased	 levels	 of	 KIF4A	
expression	at	7	dpi.	KIF4A	was	also	up-regulated	in	the	nucleus	of	DRG	cells,	at	a	lesser	extent	and	
immediately	at	2	days	after	injury.		
KIF4A	is	a	microtubule-binding	protein	that	has	a	role	in	the	transport	of	integrin	beta	1	in	
developing	cortical	neurons	in	vitro	(133).	Beta	1	integrin	is	a	cell	surface	receptor	that,	in	sensory	
axons,	 excludes	 molecules	 from	 axons	 and	 direct	 them	 to	 dendrites,	 promoting	 the	 neuronal	
polarized	structure	(134).	Beta	1	integrin	is	also	widely	known	to	connect	the	actin	cytoskeleton	to	
the	ECM,	and	 to	be	 involved	 in	processes	such	as	cell	adhesion	and	migration.	For	example,	 it	 is	
known	to	be	important	for	nerve	regeneration	in	the	peripheral	nervous	system	by	influencing	neural	
crest	cell	migration	and	axonal	outgrowth	(135).	Related	to	this	must	be	the	fact	 that	the	beta	1	
integrin	 is	 a	 subunit	 of	 various	 transmembranar	 receptors,	 including	 the	 Fibronectin-receptor	
integrin	alpha5/beta1,	which	is	also	expressed	in	axonal	growth	cones	(135).	Beta	1	integrin	is	lost	in	
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mature	CNS	neurons,	as	well	as	KIF4A	(133,134).	This	developmental	loss	of	integrins,	such	as	beta	
1	integrin,	is	said	to	be	one	of	the	responsible	facts	for	the	loss	of	regenerative	ability	of	the	CNS	
neurons	(134).	However,	our	experimental	analyses	showed	that	in	axons	of	an	adult	rat	SC	there	is	
still	KIF4A	staining.	Nevertheless,	KIF4	levels	highly	increased	above	normal	levels	following	injury,	
as	 revealed	 in	 the	 bioinformatics	 analyses	 and	 our	 qRT-PCR	 assays.	 A	 study	 comparing	 the	
transcriptome	of	a	PNS	injury	with	the	one	of	a	developmental	axonal	state	(136)	revealed	that	some	
genes	revert	to	an	embryonic	expression	pattern	during	injury.	KIF4A	might	be	following	this	type	of	
expression	after	injury.	For	example,	its	up-regulation	after	injury	in	the	cell	body	of	sciatic	sensory	
neurons	 from	 DRG	 might	 implicate	 a	 gain	 in	 a	 similar	 function	 to	 its	 described	 role	 during	
developmental	 stages	 in	 promoting	 molecules’	 transport	 in	 injured	 neurons.	 During	 axonal	
development	KIF4A	is	involved	in	the	anterograde	trafficking	of	ribosomal	constituents	to	axons	by	
its	 binding	 to	 P0,	 a	 major	 protein	 component	 of	 ribosomes,	 through	 its	 tail	 domain	 (137).	 Our	
hypothesis	is	that	KIF4A	up-regulation	in	the	nuclei	of	DRG	cells	might	facilitate	a	required	increase	
in	the	transport	of	molecules	in	the	neuron	in	response	to	a	lesion.	Furthermore,	the	transport	and	
targeting	of	RNA	granules	and	ribosomes	to	dendrites	or	dendritic	spines	 is	an	 important	sorting	
mechanism	that	has	been	implicated	 in	 local	synaptic	plasticity,	 including	spine	development	and	
long	 term	 changes	 in	 synaptic	 strength	 (137).	 Therefore,	 similar	 events	 to	 KIF4A-mediated	
translocation	of	P0	in	developing	axons	can	be	triggered	again	after	injury	stimuli.	
Immunostaining	analysis	of	DRG	from	crushed	and	transected	sciatic	nerves	showed	results	
in	agreement	with	the	qRT-PCR	analysis:	the	smaller	DRG	neurons	seemed	to	express	more	KIF4A	in	
the	 nucleus	 after	 lesion.	 This	may	 represent	 a	 possible	 attempt	 to	 increase	 axonal	 transport	 of	
molecules	and	ribosomes	to	the	lesion	site,	essential	to	the	increased	protein	requirements	in	the	
lesioned	area.	
When	 considering	 the	 nerve	 itself,	 the	 expression	 analysis	 and	 immunohistochemistry	
studies	revealed	that	KIF4A	up-regulation	upon	lesion	may	be	related	with	the	lesion	environment	
and	supporting	cells,	since	the	axonal	distribution	is	lost	in	the	distal	stump	but	still	the	expression	
levels	of	KIF4A	reach	a	high	peak	(~20x)	at	7dpi.	
Supporting	cells	are	important	partners	in	the	regeneration	processes	of	the	PNS	(80).	During	
pathophysiological	conditions	such	as	nerve	injury,	Schwann	cells	change	their	differentiation	state,	
acting	as	repairing	cells	and	forming	the	Büngner	Bands	(138).	Together	with	the	PNS	ECM,	Schwann	
cells	constitute	a	permissive	environment	that	allows	axon	regrowth.	Fibronectin-receptor	integrin	
alpha5/beta1	(already	described	above	as	being	expressed	in	neurons)	is	also	induced	in	glial	cells	
including	Schwann	cells	and	may	help	the	regeneration	process	(135).	Neuregulin-1,	a	glial	growth	
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factor	expressed	in	regenerating	axons	of	injured	peripheral	nerves,	regulates	Schwann	cells	motility	
and	migration	by	 activation	of	molecules	 of	 the	 Erb	B	 tyrosine	 kinase	 receptors	 family,	with	 the	
formation	of	alpha5/beta1	 integrin-ErbB2-FAK	complex	 (139).	Taskinen	et	al	 (140)	also	described	
that	EFLCs	are	beta	1	integrin-positive	cells,	observed	to	be	in	the	proximal	part	of	the	nerve	already	
at	 24	 h	 after	 transection.	 Following	 4	weeks	 after	 the	 start	 of	 the	WD,	 these	 cells	 form	 circular	
structures	 around	 the	 Schwann	 cells	 columns.	 The	 endoneurial	 compartimentation	 seems	 to	 be	
important	for	the	maintenance	of	the	nerve	structure,	serving	as	a	support	for	axonal	regeneration	
in	addition	to	the	Büngner	Bands	(141).	Weiss	and	Nickoloff	(142)	speculated	that	EFLCs	within	the	
nerve	might	represent	precursor	elements	or	play	a	supportive	role	for	the	Schwann	cells.	KIF4A	may	
be	transporting	integrins	to	this	complex	and	thus	its	up-regulation	can	be	promoting	Schwann	cells	
action	 in	 the	 regenerative	 processes	 of	 the	 PNS	 lesion.	 This	 protein	 can	 also	 be	 promoting	 the	
differentiation	of	other	PNS	regenerative	supporting	cells,	such	as	perineurial	or	endoneurial	cells.	
Our	 immunostaining	 data	 showed	 KIF4A-positive	 cells	 that	were	 not	 stained	 for	 S100,	 and	 have	
similar	morphology	to	the	one	described	for	EFLCs.	These	cells	may	be	supporting	Schwann	cells	in	
the	regeneration	of	the	lesioned	sciatic	nerve,	and	the	regenerative	phenotype	acquired	by	these	
cells	 after	 injury	 can	 be	 promoted	 by	 over-expression	 of	 KIF4A,	what	 increases	 the	 transport	 of	
integrin	1	to	the	alpha5/beta1	integrin-ErbB2-FAK	complex.	Alternative,	the	KIF4A	positive	cells	at	
the	distal	lesioned	nerve	can	be	perineurial	glia,	which	are	also	essential	for	motor	axon	regrowth	
following	nerve	injury	(143).	KIF4A	might	thus	be	a	protein	that	responsive	glial	supportive	cells	start	
to	express	to	support	the	regeneration	of	peripheral	nerves	after	injury.	
As	is	it	already	known,	the	axon	growth-permissive	microenvironment	of	the	PNS	is	formed	
predominantly	by	the	non-neuronal	adjacent	cells,	which	significantly	enhance	the	intrinsic	growth	
potential	of	injured	peripheral	neurons.	In	one	hand,	KIF4A	may	be	involved	in	these	processes	as	it	
is	 strongly	up-regulated	 in	 the	distal	 stump	and	expressed	 in	 the	neuronal	adjacent	cells.	On	 the	
other	 hand,	 it	 can	 be	 promoting	 axonal	 transport	 of	 organelles	 and	molecules	 essential	 for	 the	
processes	of	regeneration	by	its	up-regulation	in	the	DRG	cell	bodies	and	so,	in	the	neuron.	
	 	
	6.	Final	conclusions	 	
	
Identification	and	characterization	of	potential	therapeutic	targets	for	spinal	cord	repair	
Department	of	Medical	Sciences	⎟	University	of	Aveiro	 91	
Spinal	cord	injury	is	a	devastating	neuropathology	that	still	lacks	promising	treatments	able	
to	induce	total	regeneration	of	the	SC.	The	first	part	of	this	work,	the	bioinformatics	study,	identified	
some	 genes	 related	 with	 partial	 recovery	 from	 SCI	 via	 exogenously-imposed	 regenerative	
approaches.	MPP3,	KIF4A	and	TNN	were	selected	to	further	experimental	studies	because	of	their	
already	 known	 connection	 with	 pathways	 and	 biological	 processes	 that	 1)	 might	 be	 involved	 in	
axonal	regeneration,	but	2)	no	direct	connection	of	these	genes	and	SCI	was	yet	established	in	the	
literature.		
The	 follow	 up	 bench	 studies	 demonstrated	 that	 KIF4A	 and	 MPP3	 are	 expressed	 and	
regulated	 in	 the	 lesioned	 sciatic	 nerve	 and	 in	 the	 corresponding	dorsal	 root	 ganglia	 after	 lesion.	
Moreover,	these	genes	also	showed	protein	staining	in	normal	spinal	cord	tissue	sections,	in	sciatic	
nerve	 and	 in	DRG	 cuts,	 revealing	 that	 they	 are	expressed	 in	neuronal	 and/or	 glial.	 Based	on	 the	
results	of	this	work,	we	believe	that,	after	injury	and	at	the	lesion	site	KIF4A	looses	the	axonal	staining	
(due	to	axonal	 lesion	and	degeneration)	and	 is	more	expressed	 in	supporting	cells	and	neuroglia,	
which	 are	 fundamental	 for	 the	 creation	 of	 an	 environment	 that	 promotes	 and	 supports	 axonal	
regrowth,	while	MPP3	role	can	be	more	axonal-specific	during	regeneration	of	sciatic	nerve	after	
injury.	Furthermore,	the	increase	in	KIF4	levels	in	the	cell	bodies	affected	by	the	PNS	lesion	strongly	
supports	that	this	protein	participates	in	the	regrowth	of	the	axon	by	e.g.	delivering	structural	and	
regulatory	molecules	to	the	axonal	growth	cone	via	anterograde	transport.		
These	results	represent	important	remarks	to	instigate	further	studies	regarding	the	role	of	
these	 genes	 in	 regenerative	 processes	 of	 lesioned	 neuronal	 tissues	 and	 their	 potential	 use	 as	
therapeutic	targets	in	SCI	or	other	pathologies	affecting	the	spinal	cord	integrity.	
Further	experimental	studies	need	to	be	performed	to	prove	the	putative	role	of	MPP3	and	
KIF4A	 in	 axonal	 regeneration.	 For	 this	 purpose,	 the	 studies	 should	 include:	 1)	 the	 silencing	 or	
overexpression	of	these	genes	in	different	cell	culture	types	of	neurons,	neuroglia	and	endoneurial	
fibroblasts-like	cells,	 in	primary	or	co-cultures,	 for	 further	evaluation	of	axonal	 sprouting,	neurite	
outgrowth,	cell	migration	and	cell	proliferation;	2)	In	vitro	models	of	SCI	should	be	investigated	to	
test	if	the	regulation	of	these	genes	increases	or	decreases	axonal	regeneration	after	the	induced	
lesion;	3)	after	validation	in	cellular	cultures,	a	step	for	animal	models	should	be	taken,	for	evaluation	
of	the	effect	of	overexpression	of	the	studied	genes	in	a	rodent	model	of	SCI	or	the	gene	KO	effects.	
For	 the	 KO	 experiments	 the	 technology	 of	 Clustered	 Regularly	 Interspaced	 Short	 Palindromic	
Repeats	(CRISPR)	as	a	gene	silencing	tool	would	be	interesting	to	evaluate	if	the	candidates	show	a	
better	or	worse	regeneration	ability	after	injury	in	vivo.	To	induce	the	overexpression	of	the	putative	
genes,	Adeno-associated	viral-vectors	have	shown	to	be	a	valuable	tool	in	gene	expression	regulation	
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(144);	4)	as	the	regeneration	ability	of	PNS	is	intrinsically	related	with	Schwann	cells	and	other	glial	
activity,	the	modulation	and	implantation	of	these	cells	overexpressing	the	genes	characterized	in	
this	study	in	SC	after	lesion	can	be	also	a	promising	approach.	
Another	 interesting	feature	would	be	to	test	the	proteins	studied	in	this	work	as	possible	
biomarkers	 of	 SCI	 in	 Cerebral	 spinal	 fluid	 (CSF),	 to	 allow	 the	 stratification	 of	 patients	 and	 the	
identification	of	subgroups	within	the	heterogeneous	SCI	aetiologies	when	combined	with	the	usual	
clinical	examinations.	
A	deeper	analysis	of	the	bioinformatics	data	might	be	an	interesting	starting	point	to	study	
other	genes	and/or	pathways	unveiled	in	this	study.	The	discussed	pathways	enriched	with	the	DEGs	
common	to	the	analysed	studies	can	be	targeted	to	evaluate	its	effects	in	spinal	cord	repair,	and	the	
RAGs’	 PPI	 interaction	 network	 can	 be	 used	 to	 study	 possible	 regeneration	 pathways	 that	
interconnect	the	common	DEGs	found	in	this	study	and	already	known	RAGs.	
In	conclusion,	this	work	provides	some	clues	about	the	putative	roles	of	MPP3	and	KIF4A	
and	their	protein	distribution	in	a	degenerative	and	regenerative	environment	by	its	expression	in	
intact	and	 lesioned	 tissue,	particularly	 in	 the	axons	and	 in	non-neuronal	 cells	 that	 support	 lesion	
clearance	and	regeneration.	These	genes	might	be	future	targets	for	modulation	of	injury	conditions	
in	CNS	in	an	attempt	to	mimic	the	PNS	permissive	lesion	environment,	but	further	studies	need	to	
be	performed.	
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Supplementary	tables	
Supplementary	Table	1.	Human	orthologs	conversion.	Biomart	was	used	to	convert	Rat	or	Mice	gene	names	
found	as	differential	expressed	in	the	analysed	studies	to	the	corresponding	Human	orthologs.		
Available	at:	https://drive.google.com/open?id=0B7hTrpv5NKggNkdaeFoyRnlXMkE	
One	 Excel	 sheet:	 in	 this	 sheet	 are	 the	 up-	 and	 down-regulated	 genes	 separated	 and	
organized	by	study.	
	
Supplementary	Table	2.	Up-	and	down-DEGs	intersections	between	the	3	studies.	
Available	at:	https://drive.google.com/open?id=0B7hTrpv5NKggQkkyTVdnWXVBX0U	
Two	Excel	sheets:	the	first	one	contains	the	up-regulated	genes	and	in	the	second	one	are	
the	lists	of	the	down-regulated	genes	obtained	in	this	bioinformatics	analysis.	
	
Supplementary	Table	3.	David	clustering	analysis	table.		
Available	at:	https://drive.google.com/open?id=0B7hTrpv5NKggZm5GWXlaRVQ5LXM	
Two	Excel	sheets:	the	first	one	contains	the	clusters	retrieved	using	the	up-regulated	genes	
common	between	at	least,	two	of	the	three	studies	and	in	the	second	sheet	is	the	list	of	the	clusters	
obtained	by	the	analysis	of	down-regulated	genes	common	to	at	 least,	two	of	the	three	analysed	
studies.	
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Solutions	
DAPI	(Roche)	
• Stock	solution	20	µg/mL:	dilute	10	mg	of	DAPI	in	3	mL	of	100%	Ethanol;	
• Working	solution:	1:10	in	PBS	
	
Sudan	Black	B	(Sigma-Aldrich)	
• Prepare	0.3%	solution	in	70%	Ethanol	and	stir	it	overnight	at	RT	and	then	filter	it.	
	
RNase	free	H20	
• Add	 1	mL	 of	 DEPC	 (Diethylpyrocarbonate)	 per	 1000	mL	 of	MilliQ	water	 and	mix	
thoroughly;	
• Let	the	DEPC-mixed	water	incubate	for	12	hours	at	37°C;	
• Autoclave	DEPC-mixed	water	for	15	minutes.	
